Annual Report • May 31, 2012
Annual Report
Open in ViewerOpens in native device viewer
This interactive pdf allows you to easily access the information that you want. Use the document controls located at the top of each page to navigate through the report and use the contents to jump straight to the section you require.
Overview
PZ Cussons is an international consumer products group. We develop leading brands in selected mature and emerging markets that have potential for future growth. World class supply chain and distribution networks in Africa, Asia and Europe enable us to deliver our brands quickly and efficiently to local consumers.
We are an entrepreneurial, international company, enhancing lives of consumers, with quality, value and innovation.
Financial highlights 2012
| Year ended | Year ended | ||
|---|---|---|---|
| Reported results (before exceptional items1 ) |
31 May 2012 | 31 May 2011 | % change |
| Revenue | £858.9m | £820.7m | 4.7% |
| Operating profit | £93.4m | £108.1m | (13.6%) |
| Profit before tax | £92.3m | £108.9m | (15.2%) |
| Adjusted basic earnings per share | 14.74p | 16.20p | (9.0%) |
| Statutory results | |||
| Operating profit | £49.6m | £107.3m | (53.8%) |
| Profit before tax | £48.5m | £108.1m | (55.1%) |
| Basic earnings per share | 8.03p | 16.48p | (51.3%) |
| Total dividend per share | 6.717p | 6.61p | 1.6% |
| Net (debt)/funds2 | (£17.9m) | £51.8m |
1 Exceptional items, totalling £43.8 million before tax, are detailed in note 3.
2 Net (debt)/funds, above and hereafter, is defined as cash, short-term deposits and current asset investments less borrowings (refer to note 18).
The Group delivered revenue growth despite challenging trading conditions. Profits were lower with a robust performance in the UK, strong trading in the Beauty division and positive momentum in Indonesia, more than offset by specific market challenges in Nigeria and Australia, and the impact of the largest year-on-year increase in raw material costs we have experienced.
Despite the external challenges, the Group remains committed to driving profitable growth through brand renovation and innovation, and through further cost reduction. During the year, underlying revenue growth continued across the business, particularly in the UK, in the Beauty division and in Indonesia. As we start the current financial year this momentum, together with our new Cussons Mum & Me and Fudge ranges, will help to ensure this growth continues.
Our exciting joint venture with Wilmar is on track with the Nigerian palm oil refinery due to be completed by the end of the calendar year.
At the same time, we are working actively to reduce our cost base, and the supply chain optimisation project announced in March will significantly reduce the overhead base of our manufacturing activities.
Our balance sheet remains strong with only a small net debt position and this gives us the capacity to pursue further investment opportunities which fit our strategic aims.
Clearly the world remains uncertain and volatile. However, consumer demand for high quality innovative products serving day to day needs continues, and we are well placed to serve
those needs with a strong distribution footprint in key geographic markets. Whilst the situation in the Group's important Nigerian market remains fragile, we are confident that the Group will return to profitable growth in the current financial year. Overall performance since the year-end has been in line with expectations.
Derek Lewis, who has served the Board as a Non-executive Director since 2004, has indicated his intention to retire with effect from the 2012 Annual General Meeting on 19 September. The Board would like to thank him for his significant contribution to PZ Cussons over the past eight years. Following Mr Lewis' retirement, James Steel, a Non-executive Director since 2005, will be appointed Senior Independent Director in his place.
I would like to take this opportunity to thank all of the Group's staff for their continued hard work and dedication. Their skill and commitment will be essential in maintaining our progress and is highly appreciated both by me and by the Board of Directors.
24 July 2012
As one of our strategic pillars, our team of over 7,000 CAN DO people embodies the core values that are firmly embedded in our culture and are integral to our success. It is this CAN DO culture that we believe is the unifying strength that binds together our diverse businesses around the world.
We work with people who share our unique CAN DO values. Our CAN DO culture is the unifying strength that binds together our diverse businesses around the world. We are responsible, demanding and have a sense of fun.
Our CAN DO values are:
We challenge convention, ourselves and each other. We have the strength, willingness and determination to initiate, make things happen and to carry them through.
We are all champions of our company. We take personal responsibility for achieving our objectives. We do what we say we shall do. We do what is right, not merely what is expected.
We act with openness, integrity and trust. We ask for help, admit to our mistakes and put things right.
We are one company across all functions and geographies. We work towards a common goal through co-operation and teamwork.
We are relentless in our pursuit of success. Together we approach each day with the energy, passion and persistence to exceed expectations.
We are all PZ Cussons people. We treat each other with respect regardless of status. We act professionally and together we celebrate our success with understated pride. We are quiet achievers.
The Directors present the Group's annual report and audited financial statements for the year ended 31 May 2012.
The Group delivered revenue growth of 4.7% for the year despite challenging trading conditions in a number of markets. Profits before tax and exceptional items were 15.2% lower than the previous year reflecting a robust performance in the UK, strong trading in the Beauty division and positive momentum in Indonesia, more than offset by the impact of three factors: approximately £25 million of increased costs from the significant year-on-year raw material cost inflation; a worsening environment in the Australian Home Care category; and the social and economic tensions in Nigeria.
In Africa, revenue growth in Nigeria was strong during the first half of the financial year but then affected by the social unrest in the north and the impact of the partial removal of the fuel duty subsidy in January. Raw material cost increases dented margins in the first half although these began to improve during the second half as a result of price increases and margin improvement initiatives.
In Asia, continued positive momentum delivered another year of revenue and profit growth in Indonesia although this was more than offset by lower results in Australia as well as tough trading conditions in Thailand and the Middle East.
In Europe, continued brand innovation and renovation contributed to a robust performance from the UK Washing and Bathing division despite competitive trading conditions. The Beauty division delivered a strong performance in its first full year as a separate entity as well as completing the acquisition of Fudge in January. Trading in Poland has been strong across both Home Care and Personal Care, whilst profitability in Greece is lower as a result of the domestic economic situation although the results are immaterial to the Group as a whole.
The overall impact of exchange rate movements in the year resulted in a decrease in Group revenue and profitability of circa £16 million and £2 million respectively.
The Group's balance sheet remains strong with a net debt position of £17.9 million at the year end despite higher working capital levels particularly in Nigeria.
Underlying capital expenditure continues to run at or below normal depreciation levels. Other key cash outflows during the year included £26.3 million for the acquisition of Fudge, £16.8 million for the investment in the Wilmar palm oil joint venture, £15.3 million for contributions to the closed UK final salary schemes including the de-risking exercise, and £8.6 million for the purchase of additional shares in our Nigerian listed subsidiary.
As part of the Group's supply chain strategy, and following a number of years of rising raw material costs together with significant ongoing wage inflation in emerging markets, the Group has been developing programmes to ensure that its supply chain cost base remains at a competitive level.
As a result, a major supply chain optimisation project was initiated in March and will continue to be implemented over the remainder of this financial year. This will significantly reduce the overhead footprint of the Group's manufacturing activities. There are two components to the project:
First, in order to move to a variable cost model for its developed market Home Care businesses, the Group is closing its manufacturing facilities in Australia with supply being moved to other Group facilities as well as to third parties, and is also reviewing its manufacturing facilities in Poland.
Second, the Group intends to reduce the supply chain overhead at a number of other manufacturing facilities. This includes closing its manufacturing facilities in Ghana, with supply being moved to third parties as well as to the Group's existing Nigerian facilities, in addition to other optimisation projects in Africa and Asia.
The total cash cost of these initiatives will be approximately £19.9 million for redundancy and other associated items, with payback expected within three years. There will be a further non-cash charge of approximately £19 million for asset write downs. These have been treated as exceptional charges with £27.5 million charged in the year to 31 May 2012 and the balance falling in the next financial year.
The benefits of this project will begin to be seen in the current financial year through lower supply chain overheads, the mitigation of the impact of further wage inflation and the avoidance of the high capital maintenance cost that would have been associated with any closed or restructured facilities.
A net exceptional charge of £43.8 million before tax was recorded during the year (2011: £0.8 million). The exceptional charge relates to the net effect of: the cost of the supply chain optimisation project (£27.5 million); the Beauty division's acquisition and integration costs (£6.3 million); the full impairment of one of our Australian Home Care brands (£9.7 million); and the pension scheme de-risking charge (£0.3 million).
Of the exceptional charge of £43.8 million, £17.7 million relates to cash and £26.1 million relates to non-cash items. The majority of the cash items will impact cash flow in the 12 months to 31 May 2013.
The effective tax rate before exceptional items was 27.0% (2011: 27.8%) and is lower principally due to decreased UK corporation tax rates.
The Company aims to pay an attractive, sustainable and growing dividend. The Board is recommending a maintained final dividend of 4.487p (2011: 4.487p) per share making a total of 6.717p (2011: 6.61p) per share for the year, a 1.6% increase and the 39th successive year of dividend increases. The overall dividend remains some 2.2 times covered by earnings per share before exceptional items. Subject to approval at the AGM, the final dividend will be paid on 1 October 2012 to shareholders on the register at the close of business on 17 August 2012.
The Group's three closed UK defined benefit schemes had a surplus position at 31 May 2012 of £8.9 million (2011: surplus of £2.8 million). The Group has continued its de-risking strategy, resulting in an exceptional charge before tax of £0.3 million (2011: £2.4 million). Further details are provided in note 23.
Across the Group, the focus remains on driving profitable growth through brand innovation and renovation, and through improving margins via further cost reduction initiatives. The major supply chain optimisation project, announced in March, is on track to significantly reduce the overhead footprint of the Group's manufacturing activities, and the benefits will be seen in the current financial year.
Whilst input costs have shown signs of short-term easing, they remain volatile and in some cases close to their highest levels.
The balance sheet remains strong with only a small net debt position and the Group is well placed to pursue further growth opportunities which fit its strategic aims.
Last year's underlying revenue growth across the business, particularly in the UK, in the Beauty division and in Indonesia, together with the new Cussons Mum & Me and Fudge ranges, have provided encouraging momentum into the current financial year. As a result, overall performance since the year-end has been in line with expectations.
Clearly the world remains uncertain and volatile. However, consumer demand for high quality innovative products serving day-to-day needs continues, and we are well placed to serve those needs with a strong distribution footprint in key geographic markets. Whilst the situation in the Group's important Nigerian market remains fragile, the Board is confident of a return to profitable growth in the current financial year.
Revenues have continued to increase this year despite social unrest in the north of Nigeria and the impact from the fuel duty subsidy reduction.
2008 2009 2010 2011 2012
Operating profit before exceptional items £m
Robb, one of Africa's leading brands in the medicaments category had a number of initiatives to sustain market leadership and enter new subcategories. Robb 'Super Intense' was relaunched as 'Hot Robb' with new packaging and a campaign with Nigeria's football Premier League. In addition, Robb Menthol sweets were launched into the market giving Robb access to the soothing throat drops segment.
To consolidate its position as a leading laundry care brand, Canoe, known for its laundry soap, launched Canoe detergent into the fabric care market at a premium to our Zip detergent brand. This introduction has the objective to increase our share of branded detergents with a premium offering to meet consumer fabric care needs.
The Indonesian Cussons Baby range has continued to grow whilst the Australian business has faced a number of challenges.
158.8
50
The Cussons Kids range continues to grow in Indonesia after prior year relaunches. The range has grown 32% year-on-year in a previously untapped market segment and is marketed in Indonesia as the trusted followon range of products to the successful Cussons Baby range. It has rejuvenated its packaging and product presentation. The characters on the Cussons Kids portfolio were developed to depict child role models allowing engagement with the consumers as well as their parents.
The Radiant Laundry range including detergent, powder and liquid was relaunched in Australia. Radiant Liquid unit dose capsules were the first 'advanced' liquid formulation product to be launched in the Australian market. Delivering premium performance and creating brand differentiation through stronger brand claim, the advanced range removes seven day dried in stains. Further extensions and a pack size renovation to the core liquid range is planned later this financial year to ensure brand relevance and penetration in the fast growing liquid segment.
2008 2009 2010 2011 2012
In Australia, the trading environment in the Home Care category worsened during the year as retailers devoted greater shelf space in store to private label products, resulting in branded suppliers having to trade with lower volumes and reduced margins. Revenue in Australia declined 27% resulting in the business moving from profit to loss for the year. Measures to address the underperformance of the Australian business have been under way for some months and are proving successful with the business moving back into profitability on a monthly basis towards the end of the financial year. These measures included moving to a variable cost model via the closure of the local manufacturing facility. Revenue and profitability of the Personal Care and Beauty portfolios grew year on year and these remain the focus growth areas for the future.
In Indonesia, the positive momentum has continued with another year of growth in revenue and profitability. The market leading Cussons Baby range has continued to grow through portfolio improvements and distribution expansion. Cussons Baby has clearly established itself as the number one brand in its segment with a market share significantly ahead of its closest competitor and is well placed to capitalise on the growth in the economy and a population of circa 240 million people. Other brands in the portfolio, namely Imperial Leather, Morning Fresh and Carex, have also performed well.
Of our smaller businesses within the Asian segment, revenue and profitability in Thailand were lower than the previous year as a result of disruption caused by the significant flooding that affected the country, whilst results in The Middle East were also adversely affected by social and political unrest in that region.
revenue growth of Cussons Baby range in 2012
Cussons Baby continues to grow significantly in Indonesia after the prior year relaunch. The range has grown 22% year-on-year, strengthening its market leading position in the Indonesian baby toiletries market, with products across five key categories (powder, bar soap, liquid soap, shampoo and cologne). The rejuvenated portfolio, offering more modern packaging and improved formulations is the trusted brand of choice and has benefited from a 360° activation campaign which creates consumer awareness via TV campaigns and social media based engagement between consumers and medical experts.
This commercial awareness has been converted into sales through a committed strong team of sales and promotional staff. Additionally, the growth is supported by a 15 strong network of depots allowing an effective distribution to the most challenging of Indonesian geographies reaching both traditional and modern outlets to achieve maximum penetration and speed to market. Geographic expansion has occurred in the Philippines and Vietnam, with a roll-out planned into China, Myanmar, Pakistan and Bangladesh during the latter part of this financial year.
The Group's strategy of continuing to renovate and innovate its brand portfolios has ensured market shares have continued to increase in Europe.
brand was refreshed with new contemporary graphics in its range of bar soaps and innovative 'Foamburst' shower product. The top-selling 'Limited Editions' products across shower gels and bath foams continued to offer consumers sensual fragrances and luxurious
relaunched with stronger packaging graphics, hard-hitting claims to further strengthen its point of difference and the line-up enhanced by new seasonal editions. In addition the brand was launched in Poland into the leading Rossmann drugstore chain.
'E', our leading Polish household brand, was rejuvenated this year with a major relaunch in detergent powders with the new 'E Soft Water Active Plus' range and new formulation and packaging in its fabric conditioner range. Significant market success was also driven by the 'Shine with E' consumer promotion that was a massive hit with consumers and trade customers alike.
Business review continued
The first year of the Beauty division has seen a strong performance combined with a new brand acquisition and product innovation across all ranges.
The St Tropez 'Self Tan Bronzing Mousse' is now the top skin finishing product in the US with significant category growth predicted next year. The St Tropez range has also now started distribution in ten Latin American countries. In the UK, strong innovation through new product launches such as 'Dark and Gradual Tan Plus' are helping maintain the number one market position St Tropez holds.
This is the first year of the separate Beauty division which has seen the merger of four brand cultures, teams, systems and operations. The division has performed well, both in the UK and overseas. There has been particularly strong growth from St Tropez in the United States where revenue increased 2.5 fold to £7.5 million. This has been delivered through distribution via Sephora US, launching in over 300 JC Penney Stores and extensive media coverage including QVC. St Tropez has also seen a number of significant new product launches including a dark tan product which is proving to be extremely popular. An exciting development for Sanctuary was the launch during the year of a new range of
skincare products called 'Active Reverse' with ballet star Darcey Bussell as brand ambassador. The Charles Worthington 'Salon at Home' range has achieved a step-change for the brand into a more premium differentiated offering. In January, the division acquired the Fudge hair-care brand for £26.3 million in cash. Fudge is a leading premium hair-care brand, sold predominantly through salon distribution in the UK, Australia and New Zealand.
Looking to the future, the division is planning to extend its geographical footprint further and sell a wider range of products within its existing geographies.
investment in Fudge hair-care brand
The Fudge hair-care brand was purchased from the Australian-based Sabre Group in January 2012 for £26.3 million. Established in 1991, Fudge is a leading premium hair-care brand sold predominantly through salon distribution in the UK, Australia and New Zealand. It is best known for its styling products including the popular 'Hair Shaper' product, although the large array of products includes two styling ranges, extreme colour ranges, a hair-care range and a professional salon support range. The brand's revenue contribution in 2012 for the four months since acquisition was £5 million and its sales are split approximately 50/50 between Europe and Australasia. During the year the Fudge brand was successfully integrated into the existing Beauty division.
On behalf of and in consultation with the Board of Directors, the Group Risk Committee is responsible for identifying, assessing and prioritising all material risks facing the Group and ensuring, where possible, that appropriate action is taken to manage and mitigate those risks. The table below highlights the major risks identified which may affect the Group's ability to deliver its strategy and the measures taken to address them.
| Risks | Description of risks | Measures to reduce the risks |
|---|---|---|
| Market risks | ||
| Political and economic stability |
The Group conducts a substantial proportion of its operations outside the UK in emerging markets which have significant capacity for profitable growth but which also have an increased risk of political and economic instability. |
The Group has a diverse geographic portfolio, however, in developing its corporate strategy and in order to help mitigate the risk that could arise in any one particular territory, the Board seeks to maintain an appropriate balance both between mature and emerging markets and, within the developing world, between its operations in different territories. In addition, the Group has extensive and long established experience in all key markets and the Board continually monitors those markets to ensure that any specific risks (or opportunities) may be identified and addressed as they arise. |
| Demand risks | Demand for the Group's products may be adversely impacted by changes in consumer preferences. The increasingly competitive environment and continued growth of discounters could adversely impact the rate of sales growth and profit margins. |
Extensive knowledge of the Group's selected markets is a core strategic pillar and the Group actively monitors the needs and aspirations of consumers on a regular and ongoing basis and is continuously developing new products to satisfy them. The Group will continue to invest in selected brands and selected markets in order to drive profitable sales growth. The Board believes that competition is healthy as it encourages and motivates the Group's operations across the world to do their best to serve the interests of consumers and our brands. |
| Raw materials | In common with other companies within its sector, the Group's profitability is affected by price and supply fluctuations in raw materials used in the manufacture of its products. Key items, such as oils and fats, packaging materials and energy are subject to fluctuations in price and availability. |
The Group takes measures to protect against the short-term impact of these fluctuations and shortfalls; however, failure to recover higher costs or shortfalls in availability could have a negative impact on profits. The Group continually monitors the price and availability of materials against forecast demand to ensure that there are adequate resources to continue in production throughout the world. The Group also continues to refine its raw material forecasting processes and to strengthen its procurement capabilities. |
| Risks | Description of risks | Measures to reduce the risks | |||||
|---|---|---|---|---|---|---|---|
| Financial risks | |||||||
| Foreign currency and treasury risk |
The international nature of the Group's activities gives rise to both transactional exchange rate risk (with the main exposure relating to US Dollar trade balances) and translation exposure when the results, assets and liabilities of foreign subsidiaries are translated into Sterling. |
The Group requires its operating units to hedge their material transaction exposures on sales and purchases conducted in currencies other than their functional currencies. The Group does not actively hedge its translation exposures as these are of an accounting rather than a cash nature; however, the international spread of the Group's operations itself reduces dependence on individual currencies. |
|||||
| The Group maintains a centralised treasury function which operates on a non-speculative basis in accordance with policies and procedures approved by the Board of Directors and reviewed during the year by the Board and the Audit Committee. The aim of this function is to mitigate the effects of any adverse movements in exchange rates and interest rates on the Group's financial results and support operating units in treasury matters. |
|||||||
| The current uncertainty over the Eurozone's economic outlook and Greece's future within the single currency is a risk given the Group has a Greek operating unit. If Greece was to leave the Eurozone, it is likely that any replacement currency would devalue against the Euro/Sterling and reduce: – the carrying value of the Group's investment in Minerva; – cash reserves in Minerva; and – future income streams when converted to Sterling. |
Throughout the Eurozone uncertainty the Group has ensured that surplus funds in Minerva have been repatriated to the UK parent company and held in Sterling. It is not possible for the Group to hedge against the risk of a devaluation in the carrying value of the Greek investment or the value of future income from Minerva if the Drachma is reinstated. Overall, the Group does not have a significant exposure to the Eurozone given the geographic spread of the operating units however, the Board will continue to closely monitor the situation in Greece in an attempt to minimise any potential impact. |
||||||
| Operational risks | |||||||
| Staff retention and recruitment |
The Group recognises that in order to deliver sustained strong results it requires the right calibre of people at all levels of the business. In particular, the Group must compete to recruit and retain capable individuals within the business including training them in the skills and competencies which are required to deliver profitable growth. |
The Board believes that there is an attractive employment proposition across the Group in place which will continue to attract capable recruits and that key management and personnel are sufficiently well recognised, incentivised and challenged in order to retain them as far as possible. |
|||||
| Reputation risks | Should the Group fail to meet high product safety, social, environmental and ethical standards in all operations and activities, its corporate reputation could be damaged, leading to the rejection of our products by consumers, damage to brands and diversion of management time into rebuilding our reputation. |
Product safety, social, environmental and ethical standards continue to be the cornerstones on which our business is based. They are key focus areas for the Corporate Social Responsibility Committee, a standing sub-committee of the Board. Should any issues arise in these areas, the Group has processes in place to enable a quick response. |
PZ Cussons Plc Annual Report & Accounts 2012
We are committed to conducting our business with integrity and with care in so far as the social and environmental impact of our activities is concerned.
At PZ Cussons we believe passionately in 'Doing Good Business'. It is something we have been doing for over 125 years and it is a key part of our culture and who we are. We are committed to conducting our business with integrity and with care in so far as the social and environmental impact of our activities is concerned. We aim to make a positive impact on society through the products which we sell, through the way in which our products are designed, manufactured and packaged and through the contributions we make to the communities in which we operate.
This report sets out the Group's values and principles in relation to key aspects of corporate social responsibility (CSR) and how these have been put into practice during the year. CSR describes how a business:
We consider the principles of CSR to be integral to how the Group conducts its operations and key to the results which the Group has delivered in the past and to its continued success and development in the future. In particular, we understand the potential benefits which may be derived where CSR activities are aligned to the concerns and demands of our stakeholders (including our shareholders, customers, consumers, suppliers, employees and the wider community) and we listen to and take account of those concerns in shaping our business strategies and practices. We also recognise that companies are subject to increasing regulation, particularly in respect of environmental issues, and we believe that the pursuit of a proactive and positive CSR policy reduces the risk of adverse regulatory action.
The Board is responsible for overseeing CSR within the Company, supported by a Corporate Social Responsibility Committee (CSR Committee).
The CSR Committee was established to ensure that the principles of CSR remain at the core of the Group's business activities. Reflecting the importance of CSR within the Group, each of the Directors is a member of the CSR Committee. Accordingly, the members of the CSR Committee are Simon Heale (Chairman), Richard Harvey, Alex Kanellis, Chris Davis, Brandon Leigh, John Pantelireis, Derek Lewis, John Arnold, James Steel and, with effect from their appointment to the Board in January 2012, Ngozi Edozien and Helen Owers. The Chairman of the CSR Committee reports to the Board on the Committee's proceedings after each meeting on all matters within the scope of its duties and responsibilities.
The terms of reference of the CSR Committee and further details regarding its members are available on the Company's website (www.pzcussons.com).
The CSR Committee and the Board have reviewed and endorsed this CSR report.
Our CSR values and principles are set out in a statement on Corporate Social Responsibility, called 'Doing Good Business'. The statement sets out 'The Big 6': the six principal areas in which our operations have the greatest potential to impact – either favourably or adversely – upon our stakeholders.
Recognising that doing the 'right thing' in business can sometimes seem to involve difficult decisions, the statement is intended to provide everyone throughout the Group and, at all levels within the business, with guidance on how to conduct their business activities and on what 'good business' looks like at PZ Cussons. It is also intended to motivate and support all our employees to identify and vigorously pursue opportunities across the Group to optimise our activities so far as their social and environmental impact is concerned. In doing so, it is the belief of the Board and the CSR Committee that we will make our business stronger, more sustainable and, as a consequence, more profitable.
To date we have already delivered some significant savings in carbon across our business:
In May 2012 our Kenyan factory successful installed and commissioned a five metric tonnes per hour Biomass fuelled boiler to provide steam and hot water for the factory, saving 1,273 metric tonnes of carbon per year, which equates to 65% of the Kenyan carbon footprint for 2011/12. The Biomass boiler burns organic waste which would otherwise have gone to landfill. By using this organic waste, we are able to put a waste crop to good use and avoid the burning of fossil fuels.
(1) (2) (3) (4)
The Company has continued its commitment to participate in the CDP. The CDP is an independent, not-for-profit organisation working to drive down greenhouse gas emissions and sustainable water use by businesses and cities. The CDP operates the only global climate change reporting system, gathering data on company strategies and performance with regard to carbon emissions and water use. As a business we have been participating in the CDP for the last four years with a continued commitment to reduce our carbon footprint. Currently we report on Scope 1 and Scope 2 emissions. We have an ambition to ultimately work to Scope 3 (which includes transportation and contract manufacturing activity) and hope to be able to measure our carbon impact within Scope 3 in the coming years.
Packaging not only consumes global resources but also generates waste once our consumers have used the product. Whilst we recognise that eliminating packaging is not a realistic target, it is our ambition to reduce the amount of packaging which we use in our products and we also encourage our consumers to reuse and recycle.
In order to meet our targets for the coming years, we will optimise existing packaging formats through light weighting, optimising structural and material design and eliminating unnecessary packaging materials, while also ensuring that a 'right by design' philosophy is used for all future packaging initiatives.
Packaging reduction projects that we have delivered include;
– Our operating unit in Greece has successfully light weighted their range of tubs used for Feta cheese and Benecol white cheese sold under the Horio and Benecol brand respectively. They have also light weighted their two litre PET bottles used for our Horio, Minerva and Mana brands of Extra Virgin Olive Oils, Olive Pomace oils, Corn oil, Sunflower oil and Niki Fry seed oil. In total, these projects have successfully saved 19.8 metric tonnes of plastic
– In the UK, work has concluded on reducing the weight of our Morning Fresh 450ml, Imperial Leather Handwash 300ml and Carex Handwash 333ml bottles and we will be starting production at the end of July 2012. The light weighting has enabled us to reduce the amount of plastic we buy by 139 metric tonnes. We have identified further savings to implement in the coming years
Waste can have a significant impact on the environment, whether it is solid waste sent to landfill, burnt, or effluent. We recognise that wastage occurs through our manufacturing processes whether in the form of packaging from incoming goods, non-conforming products which require disposal or water used for cleaning our plant at the end of production. By striving to reduce the level of waste we generate we can have a positive impact on the environment by reducing the levels of natural resources which we consume and the solid waste which goes to landfill. This also delivers significant financial savings for the business.
Total waste for disposal is our key management measure to ensure that we reduce the level of waste which we generate. The total waste figure which we consider comprises of solid waste, including waste which is recycled, plus the strength of effluent as measured by Chemical Oxygen Demand (COD). As our aim is to ultimately eliminate waste generated, we have included recycled waste to help drive a culture of elimination of waste rather than one of recycling. We recognise a zero waste culture is an ambitious one; however, we will continue to encourage and support finding secondary uses or recycling of waste in a responsible manner to avoid sending waste to landfill and would expect to see a shift in the percentages of waste recycled or reused versus that which is sent to landfill.
We have just started our journey on delivering against our waste target and so far our operating unit in Poland has successfully implemented a project to reduce the amount of waste water discharged into the public drainage system by 40,800m3 by separating water which is used for cooling from water which is used in the manufacture of our products. The business has also installed a treatment plant for effluent generated during the manufacturing of our personal wash products. This effluent plant has enabled us to reduce the waste sent to a specialist treatment contractor by 30%.
Water scarcity is an increasing threat to the world's population and it has been estimated that by the year 2025 two thirds of the world's population could be facing serious water shortages. We also recognise that we operate in regions which are defined as water scarce, water stressed or water vulnerable (as defined by the United Nations) and that consequently we play a role in ensuring that water resources are used in an efficient and responsible way.
A large part of the water footprint of our products is associated with our consumers' use of our washing and bathing products and, if we are to do all we can to reduce water usage, we will not only need to focus on the water footprint of our manufacturing processes but also on that of our consumers. However, we are at the start of our journey and so will initially only focus on the volume of water which we directly abstract during the manufacturing process, including water which is extracted for cooling, even if it is returned to water courses after use.
In December 2010, we announced the expansion of our Food and Nutrition operations in Nigeria through the establishment of a food ingredients joint venture with Singapore based Wilmar International Limited, one of Asia's leading agribusiness groups.
Palm oil is an integral part of Nigerian culture and cuisine. However, the Nigerian palm industry, once a world leader, has declined in recent decades and the country is currently in a net deficit position of production versus demand. Domestic product is often produced in unhygienic conditions and widely sold in discarded second-hand water bottles.
One of the largest single agro-investments in Nigeria, our PZ Wilmar business is committed to helping to rejuvenate Nigeria's palm oil industry from 'plantation to plate' by:
There are a number of benefits for Nigeria and its people:
Palm oil is indigenous to Nigeria and therefore it does not compete against local food crops or vegetation. The establishment of local plantations also fits our Group commitment to use raw materials from sustainable and environmentally friendly sources.
sustainable forest management practises are used. As stated above, we are already focusing on reducing the amount of packaging and anticipate that this will also include the weight of wood pulp which we consume.
PZ Cussons participates annually in the Forest Footprint Disclosure (FFD) project. This is a special project of the Global Canopy Foundation, initiated in 2008. The FFD engages with private sector companies in respect of disclosure of their current understanding of their 'forest footprint' based on exposure to five key commodities – soy, palm oil, timber, cattle products and biofuels. We report on our use of palm oil and on the timber sectors of the FDD.
Our participation in the FDD has improved corporate awareness of the issues around the maintenance of tropical forests resources in developing countries and has led us to start to assess our supply chain in order to establish targets for use of certified sustainable palm oil, for sourcing sustainable wood pulp fibre and to drive a reduction in consumption.
As this is a new focus area for us we have just started to identify opportunities to make savings in our water consumption.
Palm oil is the most widely traded vegetable oil in the world and is used in many food and household products. Over 85% of the world's palm oil comes from Indonesia and Malaysia, where land is sometimes cleared of forest for palm plantations, resulting in greenhouse gas emissions, and a loss of wildlife habitat. In common with our competitors, certain parts of our businesses utilise palm oil and we share the concerns of our consumers and other stakeholders in relation to palm oil sourcing, end use and the potential for damage to the environment.
In recognition of these concerns, PZ Cussons committed to membership of the Round table for Sustainable Palm Oil (RSPO) in 2010. The RSPO, which was formed in 2004, is a not-for-profit association which unites members from across all sectors of the palm oil industry (including oil palm producers, traders, consumer goods manufacturers, retailers, banks and investors and NGOs and pressure groups) with the objective of promoting the growth and use of sustainable palm oil products through credible global standards and engagement of stakeholders. PZ Cussons is committed to promoting and communicating RSPO values across our supply chain and has committed to move to 100% Certified Sustainable Palm Oil via the use of RSPO approved supply chain mechanisms by 31 May 2015.
PZ Cussons uses wood pulp for labels to put onto our bottles and packages, in boxes for our products and in corrugated boxes and trays used for transporting our products from our factories to our customers. Though we do not directly buy wood pulp or own or manage forests, we recognise that we have a responsibility to ensure that the products which we procure are from sustainable sources and minimise our requirements for wood pulp. We have just started our journey to improve our understanding of wood pulp fibre, drive transparency in sourcing, and ensure that
Our technical teams actively work with industry associations and regulatory bodies to ensure we are aware of legislative requirements and work proactively to help shape the industry response to managing future issues. Where necessary, we use specialist expertise, such as Toxicologists, as part of the product safety assessments.
We apply the same standards to consumer safety whether our products are developed and manufactured in our own factories or externally sourced.
All products designed for the European and Asian market are developed to meet the requirements of the EU Cosmetics Directive and products designed for Africa will do so by July 2013. The EU Cosmetics Directive represents the highest safety standard and requires a detailed Cosmetic Product Safety Report to be done for every product before being placed on the market.
Personal Care Centre, Agecroft Laboratories, UK
We have established a senior level steering team to guide and direct our approach to consumer safety and policy deployment. This team will ensure a common Group approach is adopted and that actions are implemented swiftly in all parts of the business. The team will meet quarterly and be advised by experienced functional heads from around the Group.
We have adopted a Group 'Materials of Concern' list which formalises our approach to material selection and acts as the vehicle for communication around the Group. Where there are reasonable grounds for concern on consumer safety or environmental impact, we will adopt a cautionary approach and materials may be restricted or prohibited ahead of any legislation being put in place. We recognise that many of these issues are complex and the following factors will be considered before any action is taken:
The 'Materials of Concern' will be regularly reviewed by the Consumer Safety Steering Team and decisions to impose restrictions will be ratified by it.
Managing performance at PZ Cussons is more than just a set of activities and forms. It is an everyday way of working to improve performance by taking action to coach and motivate our people. We measure performance based on business objectives aligned to team, function, operating unit and global business strategies in conjunction with behaviours assessed against key competencies. Together these provide a rating which is linked to reward and to our global talent and succession planning activity. This enables us to develop and motivate high performing and high potential individuals providing them with challenging and exciting careers. Our performance development and review programmes have now been rolled out globally and have been in place for two years.
As an ongoing commitment to personal development and developing the Research and Development (R&D) capability in the African businesses, members of the R&D team in Nigeria and Kenya have successfully attained a Diploma in Cosmetic Science from the UK Society of Cosmetic Scientists through a distance learning programme. The course is recognised by the Royal Society of Chemistry and is endorsed by the Cosmetic, Toiletry and Perfumery Association (CTPA). The Diploma course gives an excellent grounding in cosmetic science, including modules on formulation development, quality and product testing.
We are committed to the training and development of our employees and have delivered more than 200 training courses across the globe in our operating units. The training courses are a combination of management competency and technical skills training and have included:
PZ Cussons is an extremely diverse organisation in terms of its ethnic and cultural make-up and this is something that we continue to promote. We employ many different nationalities including Indian, Chinese, Polish, Indonesian, Thai, Greek, Australian, Nigerian, Ghanaian, Kenyan and British. We also value diversity in respect of gender and age:
30% 42% Women employees
19.6%
Employees with over 15 years' service
Women senior managers
Employees over 50
We do not employ any person below the local legal working age and we will not, in any circumstances, employ anyone below the age of 16.
29 PZ Cussons Plc Annual Report & Accounts 2012
In the UK, both the operating unit and head office employees were busy supporting local charities with a variety of activities:
UK
PZ Cussons has been working with Salford Academy for several years to offer pupils different opportunities to learn life and work skills. This year we worked with students on how to make a profitable shampoo which the students could sell in school to raise money. This project covered Maths, English, Science, ICT, Citizenship and also taught them about careers and communication skills. Students learnt responsibility, communication skills and the value of teamwork.
The Seashell Trust is a residential special school based in Manchester supporting children and young people with sensory impairments and profound learning and communication difficulties. The Trust and PZ Cussons have now been working together for two years on research to investigate and evaluate how olfaction might affect and support the development of communication of students with multi-sensory impairment. The project has been looking at how bespoke fragrances can improve a child's understanding and communication including the ability of these children to make choices. For example, simple choices such as food or drink based on smell have now been successfully introduced into the curriculum. Further research has also taken place, and ia aimed at enhancing multi-sensory experiences for students such as releasing the scent of burning wood at Bonfire Night celebrations. The work has attracted international interest from America and Denmark and we are currently evaluating how the project might be extended to assist dementia sufferers.
Our operating unit in Poland established the Carex Clean Hands Academy in 2011 with the objective to reach 11,000 schools to educate elementary and middle school children on hand hygiene. The programme is in its second year and continues to offer educational materials for schools, to run demonstrations from medical experts and competitions for children
Our employees in Greece have supported the municipalities of Schimatari, Snt Dimitrios (Ioannina) and Andravida by providing poor and homeless people with a charity food bank.
Thailand and Indonesia, where two of our businesses are located, were affected by natural disasters during the year. Our factory in Thailand was only protected from flooding by the extraordinary efforts of our employees who, working around the clock to help strengthen the site flood defences, were able to keep the flood waters at bay when most neighbouring facilities were under water. The Board would like to say a special thank you to all of those employees for their amazing efforts.
Up to 50 of our employees were directly affected by the flooding and so our facility became their home. Offices were converted to provide basic living facilities including food, clean water and laundry facilities and a People Centre was set up to provide support for all our employees including health education and health screening at a time of increased risk of infection. Indonesia also suffered severe flooding in parts of the country. Employees in our operating units were generous in fundraising to help colleagues affected by the flooding, which enabled, with the support of the business, the distribution of 'flood survival' packs to all employees, financial support and access to loans. Local schools impacted by the flood were also supported with donations and survival bags.
Mr Kanellis has a Phd in mechanical engineering. He joined PZ Cussons in 1993. He was appointed Managing Director of the Group's business in Thailand in 1998 before becoming Managing Director of Indonesia in 2001. He was appointed to the Board in 2003 as Regional Director of Asia before becoming Chief Executive in June 2006. Mr Kanellis is a member of the Nomination, Group Risk and CSR Committees.
After working in senior Sales and Marketing roles for various consumer goods companies, Mr Davis joined PZ Cussons from the BTR Nylex Group in 1993 and became Managing Director of the Group's business in Australia in 2001. He was appointed to the Board in 2006 as Regional Director of Africa and became Group Commercial Director in 2008. Mr Davis is a member of the Group Risk and CSR Committees.
Mr Leigh qualified as a chartered accountant with Deloitte & Touche in 1996. He joined PZ Cussons in 1997 and was appointed to the Board as Group Finance Director in 2006. Mr Leigh is a member of the Group Risk and CSR Committees.
Mr Pantelireis was appointed an Executive Director of PZ Cussons in 2005 and is a member of the Group Risk and CSR Committees. He has worked in a variety of senior positions for PZ Cussons both in Nigeria and the UK and spent three years as Supply Chain Development Director prior to his appointment to the Board.
Mr Harvey was appointed a Non-executive Director of PZ Cussons Plc in January 2010 and took up the position of Chairman on 1 July 2010. A Fellow of the Institute of Actuaries, Mr Harvey became Group Chief Executive Officer of Norwich Union Plc in 1998 and subsequently Group Chief Executive of Aviva Plc, initially branded CGNU, after the merger of Norwich Union with CGU. He has worked extensively overseas in both mature and emerging markets and was Chair of the Association of British Insurers from 2003/05. Since retiring from Aviva Plc in 2007, Mr Harvey has spent time in Africa supporting charitable initiatives and has also worked on other projects to accelerate business development in Africa, including work for the Africa Progress Panel and the World Bank. He is a Non-executive Director of Jardine Lloyd Thompson Plc. Mr Harvey is the Chairman of the Nomination Committee and a member of the Group Risk and CSR Committees.
Mr Lewis has been a Non-executive Director of PZ Cussons Plc since June 2004. A retired solicitor and former partner of Addleshaw Goddard LLP, Mr Lewis specialised throughout his professional career in advising on corporate and commercial matters. Mr Lewis is the Senior Non-executive Director and a member of the Nomination, Remuneration, Audit, Group Risk and CSR Committees. After eight years' service to the Board, Mr Lewis will retire with effect from the 2012 Annual General Meeting.
Professor Arnold is Emeritus Professor of Accounting and Financial Management at Manchester Business School and has been a Non-executive Director of PZ Cussons Plc since January 2007. A chartered accountant, his previous experience includes spending 12 years as Director and Dean of Manchester Business School. Professor Arnold is currently Chairman of the Co-operative Performance Committee of Co-operatives UK, a member of the Council of the Greater Manchester Chamber, Chairman of Feelgood Theatre Productions and an academic advisor to Ashridge and to IBS-ISCTE Business School in Lisbon. Professor Arnold is Chairman of the Audit Committee and the Group Risk Committee and a member of the Nomination, Remuneration and CSR Committees.
Ms Edozien was appointed a Non-executive Director of PZ Cussons Plc in January 2012. She is Chief Executive, West Africa at Actis, a leading private equity investor in emerging markets, where she is responsible for all aspects of the Company's business in the region. Prior to joining Actis, Ms Edozien was VP Strategic Planning and Business Development for Pfizer Inc based in New York. She was transferred to Nigeria in 2005 to run Pfizer's businesses in East, West and Central Africa, before being appointed in 2008 as Chief Executive of the Equity Vehicle for Health in Africa, an investment company focused on investing in private healthcare businesses in the continent. She has a background in strategic consulting, having spent seven years with McKinsey & Co, working principally in the consumer products and healthcare sectors. A US/Nigerian citizen, she was educated in the United States at Harvard University and started her career in corporate finance at JP Morgan. She is a Non-executive Director of Diamond Bank Plc, a company listed on the Nigerian Stock Exchange. Ms Edozien is a member of the Nomination, Remuneration, Audit, Group Risk and CSR Committees.
Mr Heale was appointed a Non-executive Director of PZ Cussons Plc in January 2008 and is Chairman of the CSR Committee and a member of the Nomination, Remuneration, Audit and Group Risk Committees. A chartered accountant, Mr Heale has worked in a variety of senior positions for multi-national companies in America and the Far East and spent five years as Chief Executive of the London Metal Exchange. Mr Heale is a Non-executive Director of The Morgan Crucible Company Ltd, Kazakhmys Plc and Marex Spectron, Senior Non-executive Director of Coats Plc and a trustee and the treasurer of Macmillan Cancer Support.
Mrs Owers was appointed a Non-executive Director of PZ Cussons Plc in January 2012. Until recently she was Chief Development Officer for Thomson Reuters Professional, with responsibility for the company's expansion in rapidly developing economies, and she continues to provide consultancy services to the Thomson Reuters group. She played an important role in the development of the company's digital strategy and, as President of Global Businesses for Thomson Reuters Legal, she built new businesses in a number of emerging markets, balancing local consumer insights and needs with the globalisation of the business and key products. Before joining Thomson Reuters, Mrs Owers worked as a consultant with Gemini Consulting, developing and implementing corporate and operational strategies for a number of consumer products clients. Mrs Owers is a member of the Nomination, Remuneration, Audit, Group Risk and CSR Committees.
Mr Steel has been a Non-executive Director of PZ Cussons Plc since October 2005. After qualifying as a chartered accountant with Price Waterhouse he became a corporate financier and worked for Schroders, Citigroup and Arbuthnot Securities in a variety of positions both in the UK and overseas. He is a trustee of Independent Age. Mr Steel is Chairman of the Remuneration Committee and a member of the Nomination, Audit, Group Risk and CSR Committees. Following Mr Lewis' retirement with effect from 19 September 2012, Mr Steel will be appointed Senior Independent Director.
The Non-executive Directors do not have service contracts. Details of the letter of engagement relating to each are set out under the heading 'Service Contracts' within the Report on Directors' remuneration.
Under the Company's present Articles of Association, all Directors are subject to annual re-election by shareholders. Each of the Directors will retire immediately prior to the 2012 Annual General Meeting and, with the exception of Mr Lewis who is retiring from the Board, each, being eligible, will offer himself or herself for re-election at the meeting.
The evaluation of the Board, as reported within the Corporate governance report, concluded that each of the Directors continues to demonstrate effectiveness and commitment to his or her particular role and the re-election of each is accordingly recommended by the Board.
The principal activities of the Group are the manufacture and distribution of soaps, detergents, toiletries, beauty products, pharmaceuticals, electrical goods, edible oils, fats and spreads and nutritional products. The subsidiary undertakings and joint ventures principally affecting the profits, liabilities or assets of the Group are listed in note 31 of the consolidated financial statements.
The principal activity of the Company is a holding company.
A summary of the Group's results for the year is set out in the Financial review on pages 8 to 9 of the Annual Report.
The Directors recommend a final dividend of 4.487p (2011:4.487p) per Ordinary Share to be paid on 1 October 2012 to Ordinary Shareholders on the register at the close of business on 17 August 2012 which, together with the interim dividend of 2.23p (2011: 2.123p) paid on 2 April 2012, makes a total of 6.717p for the year (2011: 6.61p).
Executive Directors: Alex Kanellis – Group Chief Executive Chris Davis – Commercial Director
Brandon Leigh – Group Finance Director John Pantelireis – Supply Chain Director
Richard Harvey Derek Lewis Professor John Arnold Ngozi Edozien Simon Heale Helen Owers James Steel
The Directors' interests in the share capital of the Company at 31 May 2012 together with their interests at 1 June 2011 are detailed below:
| Ordinary Shares | ||
|---|---|---|
| 2012 Number |
2011 Number |
|
| Beneficial | ||
| Mr R Harvey | 33,206 | 18,360 |
| Mr G A Kanellis | 409,340 | 282,510 |
| Prof J A Arnold | 13,450 | 13,450 |
| Mr C G Davis | 258,515 | 180,899 |
| Ms N Edozien | – | – |
| Mr S J N Heale | 8,000 | 8,000 |
| Mr B H Leigh | 86,022 | 74,828 |
| Mr D W Lewis | 45,000 | 40,000 |
| Mrs H Owers | – | – |
| Mr J Pantelireis | 181,340 | 109,244 |
| Mr J T J Steel | 37,500 | 37,500 |
| Total | 1,072,373 | 764,791 |
1 The figures in the tables do not include 334,856 (2011: 1,334,578) Ordinary Shares held by the Employee Share Option Trust (ESOT) at 31 May 2012. The ESOT is a discretionary trust under which the class of beneficiaries who may benefit comprises certain employees and former employees of the Company and its subsidiaries including members of such employees and former employees' immediate families. Some or all of the shares held in the ESOT may be the subject of awards to Executive Directors of the Company under the PZ Cussons Plc Deferred Annual Share Bonus Scheme, the PZ Cussons Plc Executive Share Option Scheme and/or the PZ Cussons Plc Performance Share Plan, details of each of which are given in the Report on Directors' remuneration. Accordingly, those Executive Directors are included in the class of beneficiaries and are deemed to have a beneficial interest in all the shares acquired by the ESOT.
2 The figures in the tables do not include options granted over Ordinary Shares under the PZ Cussons Plc Executive Share Option Scheme, conditional shares granted under the PZ Cussons Plc Performance Share Plan or deferred shares granted (but not yet transferred to participants) under the PZ Cussons Plc Deferred Annual Share Bonus Scheme as at 31 May 2012.
There have been no changes in the interests of any of the Directors between 31 May 2012 and the date of this report save that Mr Harvey purchased on 30 June 2012 an additional 3,870 shares pursuant to a trading plan. The register recording the Directors' interests will be open for inspection at the 2012 Annual General Meeting. No Director had any beneficial interest during the year in shares or debentures of any subsidiary company. Save for their service contracts or letters of appointment, there were no contracts of significance subsisting during or at the end of the financial year with the Company or any of its subsidiaries in which a Director of the Company was materially interested.
During the year and up to the date of the report, the Company maintained liability insurance for its Directors and officers and pension fund trustee liability insurance for Mr Kanellis, Mr Davis, Mr Leigh and Mr Pantelireis in their capacity as trustees of certain of the Group's pension funds.
The register maintained by the Company under section 808 of the Companies Act 2006 disclosed the following interests in the shares of the Company held at 24 July 2012:
| Number of shares | % | |
|---|---|---|
| J B Zochonis | 60,619,580 | 14.14 |
| Zochonis Charitable Trust | 49,860,040 | 11.63 |
| M&G | 47,232,219 | 11.01 |
| Mrs C M Green Settlement | 20,328,280 | 4.74 |
| J B Zochonis Settlement | 19,927,130 | 4.65 |
No shares were issued during the year. Further information about the Company's share capital is given in note 24 of the consolidated financial statements.
Derek Lewis, who has served the Board as a Non-executive Director since 2004, has indicated his intention to retire with effect from the 2012 Annual General Meeting on 19 September. Following Mr Lewis' retirement, James Steel, a Non-executive Director since 2005, will be appointed Senior Independent Director in his place.
Charitable contributions in the United Kingdom during the year amounted to £253,000 (2011: £183,000). No political contributions were made (2011: nil).
The Group maintains in-house facilities for research and development in the United Kingdom, Poland, Indonesia, West Africa and Australia; in addition, research and development is sub-contracted to approved external organisations. Currently all such expenditure is charged against profit in the year in which it is incurred as it does not meet the criteria for capitalisation under IAS 38 'Intangible assets'.
The Group does not follow any code or statement on payment practice. It is the responsibility of the management of each operating unit within the Group to agree appropriate terms of business with suppliers upon entering into binding contracts and to adhere to these payment terms provided the relevant goods or services have been supplied in accordance with contractual obligations. The creditor days are disclosed in note 19 of the consolidated financial statements.
During the year the Group has maintained its policy of providing equal opportunities for the appropriate employment, training and development of disabled persons. Further information regarding the Company's policies in this respect are set out within the report on page 93.
The Group recognises the benefits of keeping employees informed of the progress of the business and of involving them in their company's performance. The methods of achieving such involvement are different in each company and country and have been developed over the years by local management working with local employees in ways which suit their particular needs and environment, with the active encouragement of the parent organisation.
PricewaterhouseCoopers LLP has signified its willingness to continue in office as Auditor to the Company and, in accordance with section 485 of the Companies Act 2006, a resolution for its appointment will be proposed at the forthcoming Annual General Meeting.
continued
A review of the functional performance of the Group is provided on pages 10 to 17.
The Group's business activities, financial condition, results of operations could be affected by a variety of risks or uncertainties. These are summarised in the Principal risks and uncertainties section on pages 18 to 19.
The Group's statement on corporate governance can be found in the Corporate governance report on pages 44 to 48 of these financial statements. The Corporate governance report forms part of this Report of the Directors and is incorporated by cross reference.
The Company's 2012 Annual General Meeting will be held at the Company's Registered Office, Manchester Business Park, 3500 Aviator Way, Manchester M22 5TG at 10.30am on 19 September 2012. The resolutions which will be proposed at the 2012 Annual General Meeting are set out in the separate Notice of Annual General Meeting which accompanies this Annual Report and Financial Statements.
As at 31 May 2012, the Company's issued share capital consisted of 428,724,960 Ordinary Shares of 1p each.
Subject to applicable statutes and other shareholders' rights, shares may be issued with such rights and restrictions as the Company may by ordinary resolution decide, or, if there is no such resolution or so far as it does not make specific provision, as the Board may decide.
Unless the Board decides otherwise, no member shall be entitled to vote at any meeting in respect of any shares held by that member if any call or other sum which is then payable by that member in respect of that share remains unpaid.
Subject to the Company's Memorandum and Articles of Association, the Companies Acts and any directions given by special resolution, the business of the Company will be managed by the Board who may exercise all the powers of the Company.
Pursuant to shareholder approval given at the 2011 Annual General Meeting, the Company is authorised to make market purchases of its own Ordinary Shares. The Directors intend to seek renewal of this authority at future Annual General Meetings including the 2012 Annual General Meeting. No shares were purchased from 1 June 2011 to 24 July 2012 (2011: nil) (other than the acquisitions undertaken by the ESOT (see note 25)).
There are no restrictions on the transfer of securities in the Company except:
In the case of each of the persons who were Directors of the Company at the date when this report was approved:
This information is given and should be interpreted in accordance with the provision of section 418(2) of the Companies Act 2006.
By order of the Board of Directors
Mr S P Plant Company Secretary 24 July 2012
The Remuneration Committee is responsible for overseeing the remuneration of the Executive Directors and the Chairman. It is also responsible for the operation of senior management incentive schemes throughout the Group. In designing an appropriate incentive structure, the Committee seeks to set challenging targets aimed at the generation of sustained shareholder value.
During the year, the Committee made a number of key decisions:
I hope you will find the Directors' remuneration report clear, transparent and informative. As always, we remain committed to ongoing dialogue with our shareholders and take an active interest in your views and voting on the remuneration report.
This report on Directors' remuneration has been prepared in accordance with the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008 and satisfies the requirements of the Listing Rules of the Financial Services Authority. A resolution to approve the report will be proposed at the 2012 Annual General Meeting.
The information on pages 41 to 43 relating to Directors' interests in shares under incentive arrangements, remuneration during the year ended 31 May 2012 and Directors' pension benefits constitutes audited information.
The Remuneration Committee of the Board (the Committee) is responsible for determining and agreeing with the Board the remuneration policy for Executive Directors. The Committee is also responsible for determining within such policy the remuneration packages of individual Executive Directors, for determining the remuneration packages of the Chairman and the Company Secretary and for approving the design and operation of all incentive schemes for the Executive Directors and senior management. The Committee meets at least twice a year and met on five occasions during the year ended 31 May 2012. The Committee's current Terms of Reference, which are reviewed annually and were last revised in March 2012, are available on the Company's website (www.pzcussons.com).
The members of the Committee during the year were Mr Steel (Committee Chairman), Professor Arnold, Mr Heale, Mr Lewis and, with effect from their appointment on 1 January 2012, Ms Edozien and Mrs Owers. Each is a Non-executive Director of the Company and all are independent of management and have no conflicts of interest or any day-to-day involvement in running the business. The remuneration of the Non-executive Directors (with the exception of Mr Harvey as Non-executive Chairman) is determined by the Board of Directors. No Director is involved in any decisions on the level and composition of his own remuneration.
The Committee was advised generally in relation to Directors' remuneration during the year by Deloitte LLP. Deloitte LLP has also provided tax advisory services to the Group. During the year, the Committee consulted Mr Harvey (in his capacity as Chairman) on issues where his experience and knowledge have been of benefit to its deliberations and Mr Harvey attended meetings by invitation. The Chief Executive has also been consulted on proposals relating to the remuneration of members of the Group's senior management team and he too attended meetings by invitation. Neither Mr Harvey nor the Chief Executive attend when the matters under consideration concern their own personal remuneration. The Global Human Resources Director also attended meetings by invitation. The Company Secretary acts as Secretary to the Committee and attends Committee meetings (save where his own remuneration is under consideration).
continued
The Group's policy is that the remuneration arrangements for Executive Directors should:
The following table summarises the key elements of the Executive Directors' current remuneration packages:
| Element | Commentary |
|---|---|
| Salary and benefits | Basic salary varies by individual and will increase by 4% with effect from 1 September 2012. Benefits include life assurance, health insurance and car benefits |
| Pension benefits | Company contribution of 20% of salary to a defined contribution pension scheme (or receipt of cash in lieu). Membership of a defined benefit pension scheme closed to further accrual since 2008 but with a continuing salary linkage until 31 May 2013 |
| Annual bonus | Maximum opportunity of 100% of salary (with 60% of salary payable for on-target performance), dependent upon profit before taxation, net working capital and operating contribution targets |
| Performance Share Plan | Annual awards of rights over shares worth 100% of salary, with 25% vesting for growth in adjusted earnings per share of RPI+4% per annum rising pro rata to 100% vesting for growth in adjusted earnings per share of RPI+10% per annum, in each case compounded over a three year performance period |
| Shareholding guidelines | Requirement over time to build up interests in the Company's shares worth 150% of salary and to reinvest half of any after-tax bonus or gain arising from share incentive plans until the guideline is met |
| Service contracts | One year rolling service contracts |
In designing an appropriate incentive structure for the Executive Directors and other senior management, the Committee seeks to set challenging performance criteria which are aligned with the Group's business strategy and the enhancement of sustained shareholder value. The Committee is also mindful of the need to avoid inadvertently encouraging risky or irresponsible behaviour including behaviour which could raise environmental, social or governance issues.
The Committee receives updates from the Global Human Resources Director on pay and employment conditions applying to other Group employees; these are taken into consideration when setting Executive Directors' remuneration, consistent with the Group's general aim of seeking to reward all employees fairly according to the nature of their role, their performance and market forces.
The Committee believes that an appropriate proportion of the executive remuneration package should be variable and performancerelated in order to encourage and reward superior corporate and individual performance. The following chart illustrates the balance between fixed and variable remuneration for Executive Directors, based on the policy for 2012/13:
| Target | 49% | 10% | 29% | 12% | |||
|---|---|---|---|---|---|---|---|
| Maximum | 31% | 6% | 31% | 31% | |||
| Salary | Pension Bonus |
Performance Share Plan |
Executive Directors' salaries are normally reviewed annually with effect from 1 September to ensure the ongoing effectiveness of remuneration arrangements. Reviews take account of various factors including individual performance, remuneration levels in companies of similar size and complexity and pay conditions elsewhere in the Group.
In 2011 the Committee undertook a benchmarking review with advice and assistance from Deloitte LLP which indicated that Executive Directors' remuneration packages had fallen below market competitive levels. The Committee concluded that an overall salary increase of 12% was required but, recognising the continuing sensitivity over executive pay and the need for restraint, determined to phase this salary increase over two years, limiting the increase in 2011 to 6% with the balance expected to become effective from 1 September 2012 if still considered appropriate at that time.
Whilst updated benchmarking indicates that an additional 6% increase in 2012 remains reasonable, the Committee has decided to restrict this year's increase in basic salaries to 4% in view of the performance achieved during the year and the general pay and conditions applying to other Group employees. The increase will take effect on 1 September 2012 and the position will be reviewed again next year. Other elements of the Executive Directors' remuneration packages remain unchanged.
Details of the Executive Directors' revised salaries (effective from 1 September 2012) are set out in the notes to the table on Directors' remuneration on page 42.
Taxable benefits, which are subject to periodic review, include life assurance, health insurance and car benefits.
Since 1 June 2008 Executive Directors have participated in a defined contribution pension scheme under which the Group pays a contribution of 20% of salary into the scheme on their behalf subject to a minimum employee contribution of 5% of salary. Executive Directors whose pension benefits have exceeded or are forecast to exceed the annual or life time allowances established by HM Revenue & Customs are eligible, at the discretion of the Committee, to receive a cash payment of 20% of salary in lieu of employer pension contributions.
Up to 31 May 2008 Executive Directors participated in a defined benefit pension scheme which provided benefits of up to two thirds of final salary subject to a scheme-specific earnings cap. With effect from 1 June 2008 no further benefits accrue under the defined benefit scheme although the benefits payable will remain linked to salary until 31 May 2013 in line with arrangements pertaining to all members of the scheme when it was closed to future accrual. Further detail on Executive Directors' benefits under the defined benefit pension scheme are set out in the table on page 43.
Executive Directors and key senior executives are generally eligible to participate in an annual bonus scheme. In respect of the year ended 31 May 2012, each of the Executive Directors participated in the Senior Executive Annual Bonus Scheme, pursuant to which they were eligible to earn a cash bonus linked to performance targets established by the Committee. For the year ended 31 May 2012, Executive Directors could receive a bonus of up to 100%1 of basic salary (with 60% of salary payable for on-target performance) dependent upon the achievement of profit before taxation, net working capital and operating contribution margin targets. These targets and bonus levels were established at the beginning of the year; no changes were made during the year.
The performance targets were not met during the year and, accordingly, no bonus payments were made to any of the Executive Directors in respect of the year ended 31 May 2012.
Each of the Executive Directors will continue to participate in the Senior Executive Annual Bonus Scheme in respect of the year ending 31 May 2013. The eligibility of the Executive Directors to earn a cash bonus in respect of that period will also be dependent upon the achievement of certain profit before taxation, net working capital and operating contribution margin targets for the Group.
The Senior Executive Annual Bonus Scheme was introduced with effect from 1 June 2010 and replaced an earlier Deferred Annual Share Bonus Scheme. Under that earlier scheme, awards of deferred shares were made to Executive Directors following the attainment of pre-determined annual financial targets. Vesting of such deferred shares was then subject to three years' continuing employment. During the year ended 31 May 2012 each Executive Director received certain shares which had been the subject of earlier deferred share awards in respect of performance for the year ended 31 May 2008 (each having satisfied the condition that he complete three years of continuing employment from the date of grant of the award). Sufficient shares to satisfy deferred share awards are generally purchased in the market and retained in an employee benefit trust pending their transfer to participants. Further details regarding the employee benefit trust are given in note 25 of the consolidated financial statements.
1 The maximum bonus opportunity available under the Senior Executive Annual Bonus Scheme may be exceeded in exceptional cases at the discretion of the Committee. The maximum bonus opportunity was not exceeded during the year ended 31 May 2012.
continued
Executive Directors and certain key executives are also generally eligible to participate in the Performance Share Plan which provides for the grant of conditional rights to receive shares subject to continued employment over a three year vesting period and the satisfaction of certain performance criteria established by the Committee. Annual awards to any participant are limited to rights over shares with a market value at the time of grant equal to 100% of basic salary1 .
The year ended 31 May 2012 represented the final year of the three year performance period for awards made under the Performance Share Plan in 2009. Despite delivering strong results in the first two years, performance in the final year was such that overall the minimum performance threshold was not met. As a result, none of the awards made to the Executive Directors in 2009 in respect of the three years ended 31 May 2012 will vest and these awards will now lapse.
During the year ended 31 May 2012 new awards were made to the Executive Directors over shares with a value equal to 100% of basic salary. These awards are subject to adjusted earnings per share growth targets measured over the single three year performance period commencing on 1 June 2011. The Committee considers adjusted earnings per share to be an important indicator of the Company's underlying financial performance providing a clear line of sight for executives between their performance and potential reward. Further details of these performance conditions are set out in the notes to the table setting out Director's interests in shares under incentive arrangements on page 41.
The Committee intends to make further awards to Executive Directors on the same basis during the year ending 31 May 2013. Such awards are expected to be subject to similar performance targets measured over a three year performance period commencing on 1 June 2012.
1 This percentage may be increased to 150% in exceptional cases at the discretion of the Committee.
Prior to the adoption by the Company of the Performance Share Plan in 2008, Executive Directors and certain other senior executives were generally eligible for the grant of options under the PZ Cussons Plc Executive Share Option Scheme. There have been no grants of options under the Executive Share Option Scheme since the introduction of the Performance Share Plan and it is not expected that any further awards will be made under this scheme.
All options granted under the Executive Share Option Scheme have now either vested (and are capable of exercise) or have lapsed.
The Company's share incentive plans may operate over new issued Ordinary Shares, treasury shares or Ordinary Shares purchased in the market. In relation to all the Company's share incentive plans, the Company may not, in any ten year period, issue (or grant rights requiring the issue of) more than 10% of the issued Ordinary Share capital of the Company to satisfy awards to participants nor more than 5% of the issued Ordinary Share capital for executive share plans.
The Committee has established Shareholding Ownership Guidelines which require Executive Directors:
All Executive Directors have complied with the above guidelines in respect of the year ended 31 May 2012.
Mr Harvey is also required under his letter of appointment to invest 20% of his fees each year in the purchase of shares in the Company and to retain such shares during the term of his appointment.
Non-executive Directors' fees are generally reviewed every two years the last such review having taken place with effect from 1 July 2010. There have been no changes in the fees payable during the year and the next review (scheduled for 1 July 2012) has been deferred until 1 June 2013. Details of the fees paid during the period are set out in the table on Directors' remuneration on page 42.
The following information on pages 41 to 43 comprises the auditable disclosures of the Report on Directors' remuneration.
Details of awards at 1 June 2011 and 31 May 2012 to Executive Directors are as follows:
| Director | Date of award | Number of options/ awards at 1 June 2011 |
Granted/ allocated in year |
Exercised/ vested in year |
Lapsed in year |
Number of options/ awards at 31 May 2012 |
Option exercise price (£) |
Market price at date of award (£) |
Earliest date of exercise |
Expiry date |
Vesting/ transfer date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| G A Kanellis | 08-Sep-051 | 184,900 | – | – | – | 184,900 | 1.298 | – | 08-Sep-08 | 08-Sep-15 | – |
| 31-Aug-06 1 | 213,210 | – | – | – | 213,210 | 1.407 | – | 31-Aug-09 | 31-Aug-16 | – | |
| 06-Aug-071 | 197,309 | – | – | – | 197,309 | 1.6725 | – | 06-Aug-10 | 06-Aug-17 | – | |
| 01-Oct-082 | 225,750 | – | 225,750 | – | – | – | 1.7275 | – | – | – | |
| 28-Jul-092 | 192,170 | – | – | – | 192,170 | – | 2.2375 | – | – | 27-Jul-12 | |
| 30-Jul-102 | 131,633 | – | – | – | 131,633 | – | 3.43 | – | – | 29-Jul-13 | |
| 28-Jul-112 | – | 127,320 | – | – | 127,320 | – | 3.77 | – | – | 28-Jul-14 | |
| 21-Aug-083 | 38,480 | – | 38,480 | – | – | – | 1.725 | – | – | – | |
| 14-Aug-093 | 60,840 | – | – | – | 60,840 | – | 2.229 | – | – | 14-Aug-12 | |
| 02-Aug-103 | 85,380 | – | – | – | 85,380 | – | 3.498 | – | – | 02-Aug-13 | |
| C G Davis | 31-Aug-061 | 71,070 | – | – | – | 71,070 | 1.407 | – | 31-Aug-09 | 31-Aug-16 | – |
| 06-Aug- 071 | 131,539 | – | – | – | 131,539 | 1.6725 | – | 06-Aug-10 | 06-Aug-17 | – | |
| 01-Oct-082 | 141,820 | – | 141,820 | – | – | – | 1.7275 | – | – | – | |
| 28-Jul-092 | 122,900 | – | – | – | 122,900 | – | 2.2375 | – | – | 27-Jul-12 | |
| 30-Jul-102 | 84,184 | – | – | – | 84,184 | – | 3.43 | – | – | 29-Jul-13 | |
| 28-Jul-112 | – | 80,900 | – | – | 80,900 | – | 3.77 | – | – | 28-Jul-14 | |
| 21-Aug-083 | 19,880 | – | 19,880 | – | – | – | 1.725 | – | – | – | |
| 14-Aug-093 | 38,220 | – | – | – | 38,220 | – | 2.229 | – | – | 14-Aug-12 | |
| 02-Aug-103 | 54,600 | – | – | – | 54,600 | – | 3.498 | – | – | 02-Aug-13 | |
| B H Leigh | 01-Oct-08 2 | 138,920 | – | 138,920 | – | – | – | 1.7275 | – | – | – |
| 28-Jul-092 | 120,670 | – | – | – | 120,670 | – | 2.2375 | – | – | 27-Jul-12 | |
| 30-Jul-102 | 82,653 | – | – | – | 82,653 | – | 3.43 | – | – | 29-Jul-13 | |
| 28-Jul-112 | – | 79,570 | – | – | 79,570 | – | 3.77 | – | – | 28-Jul-14 | |
| 21-Aug-083 | 23,320 | – | 23,320 | – | – | – | 1.725 | – | – | – | |
| 14-Aug-093 | 37,440 | – | – | – | 37,440 | – | 2.229 | – | – | 14-Aug-12 | |
| 02-Aug-103 | 53,610 | – | – | – | 53,610 | – | 3.498 | – | – | 02-Aug-13 | |
| J Pantelireis | 08-Sep-051 | 138,670 | – | – | – | 138,670 | 1.298 | – | 08-Sep-08 | 08-Sep-15 | – |
| 31-Aug-061 | 132,190 | – | – | – | 132,190 | 1.407 | – | 31-Aug-09 | 31-Aug-16 | – | |
| 06-Aug-071 | 117,189 | – | – | – | 117,189 | 1.6725 | – | 06-Aug-10 | 06-Aug-17 | – | |
| 01-Oct-082 | 127,350 | – | 127,350 | – | – | – | 1.7275 | – | – | – | |
| 28-Jul-092 | 105,020 | – | – | – | 105,020 | – | 2.2375 | – | – | 27-Jul-12 | |
| 30-Jul-102 | 71,939 | – | – | – | 71,939 | – | 3.43 | – | – | 29-Jul-13 | |
| 28-Jul-112 | – | 69,360 | – | – | 69,360 | – | 3.77 | – | – | 28-Jul-14 | |
| 21-Aug-083 | 22,850 | – | 22,850 | – | – | – | 1.725 | – | – | – | |
| 14-Aug-093 | 34,320 | – | – | – | 34,320 | – | 2.229 | – | – | 14-Aug-12 | |
| 02-Aug-103 | 46,660 | – | – | – | 46,660 | – | 3.498 | – | – | 02-Aug-13 |
1 Awarded under the PZ Cussons Plc Executive Share Option Scheme. All awards have now vested and are capable of exercise.
2 Awarded under the PZ Cussons Plc Performance Share Plan. The vesting of each award is dependent upon the extent to which an adjusted earnings per share growth target is achieved over a single three year performance period. No proportion of an award may vest unless the Company's adjusted earnings per share grows by at least RPI + 4% per annum compounded over the relevant performance period. 25% of the award will vest where adjusted earnings per share grows by RPI + 4% per annum rising on a straight line pro rata basis to 100% vesting where adjusted earnings per share grows by RPI + 10% per annum or better compounded over the performance period. Where awards vest, participants will also receive a payment (in cash and/or shares as determined by the Remuneration Committee) on or shortly following vesting of an amount equivalent to the dividends which would have been paid on those shares between the time when the awards were granted and the time when they vest. The minimum performance conditions relating to the awards made in 2009 in respect of the three years ended 31 May 2012 have not been attained with the result that the awards will lapse in their entirety.
3 Awarded under the Deferred Annual Share Bonus Scheme following the attainment of pre-determined financial targets. Deferred shares will normally be received by participants following, and conditional only upon, three years of continuing employment from the date of the grant of the award.
The aggregate gross gains made by the Directors on the exercise of share options under the PZ Cussons Executive Share Option Scheme during the year were £nil (2011: £734,132). The gains are calculated based on the market price at the date of exercise for share options although the shares may have been retained and no gain realised.
The aggregate gross gains made by the Directors during the year on the vesting of the Performance Share Plan award made in 2008 was £2,122,096. The gains are calculated based on the market price at the date of vesting although the shares may have been retained and no gain realised.
The market value of the Company's shares at 31 May 2012 was £3.23 per share. The range during the year was £2.85 to £3.88.
continued
The graph below illustrates the performance of PZ Cussons Plc measured by Total Shareholder Return (TSR) over the five year period to 31 May 2012 against the TSR of a holding of shares in the FTSE 250 index over the same period, based on an initial investment of £100. The FTSE 250 index has been chosen as PZ Cussons Plc is a constituent of that index.
The following table shows the remuneration of individual Directors for the year ended 31 May 2012:
| Salary/fees | Bonus | Pension contributions1 |
Taxable benefits |
2012 Total2 |
2011 Total |
|
|---|---|---|---|---|---|---|
| Executive Directors3 | ||||||
| G A Kanellis | 472,875 | – | 94,575 | 29,586 | 597,036 | 650,955 |
| C G Davis | 300,937 | – | 58,314 | 17,073 | 376,324 | 414,750 |
| B H Leigh | 295,875 | – | 59,175 | 17,073 | 372,123 | 407,555 |
| J Pantelireis | 257,812 | – | 51,562 | 17,073 | 326,447 | 356,843 |
| Non-executive Directors | ||||||
| R J Harvey | 250,000 | – | – | – | 250,000 | 250,000 |
| J A Arnold | 52,500 | – | – | – | 52,500 | 51,875 |
| N Edozien4 | 21,875 | – | – | – | 21,875 | – |
| S J N Heale | 52,500 | – | – | – | 52,500 | 51,458 |
| D W Lewis | 52,500 | – | – | – | 52,500 | 51,875 |
| H Owers4 | 21,875 | – | – | – | 21,875 | – |
| J T J Steel | 52,500 | – | – | – | 52,500 | 51,875 |
| 1,831,249 | – | 263,626 | 80,805 | 2,175,680 | 2,287,186 |
1 With effect from 1 June 2008, the Executive Directors became eligible for membership of the Company's new defined contribution pension arrangement. Messrs Kanellis, Leigh and Pantelireis have each elected, with the permission of the Committee, to receive instead a salary supplement equivalent to 20% of base salary; these amounts are included in the column headed 'Pension Contributions'. Mr Davis continues to participate in the defined contribution pension arrangement but, as the amount of Company contributions was less than 20% of his salary due to legislation introduced in the Finance Bill 2011, the difference between those contributions and 20% of his base salary was paid as a salary supplement. Both the pension contributions and the salary supplement are included in the column headed 'Pension contributions'.
2 In addition to the above, Executive Directors received the following cash payments during the year in lieu of dividends on past awards of deferred shares made under the Deferred Annual Share Bonus Scheme which have not yet vested: Mr Kanellis: £11,548; Mr Davis: £7,126; Mr Leigh: £7,162; and Mr Pantelireis: £6,464. The Executive Directors also received the following cash payments during the year in lieu of dividends accrued under the PZ Cussons Plc Performance Share Plan in respect of the award made in October 2008 which vested in October 2011: Mr Kanellis: £40,138; Mr Davis: £25,215; Mr Leigh: £24,699; and Mr Pantelireis: £22,642.
3 As reported on page 39, the annual salaries of the Executive Directors will be revised with effect from 1 September 2012. The following annual salaries will apply: Mr Kanellis: £499,200; Mr Davis: £317,200; Mr Leigh: £312,000; and Mr Pantelireis: £271,960.
4 Ms Edozien and Mrs Owers were each appointed to the Board on 1 January 2012 at annual fees of £52,500. The fees payable in respect of Ms Edozien are paid to her employer.
The following Executive Directors were members of the defined benefit pension arrangements provided by the Company. All of these defined benefit plans were closed to future accrual on 31 May 2008 and replaced by defined contribution arrangements. Benefits built up in the defined benefit plans will continue to receive a salary link until 31 May 2013, or the date that each Director leaves employment with the Company if sooner. The pension entitlements and corresponding transfer values below relate solely to the defined benefit arrangements.
| Increase in | Value of net | ||||||
|---|---|---|---|---|---|---|---|
| Gross | accrued | increase in | Value of | Value of | Total change | ||
| increase in | pension net | Total accrued | pension over | accrued | accrued | in value | |
| accrued | of inflation | pension at | period | pension at | pension at | during period | |
| pension | (a) | 31 May 2012 | (b) | 31 May 2011 | 31 May 2012 | (c) | |
| £ pa | £ pa | £ pa | £ | £ | £ | £ | |
| G A Kanellis | 15,095 | 7,133 | 303,428 | 115,100 | 4,344,000 | 4,896,000 | 552,000 |
| C G Davis | 1,090 | 451 | 24,243 | 8,300 | 399,000 | 444,000 | 45,000 |
| B H Leigh | 4,918 | 2,126 | 106,022 | 29,000 | 1,252,000 | 1,448,000 | 196,000 |
| J Pantelireis | 6,498 | 2,885 | 137,320 | 67,700 | 2,979,000 | 3,214,000 | 235,000 |
Notes:
Executive Directors have one year rolling service contracts. No Executive Director, including those proposed for re-election, has a service contract with a notice period in excess of one year or containing any provision for pre-determined compensation on termination exceeding one year's salary and benefits in kind.
No Executive Directors hold any other positions outside the Group.
Non-executive Directors do not have service contracts but are appointed for initial periods of three years, normally renewable on a similar basis. The present letters of appointment for Professor Arnold, Ms Edozien, Mr Heale, Mr Harvey, Mrs Owers and Mr Steel will expire on 31 December 2012, 31 December 2014, 31 December 2013, 31 December 2012, 31 December 2014 and 30 September 2014 respectively. Whilst the letter of appointment of Mr Lewis formally expires on 31 May 2013, he has indicated his intention to step down from the Board at the Company's AGM (Annual General Meeting) in 2012.
By order of the Board of Directors
The Board is committed to meeting the standards of good corporate governance as established by the Financial Reporting Council from time to time. In respect of the year ended 31 May 2012, the UK Corporate Governance Code published in June 2010 (the Code) was applied by the Company. The Code is publicly available on the Financial Reporting Council's website (www.frc.org.uk).
This report, together with the Report on Directors' remuneration in respect of remuneration matters, describes how the Board applied the Code during the year under review.
As at the date of this report, the Board of Directors has 11 members comprising the Non-executive Chairman, the Chief Executive, three other Executive Directors and six Non-executive Directors. The names of the Directors together with their biographical details are set out on pages 32 to 33. The size of the Board allows individuals to communicate openly and to make a personal contribution through the exercise of their individual skills and experience.
The Non-executive Directors have been appointed for their specific experience and expertise and are all considered to be independent of management and free from any business or other relationship which could materially interfere with the exercise of their independent judgement. Mr Harvey is a Non-executive Director of Jardine Lloyd Thompson Plc, which acts as insurance broker to the Company. Mr Lewis is a former partner of Addleshaw Goddard LLP, which acts as legal advisor to the Company. The level of fees payable to each of Jardine Lloyd Thompson Plc and Addleshaw Goddard LLP is not material and the Board is wholly satisfied that it is appropriate to designate each of Mr Harvey and Mr Lewis as independent. Neither of them participated in any way in the provision of services by the relevant supplier to the Company. In addition, in order that his independence is not compromised, if at any time the Board or a Committee of the Board is considering any matter concerning one of the suppliers, it has been agreed that the relevant individual will withdraw from that meeting until such matters have been dealt with.
Mr Lewis is the Senior Independent Non-executive Director and in this capacity he is available to shareholders if they have concerns which contact through the normal channels of Chairman, Chief Executive or Group Finance Director has failed to resolve or for which such contact is inappropriate. After eight years' service to the Board, with effect from the 2012 Annual General Meeting Mr Lewis will retire and Mr Steel will be appointed Senior Independent Non-executive Director.
Non-executive Directors may serve on the boards of other companies provided that this does not involve a conflict of interest and that the appointment does not restrict their ability to discharge their duties to the Company in any way.
As set out in the Report of the Directors, the Board has resolved to comply with the provisions of the Code and each Director will seek re-election annually.
The Executive Directors' service contracts and the letters setting out the terms of appointment of the Non-executive Directors are available for inspection at the Company's registered office during normal business hours and at the Annual General Meeting.
The Company supports the Code provision that Boards should consider the benefits of diversity, including gender, when making appointments and is committed to ensuring diversity not just at Board level but also across the Company's senior management team, not least because it believes that business benefits from the widest range of perspectives and backgrounds. The Company's aim as regards the composition of the Board is that it should have a balance of experience, skills and knowledge to enable each Director and the Board as a whole to discharge their duties effectively. Whilst the Company agrees that it is entirely appropriate that it should seek to have diversity on its Board, it does not consider that this can be best achieved by establishing specific quotas and targets and appointments will continue to be made based wholly on merit.
Further details on diversity within the business are set out in the CSR report on pages 20 to 31.
Effectiveness reviews of the Board and its committees are carried out annually. The results are reviewed by the Chairman of the Board or Board committee, discussed in a formal meeting and any appropriate recommendations are recorded and acted upon.
The review process which was undertaken during the year concluded that all Directors continue to contribute effectively and with proper commitment, devoting adequate time to carry out their duties. The performance of the Non-executive Directors is evaluated separately by the Executive Directors. The Remuneration Committee reviews Executive Directors' performance with guidance from the Chief Executive (other than in respect of his own position).
The Board is responsible for the Group's strategic development, monitoring its business objectives and maintaining a system of effective corporate governance.
Six formal meetings of the Board were scheduled during the year and the Directors met on a number of further occasions as necessary to consider specific matters arising and to review and develop the Company's corporate strategy.
The differing roles of the Chairman and Chief Executive are acknowledged and set out in terms of reference which have been adopted by the Board. The Chairman is primarily responsible for the running of the Board and ensuring that it is supplied in a timely manner with sufficient information to enable it to discharge its duties. The Chief Executive is responsible for coordinating the running of the business and implementing Group strategy.
All Directors communicate with each other on a regular basis and have regular and ready access to members of the Group's management team. Senior executives are invited to attend Board meetings to make presentations on specific matters or projects. Board papers are prepared and issued to all Directors in good time prior to each Board meeting to enable Directors to give due consideration to all matters in advance of the meeting. During the year, the Board has maintained an understanding of the views of major shareholders through face to face meetings and briefings from the Company's brokers.
The Board has adopted formal procedures for Directors to take independent professional advice where necessary at the Company's expense and each Director has full access to the services of the Company Secretary who is also responsible for ensuring that Board procedures and all applicable rules and regulations are followed.
The Board has an approved and documented schedule of matters reserved for its decision, including approval of the Group's strategy, annual budgets, material agreements and major capital expenditure and acquisitions, the approval of financial arrangements, and the monitoring of performance, health, safety and environmental matters and risk management procedures.
The Board has also adopted a formal induction process for Directors including visits to principal sites and meetings with operating management. Directors may take additional training where necessary as part of their continuing development at the expense of the Company.
The Board has established a number of standing committees to which various matters are delegated according to defined terms of reference. The terms of reference of the committees are available on the Company's website (www.pzcussons.com) and will also be available at the Annual General Meeting. Details of the principal standing committees of the Board are set out as follows:
The Nomination Committee is responsible for regularly reviewing the structure, size and composition of the Board and identifying and recommending appropriate candidates for membership of the Board when vacancies arise. During the year ended 31 May 2012, the Committee members were Mr Harvey (Committee Chairman), Professor Arnold, Mr Heale, Mr Kanellis, Mr Lewis, Mr Steel and, with effect from their appointment to the Board on 1 January 2012, Ms Edozien and Mrs Owers. The Company Secretary is secretary to the Committee.
During the year, the Committee undertook the process of identifying new independent Non-executive Directors, culminating in the appointment to the Board of Ms Edozien and Mrs Owers. In considering these appointments, the Nomination Committee evaluated the balance of skills, knowledge and experience of the Board and prepared a description of the role and capabilities required. External search agencies were engaged and a number of short-listed candidates were then invited to interview with members of the Committee. Other members of the Board were then given the opportunity of meeting with Ms Edozien and Mrs Owers, following which the Board approved their appointments.
The Remuneration Committee is responsible for reviewing and recommending the framework and policy for remuneration of the Executive Directors and senior executives, which the Board as a whole is responsible for approving. The Committee members are Mr Steel (Committee Chairman), Professor Arnold, Mr Heale, Mr Lewis, and, with effect from their appointment to the Board on 1 January 2012, Ms Edozien and Mrs Owers. The Company Secretary is secretary to the Committee.
The Remuneration Committee is responsible for evaluating the performance and determining specific remuneration packages for each Executive Director, the Chairman and the Company Secretary. With the exception of the Non-executive Chairman, the fees of the Non-executive Directors are determined by the Executive Directors.
Further details of the Committee's responsibilities and activities during the year are set out in the Report on Directors' remuneration on pages 37 to 43.
continued
The Audit Committee is responsible for reviewing, on behalf of the Board, the Group's accounting and financial policies and its disclosure practices, internal controls, internal audit and risk management. It is also responsible for overseeing all matters associated with the appointment, terms, remuneration and performance of the external auditor and for reviewing the scope and results of the audit and its cost effectiveness. These responsibilities are discharged at the Audit Committee meetings and through regular reports from the internal audit function. The Audit Committee comprises Professor Arnold (Committee Chairman), Mr Heale, Mr Lewis, Mr Steel and, with effect from their appointment to the Board on 1 January 2012, Ms Edozien and Mrs Owers. The Committee meets regularly with the external auditor. Professor Arnold, a qualified chartered accountant, brings recent and relevant financial experience to the Audit Committee. The Company Secretary is secretary to the Committee.
As indicated above, one of the duties of the Audit Committee is to make recommendations to the Board in relation to the appointment of the external auditor. Various factors are taken into account by the committee in assessing whether to recommend the auditor for reappointment. These include the quality of the reports provided to the Audit Committee and the Board and the level of understanding demonstrated of the Group's business.
PricewaterhouseCoopers LLP (PwC) has been the Group's external auditors since 2007. In the opinion of the Audit Committee, the relationship with the auditors continues to operate effectively and the Committee remains satisfied with their independence. To date, the Committee has not considered it necessary for PwC to retender for the audit engagement. It is, however, a requirement that the audit partner responsible for the audit rotates every five years and accordingly the current lead audit partner, who has been in place since 2007, will rotate at the end of this current audit cycle. There are no contractual obligations restricting the Company's choice of auditors.
The Group has a policy governing the conduct of non-audit work by the auditor. The auditor is permitted to provide non-audit services which are not, and are not perceived to be, in conflict with auditor independence, providing it has the skill, competence and integrity to carry out the work and is considered to be the most appropriate to undertake such work in the best interests of the Group. Assignments with a value of £50,000 or more must be submitted to the Committee and activities which may be perceived to be in conflict with the role of the external auditor must be submitted to the Committee for approval prior to engagement, regardless of the amounts involved. All assignments are monitored by the Committee. Details of the amounts paid to the external auditor during the year for audit and other services are set out in note 4 to the financial statements.
The Group Risk Committee is responsible for identifying, assessing and prioritising all material risks facing the Group and ensuring, where possible, that appropriate action is taken to manage and mitigate those risks. The risk areas which the Committee reviews includes general business risk including risk arising out of the external financial environment, product safety risk, physical asset risk including factory, health and safety and environmental risks, IT and infrastructure risks. At least once a year, the Board as a whole reviews any material risks facing the Group and the output of this review forms the basis of the work undertaken by the Committee during the year.
The Committee is responsible for developing and supporting the activities necessary to convert an approved framework of risk limits and risk appetite policies into an effective plan for implementation across the Group. This is achieved by ongoing review to develop and implement plans to eliminate, reduce or transfer risk where practicable. The Committee is also responsible for reviewing the risk management and control processes within the Group and encouraging and supporting two-way communications of risks both within the business and with external stakeholders including shareholders, suppliers and customers.
The Group Risk Committee comprises Professor Arnold (Committee Chairman), Mr Davis, Mr Harvey, Mr Heale, Mr Kanellis, Mr Leigh, Mr Lewis, Mr Pantelireis, Mr Steel and, with effect from their appointment to the Board on 1 January 2012, Ms Edozien and Mrs Owers. The Company Secretary is secretary to the Committee. It reports formally to the Board after each meeting. It has authority to obtain external advice as considered appropriate and the Board has resolved that it should be provided with sufficient resources to undertake fully its responsibilities.
The Board undertakes annually a formal review of the risk management process and the performance of the Group Risk Committee.
The CSR Committee is responsible for reviewing and developing the Company's corporate strategy to ensure that CSR is an integral part of the strategy and that the Group's social, environmental and economic activities are aligned. The CSR Committee is also responsible for the development of policies on all key areas of CSR including the environment, health and safety, consumer safety, business conduct and ethics, employees and local community and charity. Further details of the Committee's terms of reference and activities during the year are set out in the Corporate social responsibility report on pages 20 to 31.
The CSR Committee comprises Mr Heale (Committee Chairman), Professor Arnold, Mr Davis, Mr Harvey, Mr Kanellis, Mr Leigh, Mr Lewis, Mr Pantelireis, Mr Steel and, with effect from their appointment to the Board on 1 January 2012, Ms Edozien and Mrs Owers. The Company Secretary is secretary to the CSR Committee. The Committee reports formally to the Board after each meeting. It has authority to obtain external advice as considered appropriate and the Board has resolved that it should be provided with sufficient resources to undertake fully its responsibilities.
The number of scheduled meetings of the Board (excluding such ad hoc meetings as were necessary during the year to address specific matters arising) and of each of the Audit, Remuneration, Nomination, Group Risk and CSR Committees during the year ended 31 May 2012, together with a record of the attendance of the current Directors who are their respective members, is detailed in the table below:
| Remuneration | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Board | Audit Committee | Committee | Nomination Committee Group Risk Committee | CSR Committee | |||||||||
| Number of meetings eligible to attend |
Number of meetings attended |
Number of meetings eligible to attend |
Number of meetings attended |
Number of meetings eligible to attend |
Number of meetings attended |
Number of meetings eligible to attend |
Number of meetings attended |
Number of meetings eligible to attend |
Number of meetings attended |
Number of meetings eligible to attend |
Number of meetings attended |
||
| Mr R Harvey | 6 | 6 | n/a | n/a | n/a | n/a | 2 | 2 | 4 | 4 | 3 | 3 | |
| Mr G A Kanellis | 6 | 6 | n/a | n/a | n/a | n/a | 2 | 2 | 4 | 4 | 3 | 3 | |
| Mr C G Davis | 6 | 6 | n/a | n/a | n/a | n/a | n/a | n/a | 4 | 4 | 3 | 3 | |
| Mr B H Leigh | 6 | 6 | n/a | n/a | n/a | n/a | n/a | n/a | 4 | 4 | 3 | 3 | |
| Mr J Pantelireis | 6 | 6 | n/a | n/a | n/a | n/a | n/a | n/a | 4 | 4 | 3 | 3 | |
| Mr D W Lewis | 6 | 6 | 4 | 4 | 5 | 5 | 2 | 2 | 4 | 4 | 3 | 3 | |
| Prof J A Arnold | 6 | 6 | 4 | 4 | 5 | 5 | 2 | 2 | 4 | 4 | 3 | 3 | |
| Ms N Edozien | 3 | 3 | 2 | 2 | 3 | 3 | 0 | 0 | 2 | 2 | 1 | 1 | |
| Mr S J N Heale | 6 | 6 | 4 | 4 | 5 | 5 | 2 | 2 | 4 | 4 | 3 | 3 | |
| Mrs H Owers | 3 | 3 | 2 | 2 | 3 | 3 | 0 | 0 | 2 | 2 | 1 | 1 | |
| Mr J T J Steel | 6 | 6 | 4 | 4 | 5 | 5 | 2 | 2 | 4 | 4 | 3 | 3 |
Notes:
'n/a' indicates that the Director is not a member of the Committee.
No Director participates in meetings when matters relating to him are being discussed.
Details of Directors' remuneration are set out in the Report on Directors' remuneration.
Information on PZ Cussons business model and strategy for generating and preserving longer-term growth and delivering on the Company's stated objectives is set out in pages 6 to 7 of the Annual Report and Accounts.
The Group's business activities, together with the factors likely to affect its future development, performance and position are set out in the Business review. The financial position of the Group and liquidity position are described within the Financial review. In addition, note 18 to the financial statements includes policies in relation to the Group's financial instruments and risk management and policies for managing credit risk, liquidity, market risk, foreign exchange risk, price risk and interest rate risk.
After making enquiries, the Directors have a reasonable expectation that the Company and the Group have adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the Annual Report and Accounts.
The Board is responsible for the Group's system of internal control and for reviewing its effectiveness. Such a system is designed to manage rather than eliminate the risk of failure to achieve business objectives and can only provide reasonable and not absolute assurance against material misstatement or loss.
The Board is of the view that there is an ongoing process for identifying, evaluating and managing the Group's significant risks, that it has been in place for the year ended 31 May 2012 and up to the date of the Annual Report and Accounts, that it is regularly reviewed by the Board and that it accords with the Turnbull guidance for Directors on the Code. The process includes:
Throughout the year, the Board has carried out assessments of internal control by considering documentation from the Executive Directors, Audit Committee and internal audit function as well as taking into consideration events since the year end. The internal controls extend to the financial reporting process and the preparation of consolidated accounts. The basis for the preparation of consolidated accounts is as set out in note 1 to the financial statements.
continued
The Group continues to take steps to embed internal control and risk management further into the operations of the business and to deal with areas for improvement which come to the attention of management and the Board. The Group has ethical guidelines and defined fraud reporting and whistleblowing processes which are issued to all employees within the Group.
In its financial reporting to shareholders the Board aims to present a balanced and understandable assessment of the Group's financial position and prospects.
The Company maintains a corporate website (www.pzcussons.com), containing a wide range of information of interest to institutional and private investors and a subscription e-mail service is available which enables access to Company notifications and news releases.
The Company has periodic discussions with institutional shareholders on a range of issues affecting the Group's performance. The Board is also kept informed of investors' views through regular discussion of analysts' and brokers' briefings and investor opinion feedback.
All shareholders, including private investors, have an opportunity to present questions to the Board at the Annual General Meeting and the Directors make themselves available to meet informally with shareholders after the meeting.
The business to be conducted at the Annual General Meeting of the Company is set out in the separate Notice of Annual General Meeting which accompanies the Annual Report and Accounts. Resolutions put before shareholders at the Annual General Meeting will usually include resolutions for the appointment of Directors, approval of the Report on Directors' remuneration, declaration of the final dividend and authorisation for the Board to allot and repurchase shares. Voting at the Annual General Meeting is on a show of hands and after each show of hands, details of all proxy votes lodged for and against each resolution and the number of abstentions are disclosed.
At each Annual General Meeting there is an update on the progress of the business over the last year and also on current trading conditions.
The Directors consider that the Company complied with the provisions of section 1 of the Code with the following exception:
– Code Provision E.1.1: The Code specifies that the Senior Independent Director should attend sufficient meetings with a range of major shareholders to develop a balanced understanding of the issues and concerns of major shareholders. The Senior Independent Director met a limited number of shareholders during the year but shareholders are afforded the opportunity to meet or consult with him at their discretion in the event that they have any questions, comments or concerns and he is available to speak to all shareholders at the Company's Annual General Meeting.
The Directors are responsible for preparing the Annual Report, the Report on Directors' remuneration and the financial statements in accordance with applicable law and regulations.
Company law requires the Directors to prepare financial statements for each financial year. Under that law the Directors have prepared the Group financial statements in accordance with International Financial Reporting Standards (IFRSs) as adopted by the European Union, and the Parent Company financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under Company law the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Group and the Company and of the profit or loss of the Group for that period. In preparing these financial statements, the Directors are required to:
The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and the Group and enable them to ensure that the financial statements and the Report on Directors' remuneration comply with the Companies Act 2006 and, as regards the Group financial statements, Article 4 of the IAS Regulation. They are also responsible for safeguarding the assets of the Company and the Group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The Directors are responsible for the maintenance and integrity of the Company's website, www.pzcussons.com. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
Each of the Directors, whose names and functions are listed on pages 32 to 33, confirm that, to the best of their knowledge:
By order of the Board
Mr S P Plant Company Secretary 24 July 2012
We have audited the Group financial statements of PZ Cussons Plc for the year ended 31 May 2012 which comprise the Consolidated income statement, Consolidated statement of comprehensive income, Consolidated balance sheet, Consolidated statement of changes in equity, Consolidated cash flow statement and the related notes. The financial reporting framework that has been applied in their preparation is applicable law and International Financial Reporting Standards (IFRSs) as adopted by the European Union.
As explained more fully in the Statement of Directors' Responsibilities set out on page 49, the Directors are responsible for the preparation of the Group financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express an opinion on the Group financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's Ethical Standards for Auditors.
This report, including the opinions, has been prepared for and only for the Company's members as a body in accordance with Chapter 3 of Part 16 of the Companies Act 2006 and for no other purpose. We do not, in giving these opinions, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.
An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or error. This includes an assessment of: whether the accounting policies are appropriate to the Group's circumstances and have been consistently applied and adequately disclosed; the reasonableness of significant accounting estimates made by the Directors; and the overall presentation of the financial statements. In addition, we read all the financial and non-financial information in the Annual Report and Accounts to identify material inconsistencies with the audited financial statements. If we become aware of any apparent material misstatements or inconsistencies we consider the implications for our report.
In our opinion the Group financial statements:
In our opinion:
– the information given in the Report of the Directors for the financial year for which the Group financial statements are prepared is consistent with the Group financial statements
We have nothing to report in respect of the following:
Under the Listing Rules we are required to review:
We have reported separately on the Parent Company financial statements of PZ Cussons Plc for the year ended 31 May 2012 and on the information in the Report of Directors' remuneration that is described as having been audited.
Nicholas Boden (Senior Statutory Auditor) for and on behalf of PricewaterhouseCoopers LLP Chartered Accountants and Statutory Auditors Manchester 24 July 2012
Year ended 31 May 2012
| Year ended 31 May 2012 | Year ended 31 May 2011 | ||||||
|---|---|---|---|---|---|---|---|
| Notes | Before exceptional items £m |
Exceptional items (note 3) £m |
Total £m |
Before exceptional items £m |
Exceptional items (note 3) £m |
Total £m |
|
| Continuing operations Revenue Cost of sales |
2 | 858.9 (549.7) |
– – |
858.9 (549.7) |
820.7 (495.5) |
– – |
820.7 (495.5) |
| Gross profit | 309.2 | – | 309.2 | 325.2 | – | 325.2 | |
| Selling and distribution costs Administrative expenses Share of results of joint ventures |
12 | (134.0) (81.6) (0.2) |
– (43.8) – |
(134.0) (125.4) (0.2) |
(135.0) (82.5) 0.4 |
– (0.8) – |
(135.0) (83.3) 0.4 |
| Operating profit | 2 | 93.4 | (43.8) | 49.6 | 108.1 | (0.8) | 107.3 |
| Finance income Finance costs |
2.5 (3.6) |
– – |
2.5 (3.6) |
3.4 (2.6) |
– – |
3.4 (2.6) |
|
| Net finance (expense)/income | 6 | (1.1) | – | (1.1) | 0.8 | – | 0.8 |
| Profit before taxation | 92.3 | (43.8) | 48.5 | 108.9 | (0.8) | 108.1 | |
| Taxation | 7 | (24.9) | 14.4 | (10.5) | (30.2) | 2.0 | (28.2) |
| Profit for the year | 4 | 67.4 | (29.4) | 38.0 | 78.7 | 1.2 | 79.9 |
| Attributable to: Equity holders of the Company Non-controlling interests |
9 | 63.1 4.3 67.4 |
(28.7) (0.7) (29.4) |
34.4 3.6 38.0 |
69.2 9.5 78.7 |
1.2 – 1.2 |
70.4 9.5 79.9 |
| Basic EPS (p) Diluted EPS (p) |
9 9 |
8.03 7.99 |
16.48 16.29 |
||||
| Adjusted basic EPS (p) Adjusted diluted EPS (p) |
9 9 |
14.74 14.65 |
16.20 16.02 |
Year ended 31 May 2012
| Notes | 2012 £m |
2011 £m |
|---|---|---|
| Profit for the year | 38.0 | 79.9 |
| Other comprehensive expense | ||
| Actuarial losses on defined benefit pension schemes 23 |
(11.5) | (3.3) |
| Exchange differences on translation of foreign operations | 2.1 | (33.6) |
| Cash flow hedges – fair value (loss)/gain in year | (0.7) | 1.8 |
| Taxation on items taken directly to equity | 2.8 | 0.4 |
| Other comprehensive expense for the year net of taxation | (7.3) | (34.7) |
| Total comprehensive income for the year | 30.7 | 45.2 |
| Attributable to: | ||
| Equity holders of the Company | 23.3 | 45.6 |
| Non-controlling interests | 7.4 | (0.4) |
At 31 May2012
| Notes | 31 May 2012 £m |
31 May 2011 £m |
|
|---|---|---|---|
| Assets | |||
| Non-current assets | |||
| Goodwill and other intangible assets | 10 | 248.4 | 233.9 |
| Property, plant and equipment | 11 | 209.5 | 225.7 |
| Other investments | 13 | 0.5 | 0.6 |
| Net investment in joint ventures | 12 | 38.7 | 20.8 |
| Receivables | 15 | 1.0 | 0.8 |
| Retirement benefit surplus | 23 | 39.1 537.2 |
39.3 521.1 |
| Current assets Inventories |
14 | 173.6 | 151.7 |
| Trade receivables and prepayments | 15 | 141.0 | 155.8 |
| Investments | 16 | 7.0 | 10.6 |
| Cash and cash equivalents | 17 | 65.9 | 88.7 |
| Current taxation receivable | 5.8 | 10.6 | |
| 393.3 | 417.4 | ||
| Total assets | 930.5 | 938.5 | |
| Equity | |||
| Ordinary share capital | 24 | 4.3 | 4.3 |
| Capital redemption reserve | 0.7 | 0.7 | |
| Hedging reserve | (0.1) | 0.3 | |
| Currency translation reserve | 28.4 | 30.1 | |
| Retained earnings | 425.0 | 438.6 | |
| Equity attributable to equity holders of the Company | 458.3 | 474.0 | |
| Non-controlling interests | 61.2 | 61.1 | |
| Total equity | 519.5 | 535.1 | |
| Liabilities Non-current liabilities |
|||
| Borrowings | 18 | – | 15.0 |
| Other liabilities | 20 | 0.9 | 2.2 |
| Deferred taxation liabilities | 21 | 50.6 | 58.7 |
| Retirement benefit obligations | 23 | 37.1 | 41.9 |
| 88.6 | 117.8 | ||
| Current liabilities | |||
| Borrowings | 18 | 90.8 | 32.5 |
| Trade and other payables | 19 | 192.0 | 219.3 |
| Current taxation payable | 22.7 | 30.1 | |
| Provisions | 22 | 16.9 | 3.7 |
| 322.4 | 285.6 | ||
| Total liabilities | 411.0 | 403.4 | |
| Total equity and liabilities | 930.5 | 938.5 |
The financial statements from pages 51 to 85 were approved by the Board of Directors and authorised for issue.
They were signed on its behalf by:
R J Harvey G A Kanellis
24 July 2012
Year ended 31 May2012
| Attributable to equity owners of the Company | |||||||
|---|---|---|---|---|---|---|---|
| Share capital £m |
Currency translation reserve £m |
Capital redemption reserve £m |
Retained earnings £m |
Hedging reserve £m |
Non- controlling interests £m |
Total £m |
|
| At 1 June 2010 | 4.3 | 53.8 | 0.7 | 397.3 | (1.3) | 67.3 | 522.1 |
| Profit for the year Actuarial losses on defined benefit pension |
– | – | – | 70.4 | – | 9.5 | 79.9 |
| schemes Exchange differences on translation of foreign |
– | – | – | (3.3) | – | – | (3.3) |
| operations | – | (23.7) | – | – | – | (9.9) | (33.6) |
| Cash flow hedges – fair value gains in year | – | – | – | – | 1.8 | – | 1.8 |
| Cash flow hedges – tax on fair value gains Deferred tax on actuarial losses on defined benefit |
– | – | – | – | (0.2) | – | (0.2) |
| pension schemes | – | – | – | 0.6 | – | – | 0.6 |
| Total comprehensive income/(expense) for the year | – | (23.7) | – | 67.7 | 1.6 | (0.4) | 45.2 |
| Transactions with owners: | |||||||
| Ordinary dividends | – | – | – | (26.0) | – | – | (26.0) |
| Acquisition of shares for ESOT | – | – | – | (2.3) | – | – | (2.3) |
| Share-based payments charges | – | – | – | 2.3 | – | – | 2.3 |
| Deferred tax on share-based payments | – | – | – | 1.2 | – | – | 1.2 |
| Acquisition of non-controlling interests | – | – | – | (1.6) | – | (1.3) | (2.9) |
| Non-controlling interests dividend paid | – | – | – | – | – | (4.5) | (4.5) |
| At 31 May 2011 | 4.3 | 30.1 | 0.7 | 438.6 | 0.3 | 61.1 | 535.1 |
| At 1 June 2011 | 4.3 | 30.1 | 0.7 | 438.6 | 0.3 | 61.1 | 535.1 |
| Profit for the year Actuarial losses on defined benefit pension |
– | – | – | 34.4 | – | 3.6 | 38.0 |
| schemes Exchange differences on translation of foreign |
– | – | – | (11.5) | – | – | (11.5) |
| operations | – | (1.7) | – | – | – | 3.8 | 2.1 |
| Cash flow hedges – fair value losses in year | – | – | – | – | (0.7) | – | (0.7) |
| Cash flow hedges – tax on fair value losses Deferred tax on actuarial losses on defined benefit |
– | – | – | – | 0.3 | – | 0.3 |
| pension schemes | – | – | – | 2.5 | – | – | 2.5 |
| Total comprehensive income/(expense) for | |||||||
| the year | – | (1.7) | – | 25.4 | (0.4) | 7.4 | 30.7 |
| Transactions with owners: | |||||||
| Ordinary dividends | – | – | – | (28.8) | – | – | (28.8) |
| Acquisition of shares for ESOT | – | – | – | (2.8) | – | – | (2.8) |
| Share-based payments charges | – | – | – | (0.5) | – | – | (0.5) |
| Deferred tax on share-based payments | – | – | – | (1.4) | – | – | (1.4) |
| Acquisition of non-controlling interests | – | – | – | (5.5) | – | (3.1) | (8.6) |
| Non-controlling interests dividend paid | – | – | – | – | – | (4.2) | (4.2) |
| At 31 May 2012 | 4.3 | 28.4 | 0.7 | 425.0 | (0.1) | 61.2 | 519.5 |
Year ended 31 May2012
| Notes | 2012 £m |
2011 £m |
|
|---|---|---|---|
| Operating activities | |||
| Cash generated from operations | 26 | 57.5 | 113.0 |
| Taxation paid | (21.6) | (23.0) | |
| Net cash generated from operating activities | 35.9 | 90.0 | |
| Cash flows from investing activities | |||
| Investment income received | 2.5 | 3.4 | |
| Purchase of property, plant and equipment | (18.9) | (22.1) | |
| Proceeds from sale of property, plant and equipment | 2.4 | 0.3 | |
| Purchase of intangible assets | 10 | (0.1) | (0.4) |
| Acquisition of non-controlling interests | 29 | (8.6) | (2.9) |
| Acquisition of business | 29 | (26.3) | (62.5) |
| Repayment/(advance) of short-term deposits to joint ventures | 16 | 3.6 | (10.3) |
| Loans (granted to)/repaid by joint ventures | 12 | (16.8) | 1.0 |
| Net cash used in investing activities | (62.2) | (93.5) | |
| Financing activities | |||
| Interest paid | (3.6) | (2.6) | |
| Dividends paid to non-controlling interests | (4.2) | (3.8) | |
| Purchase of shares for ESOT | 25 | (2.8) | (2.3) |
| Dividends paid to Company shareholders | 8 | (28.8) | (26.0) |
| Repayment of term loan | 18 | (15.0) | (15.0) |
| Increase in borrowings | 18 | 59.4 | 16.4 |
| Net cash generated from/(used in) financing activities | 5.0 | (33.3) | |
| Net decrease in cash, cash equivalents and bank overdrafts | (21.3) | (36.8) | |
| Cash, cash equivalents and bank overdrafts at the beginning of the year | 17 | 87.6 | 131.2 |
| Effect of foreign exchange rates | (0.4) | (6.8) | |
| Cash, cash equivalents and bank overdrafts at the end of the year | 17 | 65.9 | 87.6 |
PZ Cussons Plc is a public limited company which is listed on the London Stock Exchange and is domiciled and incorporated in the United Kingdom under the Companies Act 2006. The address of the registered office is given on page 93.
These financial statements are presented in Pounds Sterling because that is the currency of the primary economic environment in which the Group operates. Foreign operations are included in accordance with the policies set out in note 1.
The financial statements have been prepared in accordance with International Financial Reporting Standards (IFRSs) as adopted for use in the European Union (EU), including International Accounting Standards (IAS) and interpretations issued by the International Financial Reporting Interpretations Committee (IFRIC) and the Companies Act 2006 applicable to Companies reporting under IFRS. Further standards may be issued by the International Accounting Standards Board (IASB) and standards currently in issue and endorsed by the EU may be subject to interpretations issued by the IFRIC.
The preparation of financial statements, in conformity with generally accepted accounting principles under IFRS, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management's best knowledge of the amount, event or actions, actual results ultimately may differ from those estimates.
The financial statements have been prepared on a historical cost basis except for the revaluation of certain financial assets and financial liabilities (including derivative instruments) at fair value through the income statement.
The financial statements have been prepared using consistent accounting policies except as stated below.
The following new standards and amendments to standards are mandatory for the first time for the financial year beginning 1 June 2011:
– IFRIC 19, 'Extinguishing financial liabilities with equity instruments'. This clarifies the requirements of IFRSs when an entity renegotiates the terms of a financial liability with its creditor and the creditor agrees to accept the entity's shares or other equity instruments to settle the financial liability fully or partially. The interpretation is effective for annual periods beginning on or after 1 July 2010.
The consolidated financial statements incorporate the financial statements of PZ Cussons Plc and entities controlled by PZ Cussons Plc (its subsidiaries) made up to 31 May each year. Control is achieved where the Company has the ability to govern the financial and operating policies of an investee entity so as to obtain benefits from its activities.
On acquisition, the assets and liabilities and contingent liabilities of a subsidiary are measured at their fair values at the date of acquisition. Any excess of the fair value of consideration over the fair values of the identifiable net assets acquired is recognised as goodwill. Any deficiency below the fair values of the identifiable net assets acquired (i.e. discount on acquisition) is credited to the income statement in the period of acquisition.
The total profits or losses of subsidiaries are included in the consolidated income statement and the interest of non-controlling interests is stated at the non-controlling interest's proportion of the fair values of the assets and liabilities recognised. Subsequently, losses applicable to the non-controlling interest in excess of the non-controlling interest's interest in the subsidiary's equity are allocated against the interests of the Group except to the extent that the non-controlling interest has a binding obligation and is able to make an additional investment to cover the losses. The interest of non-controlling interests in the acquiree is initially measured at the non-controlling interest's proportion of the net fair value of the assets, liabilities and contingent liabilities recognised. Where non-controlling interests are acquired, the excess of cost over the value of the non-controlling interest acquired is recorded in equity.
The results of subsidiaries acquired or disposed of during the year are included in the consolidated income statement from the effective date of acquisition or up to the effective date of disposal, as appropriate.
Where necessary, the accounts of overseas subsidiaries are adjusted to conform to the Group's accounting policies. All intra-group transactions, balances, income and expenses are eliminated on consolidation.
Operating profit is the profit of the Group before finance income, finance costs and taxation.
The Group adopts a columnar income statement format to highlight significant items within the Group results for the period. Such items are considered by the Directors to be exceptional in nature rather than being representative of the underlying trading of the Group, and may include such items as restructuring costs, acquisition related costs, material impairments of non-current assets, material profits and losses on disposal of property, plant and equipment, profit or loss on disposal or termination of operations and material pension settlements and amendments. The Directors apply judgement in assessing the particular items, which by virtue of their scale and nature should be disclosed in a separate column of the income statement and notes to the financial statements as 'Exceptional items'. The Directors believe that the separate disclosure of these items is relevant to an understanding of the Group's financial performance.
The acquisition of subsidiaries is accounted for using the purchase method. The fair value of consideration of the acquisition is measured at the aggregate of the fair values, at the date of exchange, of assets given, liabilities incurred or assumed, and equity instruments issued by the Group in exchange for control of the acquiree. The acquiree's identifiable assets, liabilities and contingent liabilities that meet the conditions for recognition under IFRS 3 'Business combinations' are recognised at their fair values at the acquisition date, except for non-current assets (or disposal groups) that are classified as held for sale in accordance with IFRS 5 'Non-current assets held for sale and discontinued operations', which are recognised and measured at the lower of the assets' previous carrying value and fair value less costs to sell.
A joint venture is a contractual arrangement whereby the Group and other parties undertake an economic activity that is subject to joint control, that is when the strategic financial and operating policy decisions relating to the activities require the unanimous consent of the parties sharing control. Joint venture arrangements that involve the establishment of a separate entity in which each venturer has an interest are referred to as jointly controlled entities. The Group reports its interests in jointly controlled entities using the equity method of accounting. Under IAS 28 'Investments in associates' and IAS 31 'Interests in joint ventures', a single figure for post-tax results is presented as a separate item on the face of the income statement as part of profit before tax within operating profit. Long-term loans which are considered to be permanent as equity are combined with the Group's share of net assets/liabilities and shown on a single line within non-current assets.
Goodwill arising on the acquisition of a subsidiary or a jointly controlled entity represents the excess of the cost of acquisition over the Group's interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the subsidiary or jointly controlled entity recognised at the date of acquisition. If, after reassessment, the Group's interest in the net fair value of the acquiree's identifiable assets, liabilities and contingent liabilities exceeds the cost of the business combination, the excess is recognised immediately in the income statement.
Goodwill also includes amounts to reflect deferred tax liabilities established in relation to acquisitions in accordance with IFRS 3 'Business Combinations'. Goodwill is initially recognised as an asset and is subsequently measured at cost less any accumulated impairment losses. Goodwill is reviewed for impairment at least annually.
For the purpose of impairment testing, goodwill is allocated to each of the Group's cash-generating units expected to benefit from the synergies of the combination. Cash-generating units to which goodwill has been allocated are tested for impairment annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit. An impairment loss recognised for goodwill is not reversed in a subsequent period. On disposal of a subsidiary or a jointly controlled entity, the attributable amount of goodwill is included in the determination of the profit or loss on disposal.
Goodwill arising on acquisitions before the date of transition to IFRS has been retained at the previous UK GAAP amounts. Goodwill written off to reserves under UK GAAP prior to 1998 has not been reinstated and is not included in determining any subsequent profit or loss on disposal.
An acquired brand is only recognised on the balance sheet where it is supported by a registered trademark, where brand earnings are separately identifiable and the brand could be sold separately from the rest of the business. Brands acquired as part of a business combination are recorded in the balance sheet at fair value at the date of acquisition. Trademarks, patents and purchased brands are recorded at purchase cost. Brands currently held are not amortised as the Directors believe they have indefinite lives due to their market leading nature. In accordance with IAS 36 'Impairment of assets', the brands are tested for impairment annually, and whenever there is an indication that the asset may be impaired. Any impairment is recognised immediately in the income statement.
Applying indefinite lives to certain acquired brands is appropriate due to the stable long-term nature of the business and the enduring nature of the brands. A core element of the Group's strategy is to invest in building its brands through an ongoing programme of product innovation and sustained and rising marketing (particularly media) investment. A brand typically comprises an assortment of base products and more innovative products. Both contribute to the enduring nature of the brand. The base products establish the long-term positioning of the brand while a succession of innovations attracts ongoing consumer interest and attention. Indefinite life brands are allocated to the cash generating units to which they relate and are tested annually for impairment.
Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset in prior years. A reversal of an impairment loss is recognised immediately as income. Profit or losses on disposal of brands are included within operating profit.
Revenue is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods and services provided in the normal course of business, net of discounts, rebates and sales related taxes but including interest receivable on sales on extended credit and income from the provision of technical services and agreements. Sales of goods are recognised when title has passed and the significant risks and rewards of ownership have been transferred.
Dividend income from investments is recognised when the shareholders' rights to receive payment have been established.
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee. All other leases are classified as operating leases.
Rentals payable under operating leases are charged to the income statement on a straight-line basis over the term of the relevant lease. Benefits received and receivable as an incentive to enter into an operating lease are also spread on a straight-line basis over the lease term.
The individual financial statements of each Group entity are presented in the currency of the primary economic environment in which the entity operates (its functional currency). For the purpose of the consolidated financial statements, the results and financial position of each entity are expressed in Sterling, which is the functional currency of the Company, and the presentation currency for the consolidated financial statements.
In preparing the financial statements of the individual entities, transactions in currencies other than the entity's functional currency are recorded at the actual rate of exchange prevailing on the dates of the transactions. At each balance sheet date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing at the balance sheet date.
Foreign exchange gains and losses arising from the settlement of foreign currency transactions and from the translation of monetary assets and liabilities denominated in foreign currencies are recognised in the income statement.
In order to hedge its exposure to certain foreign exchange risks, the Group enters into forward contracts.
On consolidation, the assets and liabilities of the Group's overseas operations are translated at exchange rates prevailing on the balance sheet date. Income and expense items are translated at the average exchange rates for the period unless exchange rates fluctuate significantly. Cumulative foreign currency translation differences arising on the translation and consolidation of foreign operations' income statements and balance sheets denominated in foreign currencies are recorded as a separate component of equity. Applying the exemption under IFRS 1 'First time adoption of International Financial Reporting Standards', the Group has set the currency reserve to zero at 1 June 2004, the date of transition to IFRS and measured and recorded separately in that currency reserve all cumulative foreign currency translation differences arising after that date. On disposal of a foreign operation the cumulative translation differences will be transferred to the income statement in the period of the disposal as part of the gain or loss on disposal.
Finance income and expense are recognised in the income statement in the period in which they are incurred.
Government grants related to property, plant and equipment are reflected in the balance sheet as deferred income and credited to the income statement over the useful lives of the assets concerned. Government grants relating to income are reflected in the balance sheet as deferred income and credited to the income statement over the period to which the grant relates.
The Group operates retirement benefit schemes in the United Kingdom and for most overseas countries in which it carries on business. Those in the United Kingdom are defined benefit schemes and defined contribution schemes; overseas schemes vary in detail depending on local practice. The UK defined benefit schemes were closed to future accrual on 31 May 2008.
In respect of the defined benefit schemes, the cost of providing benefits is determined using the projected unit credit method, with full actuarial valuations being carried out every three years or more frequently should a material change occur in any of the schemes. Actuarial gains and losses are recognised in full in the period in which they occur. They are recognised outside the income statement and presented in the statement of comprehensive income.
Past service cost is recognised immediately to the extent that the benefits have already vested, and otherwise amortised on a straight-line basis over the average period until the benefits become vested. The retirement benefit obligation recognised in the balance sheet represents the present value of the defined benefit obligation as adjusted for unrecognised past service cost, and as reduced by the fair value of scheme assets. Any asset resulting from this calculation is limited to past service cost, plus the present value of available refunds and reductions in future contributions to the plan. All components of the pension cost are included within operating profit.
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
The Group operates a Deferred Annual Share Bonus Scheme, a Performance Share Plan and an Executive Share Option Scheme for senior executives, all of which involve equity-settled share-based payments.
Equity-settled share-based payments under the Executive Share Option Scheme are measured at fair value (excluding the effect of non-market based vesting conditions) at the date of grant. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period. Fair value is measured using the Black-Scholes pricing model. The expected life used in the model has been adjusted, based on management's best estimate, for the effects of non-transferability, exercise restrictions and behavioural considerations.
The awards under the Performance Share Plan are measured at the fair value at the date of grant and are expensed over the period to which the performance relates based on the expected outcome of the vesting conditions.
The awards under the Deferred Annual Share Bonus Scheme are measured at fair value at the date of grant and are expensed over the period to which the performance relates.
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The Group's liability for current and deferred tax is calculated using tax rates that have been enacted or substantively enacted at the balance sheet date.
Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit, and is accounted for using the balance sheet liability method. Deferred tax liabilities are generally recognised for all taxable temporary differences and deferred tax assets are recognised to the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilised. Such assets and liabilities are not recognised if the temporary difference arises from goodwill or from the initial recognition (other than in a business combination) of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
Deferred tax liabilities are recognised for taxable temporary differences arising on investments in subsidiaries and interests in joint ventures, except where the Group is able to control the reversal of the temporary difference and it is probable that the temporary difference will not reverse in the foreseeable future.
The carrying amount of deferred tax assets is reviewed at each balance sheet date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited to the income statement, except when it relates to items charged or credited to equity, in which case the deferred tax is also dealt with in equity.
Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Group intends to settle its current tax liabilities on a net basis.
Land and buildings held for use in the production or supply of goods or services, or for administration purposes, are stated in the balance sheet at deemed cost at the date of transition to IFRS less accumulated depreciation and any accumulated impairment losses. All other assets are stated at historical cost less accumulated depreciation and accumulated impairment losses. Historical cost includes expenditure that is directly attributable to the acquisition of the item.
Depreciation is charged so as to write off the cost or valuation of assets, other than land, over their estimated useful lives, using the straight-line method, on the following basis:
| Freehold buildings at rates not less than | 2% |
|---|---|
| Leasehold buildings at rates which will reduce the book value to nil on or before the termination of the leases with a | |
| minimum of | 2% |
| Plant and machinery not less than | 8% |
| Fixtures, fittings and vehicles not less than | 20% |
In the case of major projects depreciation is provided from the date the project in question is brought into use.
The gain or loss arising on the disposal or retirement of an asset is determined as the difference between the sales proceeds and the carrying amount of the asset and is recognised in the income statement for the period.
The assets' residual values and useful lives are reviewed and adjusted if appropriate at each balance sheet date.
Inventories are stated at the lower of cost and estimated net realisable value. Cost comprises direct materials and where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. Cost is calculated using the FIFO method. Net realisable value represents the estimated selling price less all estimated costs of completion and costs to be incurred in marketing, selling and distribution.
Trade receivables are recognised initially at fair value and subsequently measured at amortised cost using the effective interest rate method, less provision for impairment. A provision for impairment of trade receivables is established when there is objective evidence that the Group will not be able to collect all amounts due according to the original terms of the receivables.
Research and development expenditure is charged against profits in the year in which it is incurred, unless it meets the criteria for capitalisation set out in IAS 38 'Intangible assets'.
Cash, cash equivalents and bank overdrafts includes cash at bank and in hand plus short-term deposits less overdrafts. Short-term deposits have a maturity of less than three months from the date of acquisition. Bank overdrafts are repayable on demand and form an integral part of the Group's cash management.
Financial assets and financial liabilities are recognised on the Group's balance sheet when the Group becomes a party to the contractual provisions of the instrument.
The Group's activities expose it primarily to the financial risks of changes in foreign exchange rates and to fluctuations in interest rates. The Group uses derivative financial instruments (primarily foreign currency forward contracts) to hedge its risks associated with foreign currency fluctuations relating to certain firm commitments and forecasted transactions. The Group uses derivative financial instruments (primarily interest rate swaps) to hedge a proportion of the exposure to floating interest rate fluctuations.
The use of financial derivatives is governed by the Group's policies approved by the Board of Directors, which provide written principles in the use of financial derivatives consistent with the Group's risk management strategy. The Group does not use derivative financial instruments for speculative purposes.
Derivative financial instruments are initially measured at fair value at the contract date, and are remeasured to fair value at subsequent reporting dates. Changes in the fair value of derivative financial instruments that are designated and effective as hedges of future cash flows are recognised directly in other comprehensive income, and any ineffective portion is recognised immediately in the income statement.
Interest-bearing bank loans and overdrafts are recorded at the proceeds received, net of direct issue costs. Finance charges, including premiums payable on settlement or redemption and direct issue costs, are accounted for on an accruals basis through the income statement using the effective interest method and are added to the carrying amount of the instrument to the extent they are not settled in the period in which they arise.
Trade payables are not interest bearing and are stated at their nominal value.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Group after deducting all of its liabilities.
Investments (other than interests in joint ventures) are recognised and derecognised on a trade date when a purchase or sale of an investment is under a contract whose terms require delivery of the investment within the timeframe established by the market concerned, and are initially measured at cost, including transaction costs.
Investments are classified as either held-to-maturity, held-for-trading, loans and receivables or available-for-sale. Held-to-maturity investments and loans and receivables are measured at amortised cost. Held-for-trading and available-for-sale investments are measured at subsequent reporting dates at fair value. Where securities are held-for-trading purposes, gains and losses arising from changes in fair value are included in the income statement for the period. For available-for-sale investments, gains and losses arising from changes in fair value are recognised directly in equity, until the security is disposed of or is determined to be impaired, at which time the cumulative gain or loss previously recognised in equity is included in the income statement for the period.
Provisions are recognised when the Group has a present obligation as a result of a past event, and it is probable that the Group will be required to settle that obligation. Provisions are measured at the Directors' best estimate of the expenditure required to settle the obligation at the balance sheet date. Provisions for restructuring costs are recognised when the Group has a detailed formal plan for the restructuring that has been communicated to affected parties.
Dividend distribution to the Company's shareholders is recognised as a liability in the Group's financial statements in the period in which the dividends are approved by the Company's shareholders. In respect of interim dividends these are recognised once paid.
Estimates and accounting judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
The preparation of financial statements under IFRS requires management to make assumptions and estimates about future events. The resulting accounting estimates will, by definition, differ from the actual results. The assumptions and estimates that have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities within the next financial year, follow below.
The Group records all intangible assets acquired as part of a business combination at fair value. Intangible assets are deemed to have indefinite lives and as such are not amortised but are subject, as a minimum, to annual tests for impairment. Determining whether intangible assets are impaired requires an estimation of the value in use of the cash-generating units to which the intangible asset has been allocated. The value in use calculation requires management to estimate the future cash flows expected to arise from the cash-generating unit and a suitable discount rate in order to calculate present value. Details of key estimates are discussed in note 10.
The Group has three main defined benefit schemes which are based and administered in the UK and are independent of the Group's finances. These schemes were closed to future accrual on 31 May 2008. Actuarial valuations are carried out as determined by the trustees at intervals of not more than three years. The retirement benefit cost under IAS 19 is assessed in accordance with the advice of a firm of actuaries based on the latest actuarial valuation and assumptions advised by the actuary. The assumptions are based on information supplied to the actuary by the Company, supplemented by discussions between the actuary and management. The assumptions are disclosed in note 23. Operating results are affected by the actuarial assumptions used. These assumptions include discount rates, mortality rates, inflation rates, expected long-term rates of return on assets, take up rates on enhanced transfer value exercises and may differ from actual results due to changing market and economic conditions and longer or shorter lives of participants.
The Group recognises revenue generally at the time of delivery, which represents the point at which the significant risks and rewards of ownership are transferred to the customer, and when collection of the resulting consideration for those goods is reasonably assured. Should management consider that the criteria for recognition are not met, revenue is deferred until such time as the consideration has been fully earned. Revenue is measured at the fair value of the consideration received or receivable and represents amounts receivable net of discounts, rebates and sales-related taxes but including interest receivable on sales on extended credit and income from the provision of technical services and agreements. Dividend income from investments is recognised when the right to receive payment is established.
The chief operating decision-maker has been identified as the Executive Board which comprises the four Executive Directors.
The Executive Board reviews the Group's internal reporting in order to assess performance and allocate resources. Management has determined the operating segments based on these reports which include an allocation of central revenue and costs as appropriate.
The Executive Board considers the business from a geographic perspective, with Africa, Asia and Europe being the reporting segments. The Executive Board assesses the performance based on operating profit before any exceptional items. Other information provided, except as noted below, to the Executive Board is measured in a manner consistent with that of the financial statements.
Sales between segments are carried out at an arms length.
| Business segments | |||||
|---|---|---|---|---|---|
| Africa | Asia | Europe1 | Eliminations | Total | |
| 2012 | £m | £m | £m | £m | £m |
| Total gross segment revenue | 375.2 | 171.3 | 512.5 | (200.1) | 858.9 |
| Inter segment revenue | (13.0) | (12.5) | (174.6) | 200.1 | – |
| Revenue | 362.2 | 158.8 | 337.9 | – | 858.9 |
| Segmental operating profit before exceptional items and share of results of | |||||
| joint ventures | 33.7 | 8.3 | 51.6 | – | 93.6 |
| Share of results of joint ventures | (0.2) | – | – | – | (0.2) |
| Segmental operating profit before exceptional items | 33.5 | 8.3 | 51.6 | – | 93.4 |
| Exceptional items | (6.1) | (30.1) | (7.6) | – | (43.8) |
| Segmental operating profit | 27.4 | (21.8) | 44.0 | – | 49.6 |
| Finance income | 2.5 | ||||
| Finance cost | (3.6) | ||||
| Profit before taxation | 48.5 | ||||
| Depreciation | 8.4 | 5.8 | 8.3 | – | 22.5 |
1 Europe segmental result includes revenue and profit from US and Australia in relation to Beauty division that is deemed to be immaterial.
| 2011 | Africa £m |
Asia £m |
Europe1 £m |
Eliminations £m |
Total £m |
|---|---|---|---|---|---|
| Total gross segment revenue Inter segment revenue |
343.4 (4.3) |
189.0 (12.9) |
480.0 (174.5) |
(191.7) 191.7 |
820.7 – |
| Revenue | 339.1 | 176.1 | 305.5 | – | 820.7 |
| Segmental operating profit before exceptional items and share of results of joint ventures Share of results of joint ventures |
40.6 0.4 |
17.5 – |
49.6 – |
– – |
107.7 0.4 |
| Segmental operating profit before exceptional items | 41.0 | 17.5 | 49.6 | – | 108.1 |
| Exceptional items | – | – | (0.8) | – | (0.8) |
| Segmental operating profit | 41.0 | 17.5 | 48.8 | – | 107.3 |
| Finance income Finance cost |
3.4 (2.6) |
||||
| Profit before taxation | 108.1 | ||||
| Depreciation | 8.3 | 5.6 | 7.7 | – | 21.6 |
1 Europe segmental result includes revenue and profit from US that is deemed to be immaterial.
| Exceptional items included within operating profit: | Exceptional item before taxation £m |
Taxation £m |
Exceptional item after taxation £m |
|---|---|---|---|
| Supply chain optimisation | 27.5 | (9.7) | 17.8 |
| Pension scheme de-risking charge | 0.3 | (0.1) | 0.2 |
| Beauty division acquisition and integration costs | 6.3 | (1.6) | 4.7 |
| Australian Home Care brand impairment | 9.7 | – | 9.7 |
| Deferred tax benefit of reduction in UK Corporation tax rate principally relating to brands | – | (3.0) | (3.0) |
| 43.8 | (14.4) | 29.4 |
| Year to 31 May 2011 Exceptional items included within operating profit: |
Exceptional item before taxation £m |
Taxation £m |
Exceptional item after taxation £m |
|---|---|---|---|
| Pension scheme de-risking charge | 2.4 | (0.7) | 1.7 |
| Pension schemes – benefit of change from RPI to CPI | (7.5) | 2.0 | (5.5) |
| Acquisition expenses – St Tropez | 1.7 | (0.2) | 1.5 |
| Beauty division formation costs | 4.2 | (1.0) | 3.2 |
| Deferred tax benefit of reduction in UK Corporation tax rate principally relating to brands | – | (2.1) | (2.1) |
| 0.8 | (2.0) | (1.2) |
To ensure that the supply chain cost base remains at a competitive level a supply chain optimisation project has been implemented to significantly reduce the overhead footprint of the Group's manufacturing activities. The main activities involved in this project are the closing of manufacturing facilities in Australia and Ghana, in addition to other optimisation projects in Africa and Asia. Exceptional costs principally relating to the write down of manufacturing facilities and certain other restructuring costs have therefore been incurred.
The Group has finalised the de-risking exercise that was commenced in the prior year in relation to the enhanced transfer value exercise for deferred members of the main UK defined benefit pension scheme.
The Group incurred £1.1 million of acquisition and related costs for the purchase of the Fudge hair-care brand and associated inventory. Details of the acquisition are given in note 29. In addition, charges totalling £3.2 million were incurred in integrating the Fudge brand selling and logistics activities into the Beauty division. Further costs totalling £2.0 million have been incurred rationalising the activities of the Beauty division post Fudge integration.
The current year performance and forward projections of our value dish-care brand in Australia, Trix, have been significantly affected by both market competition and rationalisation by key retailers resulting in significant uncertainty over future expected cash flows. Therefore a decision was made to fully impair the brand at 31 May 2012.
The UK corporation tax rate reduced to 24% from 26% on 1 April 2012. As a result of this change, the deferred tax balances relating to UK assets and liabilities have been reduced to take account of the substantively enacted rate change. The largest single effect of the rate change is in relation to the deferred tax liabilities recognised when the Sanctuary, St Tropez and Charles Worthington brands were acquired and this has been disclosed as an exceptional item due to its size and the fact that it relates to previous acquisitions.
The Group commenced a de-risking exercise in relation to the UK defined benefit pension schemes in order to reduce the impact of future volatility in the valuation of the schemes' assets and liabilities. The first element of this de-risking exercise was an enhanced transfer value exercise for deferred members of the main UK pension scheme. This exercise commenced in May 2011 and the charge in the year of £2.4 million represented an assessment of the likely cost based on expected take-up rates.
The Government announced in December 2010 that the inflation measure for determining minimum pension increases would move from RPI to CPI. In general the CPI index is lower than RPI and this led to a reduction in the scheme liabilities as at 31 May 2011. The effect of this change on the liabilities was reported through the income statement as a past service credit of £7.5 million due to it being a change in benefit.
The Group incurred £1.7 million of acquisition and related costs for the purchase of St Tropez Holdings Limited.
In February 2011, the Group announced the formation of the Beauty division, bringing the Group's more premium brands – Sanctuary, Charles Worthington and St Tropez – together as one strategic business unit. The formation of the Beauty division led to the consolidation of the operations into a new Central London office and resulted in the closure of St Tropez's Nottingham site and the closure of the Sanctuary offices in London. The Charles Worthington business, previously integrated into the PZ Cussons UK operating unit, was also transferred. The exceptional costs principally related to restructuring costs and certain other costs of integrating the three brands into a new single operating unit.
The UK corporation tax rate reduced to 26% from 28% on 1 April 2011. As a result of this change, the deferred tax balances relating to UK assets and liabilities were reduced to take account of the substantively enacted rate change. The largest single effect of the rate change was in relation to the deferred tax liability recognised when the Sanctuary and Charles Worthington brands were acquired and this was disclosed as an exceptional item due to its size and the fact that it related to previous acquisitions.
Profit for the year has been arrived at after charging/(crediting):
| 2012 £m |
2011 £m |
|
|---|---|---|
| Net foreign exchange (gain)/losses | (2.3) | 4.1 |
| Research and development costs | 3.5 | 3.2 |
| Amortisation of government grants | (0.3) | (0.2) |
| Impairment loss on intangible assets | 9.7 | – |
| Impairment loss on tangible fixed assets | 12.4 | – |
| Depreciation of property, plant and equipment | 22.5 | 21.6 |
| (Profit)/loss on disposal of property, plant and equipment | (0.5) | 0.1 |
| Loss on disposal of intangible asset | 0.1 | – |
| Raw and packaging materials and goods purchased for resale | 445.6 | 396.0 |
| Operating lease rentals | 2.9 | 3.5 |
| Employee costs (note 5) | 111.2 | 110.3 |
| Auditors' remuneration (see below) | 1.1 | 1.2 |
A more detailed analysis of auditors' remuneration on a worldwide basis is provided below:
| 2012 £m |
2011 £m |
|
|---|---|---|
| Fees payable to the Company's auditors for the audit of the Company's annual accounts Fees payable to the Company's auditors and their associates for other services to the Group |
0.1 | 0.1 |
| – The audit of the Company's subsidiaries pursuant to legislation | 0.5 | 0.5 |
| Total audit fees | 0.6 | 0.6 |
| Fees payable to the Company's auditors and its associates for other services | ||
| – Tax services pursuant to legislation | 0.2 | 0.2 |
| – Other tax services | 0.2 | 0.2 |
| – Other services | 0.1 | 0.2 |
| Total fees | 1.1 | 1.2 |
Fees payable to PricewaterhouseCoopers LLP and its associates for non-audit services to the Company are not required to be disclosed because the consolidated financial statements are required to disclose such fees on a consolidated basis. Included in the other services amount above are fees paid to the Group's auditors in respect of their audit of the Group's UK retirement benefit schemes totalling £18,200 (2011: £18,200).
The average number of employees (including Executive Directors) was as follows:
| 2012 Number |
2011 Number |
|
|---|---|---|
| Production Selling and distribution Administration |
3,891 2,653 792 |
4,145 2,875 981 |
| 7,336 | 8,001 | |
| The costs incurred in respect of the above were as follows: | 2012 | 2011 |
| £m | £m | |
| Wages and salaries Social security and other costs Post-employment benefits Share-based payments (credit)/charge (note 28) |
101.3 7.8 2.6 (0.5) |
101.7 8.5 (2.2) 2.3 |
| 111.2 | 110.3 | |
| The post-employment benefits consist of: | 2012 £m |
2011 £m |
| Defined benefit schemes (note 23) | (1.0) | (6.3) |
| Defined contribution schemes (note 23) Overseas minor defined benefit schemes and Nigerian gratuity scheme (note 23) |
2.8 0.8 |
3.3 0.8 |
| 2.6 | (2.2) |
The costs incurred in respect of the Directors, who are regarded as the key management personnel, were as follows:
| 2012 £m |
2011 £m |
|
|---|---|---|
| Fees to Non-executive Directors | 0.5 | 0.5 |
| Wages and salaries | 1.3 | 1.3 |
| Bonus – cash bonus | – | 0.2 |
| Benefits | 0.1 | 0.1 |
| Post-employment benefits | 0.3 | 0.3 |
| Share-based payments | (0.2) | 1.0 |
| Total | 2.0 | 3.4 |
Additional details are within the Report on Directors' remuneration on pages 37 to 43.
| 2012 £m |
2011 £m |
|
|---|---|---|
| Net investment gains | 0.5 | 0.2 |
| Interest receivable from joint ventures | – | 0.1 |
| Interest and dividends receivable | 2.0 | 3.1 |
| 2.5 | 3.4 | |
| Interest payable on bank loans and overdrafts | (3.6) | (2.6) |
| Net finance (expense)/income | (1.1) | 0.8 |
| 7. Taxation | ||
| 2012 | 2011 | |
| £m | £m | |
| Current tax | ||
| UK corporation tax charge for the year | 8.3 | 7.4 |
| Adjustments in respect of prior periods | (2.4) | (1.0) |
| 5.9 | 6.4 | |
| Overseas corporation tax charge for the year | 12.3 | 16.6 |
| Adjustments in respect of prior periods | (0.4) | (0.4) |
| 11.9 | 16.2 | |
| Total current tax charge | 17.8 | 22.6 |
| Deferred tax Temporary differences, origination and reversal |
(7.3) | 4.5 |
| Adjustments in respect of prior periods | – | 1.1 |
| Total deferred tax (note 21) | (7.3) | 5.6 |
| Total tax charge | 10.5 | 28.2 |
UK corporation tax is calculated at 25.69% (2011: 27.69%) of the estimated assessable profit for the year. Taxation for other jurisdictions is calculated at the rates prevailing in the respective jurisdictions.
Taxation on items taken directly to equity was a credit of £1.4 million (2011: £1.6 million) and relates to the movement in deferred tax on actuarial losses, on share option schemes and on financial derivatives recognised in the hedging reserve.
The tax charge for the year can be reconciled to the profit per the consolidated income statement as follows:
| 2012 £m |
2011 £m |
|
|---|---|---|
| Profit before tax | 48.5 | 108.1 |
| Tax at the UK corporation tax rate of 25.69% (2011: 27.69%) | 12.5 | 29.9 |
| Tax effect of revenue/expenses that are not taxable/deductible | 3.9 | 0.4 |
| Effect of different tax rates of subsidiaries in overseas jurisdictions | (2.0) | (0.6) |
| Effect of UK rate change on deferred taxation | (3.0) | (2.0) |
| Tax effect of share of results of joint ventures | 0.1 | (0.1) |
| Overseas withholding tax suffered on dividends | 1.8 | 0.9 |
| Prior period adjustment | (2.8) | (0.3) |
| Tax charge for the year | 10.5 | 28.2 |
The main rate of corporation tax in the UK reduced from 26% to 24% from 1 April 2012. The change in deferred tax has resulted in a reduction in deferred tax liabilities of £3.8 million of which £3.0 million has been recognised in the income statement as exceptional income and £0.8 million direct to equity.
The Finance Act 2012 was substantively enacted on 26 March 2012 and included legislation to reduce the main rate of corporation tax from 26% to 24% from 1 April 2012. A further reduction to 23% from 1 April 2013 was substantively enacted by subsequent legislation on 2 July 2012. All deferred tax assets have been remeasured at 24% as at the balance sheet date.
Further reductions to the UK corporation tax rate were announced in the 2012 Budget on 21 March 2012, which proposed to reduce the rate by 1% per annum to 22% by 1 April 2014. The changes had not been substantively enacted at the balance sheet date and therefore are not recognised in these financial statements. The impact of the proposed changes will be to reduce deferred tax liabilities in the balance sheet by around £3.0 million.
| 8. Dividends | ||
|---|---|---|
| 2012 | 2011 | |
| £m | £m | |
| Amounts recognised as distributions to Ordinary Shareholders in the year comprise: | ||
| Final dividend for the year ended 31 May 2011 of 4.487p (2010: 3.970p) per Ordinary Share | 19.2 | 17.0 |
| Interim dividend for the year ended 31 May 2012 of 2.23p (2011: 2.123p) per Ordinary Share | 9.6 | 9.0 |
| 28.8 | 26.0 | |
| Proposed final dividend for the year ended 31 May 2012 of 4.487p (2011: 4.487p) per Ordinary Share | 19.2 | 19.2 |
The proposed final dividends for the years ended 31 May 2011 and 31 May 2012 were subject to approval by shareholders at the Annual General Meeting and hence have not been included as liabilities in the financial statements at 31 May 2011 and 31 May 2012 respectively.
At 31 May 2012, the Employee Share Option Trust held 334,856 Ordinary Shares (2011: 1,334,578 Ordinary Shares). The trust waived any entitlement to the dividends on these shares.
| 9. Earnings per share | ||
|---|---|---|
| 2012 | 2011 | |
| Profit attributable to Ordinary Equity Shareholders (£ million) | 34.4 | 70.4 |
| Basic earnings per share | 8.03p | 16.48p |
| Diluted earnings per share | 7.99p | 16.29p |
Basic earnings per share and diluted earnings per share are calculated by dividing profit for the period attributable to equity holders by the weighted average number of shares in issue.
| 2012 | 2011 | |
|---|---|---|
| Number | Number | |
| 000 | 000 | |
| Basic weighted average | 428,195 | 427,215 |
| Diluted weighted average | 430,629 | 432,048 |
The difference between the basic and diluted weighted average number of shares represents the dilutive effect of the Deferred Annual Share Bonus Scheme, the Executive Share Option Scheme and the Performance Share Plan. The weighted average number of shares can be reconciled to the weighted average number of shares including dilutive shares as follows:
| 2012 Number 000 |
2011 Number 000 |
|
|---|---|---|
| Basic weighted average Ordinary Shares in issue during the year Dilutive effect of share incentive plans |
428,195 2,434 |
427,215 4,833 |
| Diluted weighted average | 430,629 | 432,048 |
| Adjusted earnings per share | 2012 | 2011 |
| Basic earnings per share Exceptional items |
8.03p 6.71p |
16.48p (0.28)p |
| Adjusted basic earnings per share | 14.74p | 16.20p |
| Diluted earnings per share | 7.99p | 16.29p |
|---|---|---|
| Exceptional items | 6.66p | (0.27)p |
| Adjusted diluted earnings per share | 14.65p | 16.02p |
67 PZ Cussons Plc Annual Report & Accounts 2012
continued
Adjusted basic and diluted earnings per share figures are calculated by dividing adjusted profit for the year by the weighted average number of shares in issue (as above). The adjusted profit for the year is as follows:
| 2012 £m |
2011 £m |
|
|---|---|---|
| Profit attributable to Ordinary Equity Shareholders | 34.4 | 70.4 |
| Exceptional items (net of taxation effect) | 28.7 | (1.2) |
| Adjusted profit after tax | 63.1 | 69.2 |
| Other intangible |
|||
|---|---|---|---|
| Goodwill £m |
assets £m |
Total £m |
|
| Cost At 1 June 2010 |
34.7 | 128.3 | 163.0 |
| Acquired during the year Additions Currency retranslation |
11.1 – – |
58.4 0.4 1.0 |
69.5 0.4 1.0 |
| At 31 May 2011 | 45.8 | 188.1 | 233.9 |
| Acquired during the year (note 29) Additions Disposals Impairment loss Currency retranslation |
– – – – – |
24.6 0.1 (0.1) (9.7) (0.4) |
24.6 0.1 (0.1) (9.7) (0.4) |
| At 31 May 2012 | 45.8 | 202.6 | 248.4 |
Other intangible assets include the Group's acquired brands which are deemed to have indefinite lives.
On 24 January 2012, the Group acquired the Fudge brand, intellectual property, inventory and certain other business assets. The Fudge hair-care brand was valued at £24.6 million.
Goodwill and other intangible assets, which all have indefinite useful lives, are subject to annual impairment testing, or more frequent testing if there are indications of impairment. Intangible assets and goodwill are allocated to the appropriate cash-generating units (CGUs) based on the smallest identifiable group of assets that generates cash inflows independently in relation to the specific intangible/goodwill. In the prior year the St Tropez, Sanctuary and Charles Worthington brands and associated goodwill were treated as individual CGUs and tested separately for impairment. Following the formation of the Beauty division and the associated transfer of the aforementioned brand related trade and assets into the division in June 2011, the Directors consider the most appropriate level for testing the impairment of these brands and the newly acquired Fudge brand to be as one Beauty CGU. This represents a change from the prior year presentation, which has been restated accordingly. The recoverable amounts of the CGU's are determined from value-in-use calculations that use amounts from approved budgets and plans over a period of five years (2011: five years) and pre-tax cash flows projected forward assuming a perpetual growth rate of 2.3% (2011: 3.0%). The discount rate applied to the cash flow projections was 11.3% on a pre-tax basis (2011: 8.0% to 10.0%). The average per-annum growth rate applied to the initial period ranged from 5.0% to 20.0% (2011: 5.0% to 10.0%) and was based on industry growth rates. The net book value of goodwill and other intangible assets by CGUs was as follows:
| Other | Other | |||
|---|---|---|---|---|
| intangible | intangible | |||
| Goodwill | Goodwill | assets | assets | |
| 2012 | 2011 | 2012 | 2011 | |
| £m | £m | £m | £m | |
| Original Source | – | – | 9.8 | 9.8 |
| Trix | – | – | – | 9.6 |
| Beauty division | 40.4 | 40.4 | 188.2 | 163.6 |
| Other | 5.4 | 5.4 | 4.6 | 5.1 |
| Total | 45.8 | 45.8 | 202.6 | 188.1 |
The current year performance and forward projections of the Trix brand have been significantly affected by market competition and retailer rationalisation resulting in uncertainty over future expected cash flows. A decision was therefore made to fully impair the Trix brand at year-end. The loss has been charged within exceptional administrative expenses in the income statement.
A sensitivity analysis has been performed around the base assumptions and with the conclusion that no reasonable possible changes in key assumptions would cause the recoverable amount of the goodwill and other intangible assets to be less than the carrying value.
| Land and buildings £m |
Plant and machinery £m |
Fixtures, fittings and vehicles £m |
Assets in course of construction £m |
Total £m |
|
|---|---|---|---|---|---|
| Cost At 1 June 2010 |
140.8 | 184.6 | 40.5 | 33.3 | 399.2 |
| Currency retranslation Acquisitions Additions Disposals Reclassifications |
(8.2) – 2.3 (0.2) 11.3 |
(7.1) – 3.5 (1.7) 16.7 |
(1.5) 0.1 2.4 (3.6) 11.7 |
(2.1) – 14.0 – (39.7) |
(18.9) 0.1 22.2 (5.5) – |
| At 31 May 2011 | 146.0 | 196.0 | 49.6 | 5.5 | 397.1 |
| Currency retranslation Additions Disposals Reclassifications |
(0.6) 0.3 (0.1) 1.6 |
(1.7) 1.7 (2.1) 7.0 |
(0.9) 1.5 (4.1) 4.6 |
– 15.4 .(0.2) (13.2) |
(3.2) 18.9 (6.5) – |
| At 31 May 2012 | 147.2 | 200.9 | 50.7 | 7.5 | 406.3 |
| Depreciation and amounts written off | |||||
| At 1 June 2010 | 16.4 | 110.5 | 30.3 | – | 157.2 |
| Currency retranslation Charge for the year Disposals |
(0.7) 3.5 (0.1) |
(0.8) 11.2 (1.5) |
(0.8) 6.9 (3.5) |
– – – |
(2.3) 21.6 (5.1) |
| At 31 May 2011 | 19.1 | 119.4 | 32.9 | – | 171.4 |
| Currency retranslation Charge for the year Disposals Impairment loss |
(0.5) 9.7 – – |
(3.4) 5.4 (1.7) 12.4 |
(0.9) 7.4 (3.0) – |
– – – – |
(4.8) 22.5 (4.7) 12.4 |
| At 31 May 2012 | 28.3 | 132.1 | 36.4 | – | 196.8 |
| Net book values At 31 May 2012 |
118.9 | 68.8 | 14.3 | 7.5 | 209.5 |
| At 31 May 2011 | 126.9 | 76.6 | 16.7 | 5.5 | 225.7 |
At 31 May 2012, the Group had entered into commitments for the acquisition of property, plant and equipment amounting to £1.5 million (2011: £3.2 million). At 31 May 2012, the Group's share in the capital commitments of the joint ventures was £3.0 million (2011: £1.7 million).
A decision was made to impair the Australian manufacturing facilities at year end as part of the supply chain optimisation project. The loss has been charged within exceptional administrative expenses in the income statement.
| £m | ||
|---|---|---|
| Carrying value At 1 June 2010 |
(1.0) | |
| Exchange differences on translation of overseas net assets recognised in equity Share of result for the year taken to the income statement |
(3.5) 0.4 |
|
| At 31 May 2011 | (4.1) | |
| Exchange differences on translation of overseas net assets recognised in equity Share of result for the year taken to the income statement |
1.3 (0.2) |
|
| At 31 May 2012 | (3.0) | |
| 2012 £m |
2011 £m |
|
| Aggregated amounts relating to joint ventures Total assets Total liabilities |
100.2 (106.5) |
67.7 (75.9) |
| Net liabilities Revenues (Loss)/profit after taxation |
(6.3) 90.2 (0.5) |
(8.2) 68.7 0.8 |
The Group accounts for joint ventures using the equity method. A list of the investments in joint ventures, including the name, country of incorporation and proportion of ownership interest is given in note 31.
The net investment in joint ventures is broken down as follows:
| 2012 £m |
2011 £m |
|
|---|---|---|
| Investment in joint ventures – share of net liabilities | (3.0) | (4.1) |
| Long-term loans receivable from joint ventures | 41.7 | 24.9 |
| 38.7 | 20.8 |
The long-term loans receivable from the joint ventures are considered to be part of the Group's net investment in the joint ventures.
Non-current asset investments of £0.5 million (2011: £0.6 million) comprise a 31% investment in Norpalm Ghana Limited, a palm oil plantation in Ghana (note 31). The Group does not exercise significant influence over the affairs of this Company as it does not have the ability to participate in the financial and operating policies of the entity, and it is therefore not treated as an associated Company. The Directors consider the historical cost of the investment to be representative of its fair value at both 31 May 2012 and 31 May 2011.
| 2012 £m |
2011 £m |
|
|---|---|---|
| Raw materials and consumables | 67.7 | 58.5 |
| Work in progress | 7.5 | 9.6 |
| Finished goods and goods for resale | 98.4 | 83.6 |
| 173.6 | 151.7 |
During the year ended 31 May 2012 £1.7 million (2011: £2.6 million) was charged to the income statement for damaged, obsolete and lost inventories. The cost of the inventories recognised as an expense and included in cost of sales amounts to £445.6 million (2011: £396.0 million).
| 2012 £m |
2011 £m |
|
|---|---|---|
| Trade receivables Less: provision for impairment of trade receivables |
121.1 (7.0) |
127.6 (5.1) |
| Net trade receivables | 114.1 | 122.5 |
| Amounts owed by joint ventures | 4.8 | 7.8 |
| Other receivables | 14.8 | 18.6 |
| Prepayments and accrued income | 7.3 | 6.5 |
| Currency derivative instruments (note 18) | – | 0.4 |
| 141.0 | 155.8 | |
| Receivables due after more than one year | 2012 | 2011 |
| £m | £m | |
| Prepayments and accrued income | 0.6 | 0.3 |
| Other receivables | 0.4 | 0.5 |
| Total | 1.0 | 0.8 |
| Movements in the Group provision for impairment of trade receivables are as follows: | ||
| 2012 | 2011 | |
| £m | £m | |
| At 1 June | (5.1) | (8.5) |
| Provision for receivables impairment | (2.0) | (0.5) |
| Acquisition during the year | – | (0.2) |
| Receivables written off during the year | – | 2.3 |
| Unused amounts reversed | 0.1 | 1.3 |
| Currency translation | – | 0.5 |
| At 31 May | (7.0) | (5.1) |
Trade receivables consist of a broad cross section of our international customer base for whom there is no significant history of default. The credit risk of customers is assessed at a subsidiary and Group level, taking into account their financial positions, past experiences and other relevant factors. Individual customer credit limits are imposed based on these factors.
The credit period taken on sales ranges from 15 to 100 days (2011: 19 to 95 days) due to the differing nature of trade receivables in the Group's geographical segments.
No other receivables have been deemed to be impaired.
The carrying amount of the Group's trade receivables are denominated in the following currencies:
| 2012 | 2011 | |
|---|---|---|
| £m | £m | |
| Sterling | 26.6 | 28.0 |
| US Dollar | 6.0 | 5.5 |
| Nigerian Naira | 25.8 | 35.1 |
| Euro | 18.8 | 21.5 |
| Polish Zloty | 8.8 | 6.2 |
| Indonesian Rupiah | 10.5 | 9.0 |
| Ghanaian Cedi | 5.7 | 4.6 |
| Australian Dollar | 7.2 | 7.6 |
| Other minor currencies | 4.7 | 5.0 |
| 114.1 | 122.5 |
continued
The following table shows the age of trade receivables at the reporting date for which no allowance for impairment of trade receivables has been raised:
| 2012 £m |
2011 £m |
|
|---|---|---|
| Not past due | 94.7 | 104.4 |
| Past due 0–90 days | 18.6 | 15.7 |
| Past due 90–180 days | 0.6 | 1.0 |
| Past due > 180 days | 0.2 | 1.4 |
| 114.1 | 122.5 | |
| 16. Current asset investments | 2012 | 2011 |
| £m | £m | |
| Unlisted | 0.3 | 0.3 |
| Short-term deposits with joint ventures | 6.7 | 10.3 |
| 7.0 | 10.6 | |
| 17. Cash and cash equivalents | ||
| 2012 £m |
2011 £m |
|
| Cash at bank and in hand | 34.2 | 24.0 |
| Short-term deposits | 31.7 | 64.7 |
| Cash and short-term deposits | 65.9 | 88.7 |
| Less: bank overdrafts (included in borrowings, note 18) | – | (1.1) |
| Cash and cash equivalents | 65.9 | 87.6 |
| The effective interest rate on cash and cash equivalents during the year ended 31 May 2012 was 2.9% (2011: 3.2%). | ||
| 18. Borrowings | ||
| 2012 | 2011 | |
| £m | £m |
| £m | £m | |
|---|---|---|
| Overdrafts due within one year | – | 1.1 |
| Bank loans due within one year | 90.8 | 31.4 |
| Bank loans due after one year | – | 15.0 |
| 90.8 | 47.5 | |
| The borrowings are repayable as follows: | ||
|---|---|---|
| 2012 | 2011 | |
| £m | £m | |
| Within one year | 90.8 | 32.5 |
| Between one to two years | – | 15.0 |
| 90.8 | 47.5 |
Bank overdrafts are repayable on demand. The weighted average rate of interest on bank overdrafts was 1.9% (2011: 2.3%). Bank overdrafts are at floating rates of interest and hence expose the Group to cash flow interest rate risk. All covenants attached to borrowings have been complied with throughout the year.
All borrowings are at floating rate and the applicable weighted average interest rates are as follows:
| 2012 | ||||
|---|---|---|---|---|
| Interest | Interest | |||
| 2012 | rate | 2011 | rate | |
| £m | (%) | £m | (%) | |
| Borrowings | 90.8 | 1.7 | 47.5 | 1.4 |
| The Group's borrowings were denominated in the following currencies: | ||||
| 2012 | ||
|---|---|---|
| Sterling | Total | |
| £m | £m | |
| Analysis of borrowings by currency: | ||
| Bank loans | 90.8 | 90.8 |
| 90.8 | 90.8 | |
| 2011 | ||
| Sterling | Total | |
| £m | £m | |
| Analysis of borrowings by currency: | ||
| Bank overdrafts | 1.1 | 1.1 |
| Bank loans | 46.4 | 46.4 |
| 47.5 | 47.5 |
The functional currency of the majority of Group entities is local currency. Debt raised in currencies other than Sterling is, in most cases, raised in the functional currency of the entity raising the debt.
At 31 May 2012, the Group had un-drawn facilities of £101.7 million (2011: £123.6 million) available to it. Subsequent to the year end the Group has refinanced its committed borrowing facilities in the UK. The new facility provided by three banks is composed of a £45 million term loan and a £90 million revolving credit facility with a final termination date of 1 March 2016. The covenants are materially in line with the covenants of the previous facility.
The Group's operations expose it to a variety of financial risks that include the effects of changes in foreign exchange rates, credit risk, liquidity and interest rates. The primary risk faced by the Group is exchange rate risk. The Board has reviewed and agreed policies for management of this risk and has also approved all of the classes of financial instruments that may be used by the Group. The Group's treasury function reports to the Board at least annually with reference to the application of the Group treasury policy. The policy addresses issues of liquidity, funding and investment as well as interest rate, currency and commodity risks.
The Group's risk management policies are designed to identify and analyse these risks, to set appropriate risk limits and controls and to monitor the risks and limits continually by means of reliable and up-to-date systems. The Group modifies and enhances its risk management policies and systems to reflect changes in markets and products. The Group Risk Committee, under authority delegated by the Board, formulates the high level Group risk management policy, monitors risk and receives reports that allow it to review the effectiveness of the Group's risk management policies.
Credit risk is the risk that financial loss arises from the failure of a customer or counterparty to meet its obligations under a contract. It arises principally from lending, trade finance, treasury and leasing activities. The Group has dedicated standards, policies and procedures to control and monitor all such risks. Although the Group is potentially exposed to credit loss in the event of non-performance by counterparties, such credit risk is controlled through credit rating and equity price reviews of the counterparties and by limiting the total amount of exposure to any one party. The Group does not believe it is exposed to any material concentrations of credit risk.
Liquidity risk is the risk that the Group will not be able to meet its financial obligations as they fall due. The Group maintains a strong liquidity position and manages the liquidity profile of its assets, liabilities and commitments so that cash flows are appropriately balanced and all funding obligations are met when due.
The Group has committed credit facilities with high-quality international banks. All of these facilities have similar or equivalent terms and conditions. The Group has negotiated facilities with its bankers that provide sufficient headroom to ensure liquidity and continuity of funding.
Market risk is the risk that movements in market rates, including foreign exchange rates, interest rates, equity and commodity prices will reduce the Group's income. The management of market risk is undertaken using risk limits approved by the operating unit Finance Directors under delegated authority.
The Group's activities expose it to the financial risks of changes in foreign currency exchange rates. Subsidiary undertakings must ensure that all transactional exposures arising from commitments in a currency other than their functional currency are identified and monitored. The Group uses foreign currency forward contracts to manage these exposures.
The Group is not exposed to equity securities price risk. Due to the nature of the business, the Group is exposed to commodity price risk. The Group does take measures to protect against short-term impacts of these fluctuations, however, failure to recover higher costs could have a negative impact on profits.
The Group's objectives when managing capital are to safeguard the Group's ability to continue as a going concern in order to provide returns for shareholders and benefits for other stakeholders and to maintain an optimal capital structure to reduce the cost of capital.
In order to maintain or adjust the capital structure, the Group may adjust the amount of dividends paid to shareholders, return capital to shareholders, issue new shares or sell assets to reduce debt. The Group's capital is not restricted.
The Group had net (debt)/funds positions as at 31 May 2012 and 31 May 2011 respectively, as shown below:
| 2012 £m |
2011 £m |
|
|---|---|---|
| Cash at bank and in hand (see note 17) | 34.2 | 24.0 |
| Overdrafts (see note 17) | – | (1.1) |
| Short-term deposits (see note 17) | 31.7 | 64.7 |
| Cash and cash equivalents | 65.9 | 87.6 |
| Current asset investments | 7.0 | 10.6 |
| Bank loans less than one year | (90.8) | (31.4) |
| Bank loans greater than one year | – | (15.0) |
| Net (debt)/funds | (17.9) | 51.8 |
A 10% weakening of the Pound Sterling against the following currencies at 31 May would have increased equity and increased/ (decreased) profit/(loss) by the following amounts shown below. This analysis assumes that all other variables, in particular interest rates, remain constant.
| 2012 | 2011 | |||
|---|---|---|---|---|
| Equity £m |
Income statement £m |
Equity £m |
Income statement £m |
|
| Nigerian Naira Euro Indonesian Rupiah Australian Dollar |
18.7 4.3 3.9 2.0 |
1.1 0.2 0.7 (2.5) |
17.3 4.6 4.2 3.5 |
2.4 0.2 0.6 0.7 |
| Polish Zloty | 2.2 | 0.3 | 2.5 | 0.2 |
A 10% strengthening of the Pound Sterling against the above currencies would have had the equal and opposite effect on equity and profit by the amounts shown above, on the basis that all other variables remain constant.
The Group's variable rate borrowings are exposed to a risk of change in cash flows due to changes in interest rates.
Financial instruments utilised by the Group during the years ended 31 May 2012 and 31 May 2011, together with information regarding the methods and assumptions used to calculate fair values, can be summarised as follows:
In accordance with IAS 39 'Financial instruments: Recognition and Measurement', unlisted investments are held in the Group's balance sheet at cost because their fair value cannot be measured reliably due to the lack of quoted market prices.
Financial instruments included within current assets and liabilities (excluding cash and borrowings) are generally short-term in nature and accordingly their fair values approximate to their book values.
The carrying values of cash and short-term borrowings approximate to their fair values because of the short-term maturity of these instruments.
The financial instruments held by the Group do not, either individually or as a class, create a potentially significant exposure to market, credit, liquidity or cash flow interest rate risk.
Set out below is a comparison by category of the carrying values and fair values of all the Group's financial assets and financial liabilities as at 31 May 2012 and 31 May 2011. None of the financial assets and liabilities has been reclassified during the year.
| 2012 | 2011 | |
|---|---|---|
| Carrying | Carrying | |
| amount and | amount and | |
| fair value | fair value | |
| £m | £m | |
| Loans and receivables | ||
| Cash and short-term deposits | 65.9 | 88.7 |
| Trade and other receivables | 133.7 | 148.9 |
| Short-term deposit with joint ventures | 6.7 | 10.3 |
| Financial derivative assets | – | 0.4 |
| Loans to joint ventures | 41.7 | 24.9 |
| Financial liabilities | ||
| Trade and other payables | (182.6) | (206.5) |
| Bank overdrafts | – | (1.1) |
| Bank loans | (90.8) | (46.4) |
| Financial derivative liabilities | (0.8) | (0.6) |
| Amounts owed to joint ventures | (3.4) | (1.1) |
The fair value of trade receivables and payables is considered to be equal to the carrying amount of these items due to their short-term nature.
An analysis of the international long-term credit ratings of counterparties where cash and short-term deposits are held is as follows:
| 2012 £m |
2011 £m |
|
|---|---|---|
| AA | 26.4 | 46.0 |
| A | 8.6 | 15.1 |
| B | 30.0 | 27.6 |
| C | 0.9 | – |
| Total | 65.9 | 88.7 |
The short-term deposit of £6.7 million (2011: £10.3 million) is a repayable on-demand balance with Nutricima Ltd. The balance earns interest at a rate of 11% (2011: 7%).
continued
| 2012 | 2011 | |||
|---|---|---|---|---|
| Assets £m |
Liabilities £m |
Assets £m |
Liabilities £m |
|
| Forward foreign exchange contracts – cash flow hedges | – | (0.8) | 0.4 | (0.6) |
| Total | – | (0.8) | 0.4 | (0.6) |
Trading derivatives are classified as a current asset or liability. The full fair value of a hedging derivative is classified as a non-current asset or liability if the remaining maturity of the hedged item is more than 12 months and as a current asset or liability if the maturity of the hedged item is less than 12 months.
The net notional principal amounts of the outstanding forward foreign exchange contracts at 31 May 2012 were £39.6 million (2011: £33.3 million).
The hedged highly probable forecast transactions denominated in foreign currency are expected to occur at various dates during the next 12 months. Gains and losses recognised in the hedging reserve in equity on forward foreign exchange contracts as of 31 May 2012 are recognised in the income statement in the period or periods during which the hedged forecast transaction affects the income statement. This is generally within 12 months from the balance sheet date unless the gain or loss is included in the initial amount recognised for the purchase of fixed assets, in which case recognition is over the lifetime of the asset.
| 2012 £m |
2011 £m |
|
|---|---|---|
| Trade payables | 104.0 | 117.8 |
| Amounts owed to joint ventures | 3.4 | 1.1 |
| Other taxation and social security | 5.2 | 11.1 |
| Other payables | 9.4 | 22.7 |
| Financial derivative liabilities (note 18) | 0.8 | 0.6 |
| Accruals and deferred income | 69.2 | 66.0 |
| 192.0 | 219.3 |
Trade and other payables comprise amounts outstanding for trade purchases and ongoing costs. The average credit period taken for trade purchases is 56 days (2011: 55 days). The Directors consider the carrying amount of trade and other payables approximates their fair value.
| 2012 £m |
2011 £m |
|
|---|---|---|
| Other payables Accruals and deferred income |
0.9 – |
1.9 0.3 |
| 0.9 | 2.2 |
| At 31 May 2012 | (15.0) | 0.3 | (13.3) | 10.8 | (34.6) | 1.2 | (50.6) |
|---|---|---|---|---|---|---|---|
| Other | – | – | – | 1.0 | – | – | 1.0 |
| Currency translation | (0.3) | – | (0.5) | (0.8) | – | – | (1.6) |
| Credit/(charge) to equity | – | 2.5 | – | 0.3 | – | (1.4) | 1.4 |
| (Charge)/credit to income | (1.3) | (2.8) | (0.1) | 10.0 | 2.9 | (1.4) | 7.3 |
| At 31 May 2011 | (13.4) | 0.6 | (12.7) | 0.3 | (37.5) | 4.0 | (58.7) |
| Currency translation | 1.5 | 0.2 | 1.5 | 0.1 | – | – | 3.3 |
| Reclassification | – | (0.5) | – | 0.5 | – | – | – |
| Acquisition | – | – | – | – | (9.2) | – | (9.2) |
| Credit/(charge) to equity | – | 0.6 | – | (0.2) | – | 1.2 | 1.6 |
| (Charge)/credit to income | (2.1) | (3.7) | – | (0.2) | 1.0 | (0.6) | (5.6) |
| At 1 June 2010 | (12.8) | 4.0 | (14.2) | 0.1 | (29.3) | 3.4 | (48.8) |
| equipment £m |
obligations £m |
equipment £m |
differences £m |
combinations £m |
payments £m |
Total £m |
|
| Property, plant and |
Retirement benefit |
of property, plant and |
and other timing |
Business | Share-based | ||
| Revaluation | Tax losses |
Certain deferred tax assets and liabilities have been offset in accordance with IAS 12 'Income taxes'. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:
| 2012 | 2011 | |
|---|---|---|
| £m | £m | |
| Deferred tax assets | 10.7 | 10.3 |
| Deferred tax liabilities | (61.3) | (69.0) |
| (50.6) | (58.7) |
Deferred tax assets are recognised for tax loss carry-forwards to the extent that the realisation of the related tax benefit through future taxable profits is probable. At the balance sheet date, the Group recognised £8.1 million in respect of unused tax losses (2011: £0.4 million) available against future profits. None of the recognised losses are expected to expire. Temporary differences arising in connection with interests in associates and joint ventures are not significant.
| At 31 May 2012 | 16.9 |
|---|---|
| Utilised in the year | – |
| Income statement | 13.8 |
| Currency retranslation | (0.6) |
| At 31 May 2011 | 3.7 |
| Utilised in the year | (2.0) |
| Income statement | 3.1 |
| Currency retranslation | (0.5) |
| At 1 June 2010 | 3.1 |
| provisions £m |
|
| Restructuring and warranty |
Provisions as at 31 May 2012 relate to restructuring costs in connection with the formation of the Beauty division, other restructuring costs in relation to supply chain optimisation and warranty costs. Warranty costs account for £0.9 million (2011: £0.8 million) of the total and are expected to be utilised over a three year period. Restructuring provisions are expected to be utilised in the next 12 months.
The Group operates retirement benefit schemes for most of its United Kingdom and overseas subsidiaries. These obligations have been measured in accordance with IAS 19 and are as follows:
| 2012 | 2011 | |||||
|---|---|---|---|---|---|---|
| Surplus £m |
Deficit £m |
Total £m |
Surplus £m |
Deficit £m |
Total £m |
|
| Expatriate plan | 39.1 | – | 39.1 | 39.3 | – | 39.3 |
| Directors plan | – | (4.3) | (4.3) | – | (8.3) | (8.3) |
| Main staff plan | – | (25.9) | (25.9) | – | (28.2) | (28.2) |
| Other overseas units | – | (6.9) | (6.9) | – | (5.4) | (5.4) |
| 39.1 | (37.1) | 2.0 | 39.3 | (41.9) | (2.6) |
The movements in the year are as follows:
| benefits and similar |
benefits and similar |
||
|---|---|---|---|
| obligations £m |
obligations £m |
Total £m |
|
| At 1 June 2010 | (7.3) | (7.4) | (14.7) |
| Currency retranslation | 0.3 | – | 0.3 |
| Income statement | (0.8) | 6.3 | 5.5 |
| Reclassification to provisions and other creditors | 2.4 | – | 2.4 |
| Contributions paid | – | 6.7 | 6.7 |
| Utilised in the year | 0.5 | – | 0.5 |
| Actuarial movement | (0.5) | (2.8) | (3.3) |
| At 31 May 2011 | (5.4) | 2.8 | (2.6) |
| Currency retranslation | 0.3 | – | 0.3 |
| Income statement | (0.8) | 1.0 | 0.2 |
| Contributions paid | – | 15.3 | 15.3 |
| Utilised in the year | 0.3 | – | 0.3 |
| Actuarial movement | (1.3) | (10.2) | (11.5) |
| At 31 May 2012 | (6.9) | 8.9 | 2.0 |
Included within 'Overseas retirement benefits and similar obligations' are unfunded retirement benefit obligations relating to certain of the Group's overseas subsidiaries and other employee related provisions for long service and sick leave. These obligations have been measured in accordance with IAS 19.
The most significant overseas scheme as at 31 May 2012 is the Indonesian post retirement benefit scheme. The obligations have been measured in accordance with IAS 19 and a discount rate of 6.75% (2011: 8.25%) and salary inflation rate of 8.0% (2011: 8.0%) have been used. The scheme is unfunded and provision for future obligations included in the above table is £5.5 million (2011: £3.9 million).
The following three defined benefit schemes are the Group's main schemes, which are based and administered in the UK:
– Main staff plan – for all eligible UK based staff, excluding PZ Cussons Plc Executive Directors
– Directors plan – for PZ Cussons Plc Executive Directors
– Expatriate plan – for all eligible expatriate staff based outside the UK
On 31 May 2008 the three defined benefit schemes in the UK were closed to future accrual.
Employees within these schemes are provided with defined benefits based on service and final salary. The assets of the schemes are administered by trustees and are held in trust funds independent of the Group.
The Group also operates an unfunded, unapproved retirement benefit scheme. The cost of the unfunded, unapproved retirement benefit scheme is included in the total pension cost, on a basis consistent with IAS 19 'Employee benefits' and the assumptions set out below. In accordance with these unfunded arrangements, the Group made payments during the year to former Directors of £147,534 (2011: £141,338).
The last triennial actuarial valuations of the schemes administered in the UK were performed by independent professional actuaries at 1 June 2009 using the projected unit method of valuation.
The Group has finalised the de-risking exercise that was commenced in the prior year in relation to the enhanced transfer value exercise for deferred members of the main UK defined benefit pension scheme. The exceptional charge of £0.3 million is in respect of professional fees only. For the year to 31 May 2012 the total defined benefit pension credit arising from the three schemes amounted to £1.0 million (2011: credit of £6.3 million).
The major financial assumptions used by the actuary were as follows:
| 2012 | 2011 | |||||
|---|---|---|---|---|---|---|
| Rate of increase in salaries | 3.90% | 4.35% | ||||
| Rate of increase in retirement benefits in payment | 2.90% | 3.35% | ||||
| Discount rate | 4.60% | 5.25% | ||||
| Inflation assumption | 2.90% | 3.35% | ||||
| The mortality assumptions used were as follows: | ||||||
| 2012 Years |
2011 Years |
|||||
| Weighted average life expectancy on post-retirement mortality table used to determine benefit obligations: – Member age 65 (current life expectancy) |
22.5 | 22.1 | ||||
| – Member age 40 (life expectancy at age 65) | 25.6 | 24.6 | ||||
| The assets in the schemes and the expected rates of return were: | ||||||
| 2012 | 2011 | 2010 | ||||
| £m | £m | £m | ||||
| Equities | 6.60% | 120.0 | 7.60% | 121.0 | 7.75% | 114.5 |
| Bonds | 2.85% | 99.8 | 4.10% | 96.9 | 5.90% | 41.3 |
| Property | 4.90% | 43.7 | 5.65% | 38.8 | 5.90% | 72.5 |
| Cash and other | 0.50% | 9.8 | 0.50% | 5.2 | 0.50% | 8.1 |
| Total fair value of scheme assets | 273.3 | 261.9 | 236.4 | |||
| Present value of scheme liabilities | (264.4) | (259.1) | ||||
| (243.8) | ||||||
| Surplus/(deficit) in the schemes | 8.9 | 2.8 | (7.4) | |||
| Related deferred tax (liability)/asset | (2.1) | (0.7) | 2.0 |
To develop the expected long-term rate of return on assets assumptions, the Group considered the level of expected returns on risk-free investments, the historical level of the risk premium associated with the other asset class in which the portfolio is invested, and the expectations for future returns of each class of asset. The expected return for each class of asset was then weighted based on the actual asset allocation to develop the expected long-term return on assets assumption for the portfolio. The actual gain on plan assets was £16.5 million (2011: £28.8 million).
The net retirement benefit income/(expense) before taxation recognised in the income statement in respect of the defined benefit schemes is summarised as follows:
| 2012 £m |
2011 £m |
|
|---|---|---|
| Expected return on scheme assets Interest cost |
14.1 (13.1) |
14.2 (13.4) |
| Net retirement benefit income before taxation | 1.0 | 0.8 |
All above amounts are recognised in the Group's income statement before arriving at operating profit.
The reconciliation of the opening and closing balance sheet position is as follows:
| 2012 £m |
2011 £m |
|
|---|---|---|
| Surplus/(deficit) at beginning of year | 2.8 | (7.4) |
| Income recognised in the consolidated income statement | 1.0 | 0.8 |
| Exceptional income recognised in the consolidated income statement | – | 5.5 |
| Contributions paid | 15.3 | 6.7 |
| Actuarial loss | (10.2) | (2.8) |
| Net surplus at end of year | 8.9 | 2.8 |
| Analysed between: | ||
| Retirement benefit surplus | 39.1 | 39.3 |
| Retirement benefit obligation | (30.2) | (36.5) |
Actuarial gains and losses are recognised directly in the Consolidated statement of comprehensive income. At 31 May 2012, a cumulative pre-tax loss of £37.6 million (2011: £27.4 million) was recorded directly in the Consolidated statement of comprehensive income.
Movements in the fair value of plan assets were as follows:
| Assets 2012 £m |
Assets 2011 £m |
|
|---|---|---|
| 1 June | 261.9 | 236.4 |
| Expected return on assets | 14.1 | 14.2 |
| Actuarial gains | 2.4 | 14.6 |
| Employer contribution | 15.3 | 6.7 |
| Benefits paid | (20.4) | (10.0) |
| 31 May | 273.3 | 261.9 |
Movements in the present value of the defined benefit obligations were as follows:
| Obligations 2012 |
Obligations 2011 |
|
|---|---|---|
| £m | £m | |
| 1 June | (259.1) | (243.8) |
| Interest cost | (13.1) | (13.4) |
| Actuarial losses | (12.6) | (17.4) |
| Past service credit | – | 7.5 |
| Plan settlements | – | (2.0) |
| Benefits paid | 20.4 | 10.0 |
| 31 May | (264.4) | (259.1) |
| Plans that are wholly or partly funded | (260.3) | (254.4) |
| Plans that are wholly unfunded | (4.1) | (4.7) |
| (264.4) | (259.1) |
The history of the plan for the current and prior years is as follows:
| 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|
| Defined benefit obligation | 264.4 | 259.1 | 243.8 | 196.1 | 251.3 |
| Plan assets | 273.3 | 261.9 | 236.4 | 191.8 | 224.9 |
| Benefit/(deficit) | 8.9 | 2.8 | (7.4) | (4.3) | (26.4) |
| Experience adjustments on plan assets | 2.4 | 14.6 | 36.8 | (42.0) | (16.9) |
| Experience adjustments on plan liabilities | (12.6) | (17.4) | (44.0) | 61.5 | (4.5) |
| Total actuarial gains and losses recognised in consolidated statement | |||||
| of changes in equity | (10.2) | (2.8) | (7.2) | 19.5 | (21.4) |
During the year ending 31 May 2013 the Group expects to make cash contributions of £6.5 million (2012: £15.3 million) to funded defined benefit plans. A further £2.8 million (2012: £2.8 million) is expected to be contributed to defined contribution plans.
The amount recognised as an expense in the consolidated income statement in relation to defined contribution schemes is £2.8 million (2011: £3.3 million).
| 2012 | 2011 | ||||
|---|---|---|---|---|---|
| Number 000 |
Amount £m |
Number 000 |
Amount £m |
||
| Authorised: Ordinary Shares of 1p each |
570,000 | 5.7 | 570,000 | 5.7 | |
| Total authorised share capital | 570,000 | 5.7 | 570,000 | 5.7 | |
| Allotted, called up and fully paid: | |||||
| Ordinary Shares of 1p each | 428,725 | 4.3 | 428,725 | 4.3 | |
| Total called up share capital | 428,725 | 4.3 | 428,725 | 4.3 |
Included within retained earnings is the Employee Share Option Trust (ESOT).
The ESOT purchases shares to fund the Deferred Annual Share Bonus Scheme, the Executive Share Option Scheme and the Performance Share Plan, details of which are provided in the Report on Directors' Remuneration. At 31 May 2012, the trust held 334,856 (2011: 1,334,578) Ordinary Shares with a book value of £1.0 million (2011: £3.9 million). The market value of these shares as at 31 May 2012 was £1.1 million (2011: £4.9 million). During the year the ESOT purchased 854,383 shares of the Company at a cost of £2.8 million (2011: 780,650 at a cost of £2.3 million). The trust has waived any entitlement to dividends in respect of all the shares it holds.
| 2012 £m |
2011 £m |
|
|---|---|---|
| Profit before tax | 48.5 | 108.1 |
| Adjustment for net finance expense/(income) | 1.1 | (0.8) |
| Operating profit | 49.6 | 107.3 |
| Depreciation | 22.5 | 21.6 |
| Impairment loss on intangible assets – exceptional | 9.7 | – |
| Impairment loss of tangible fixed assets – exceptional | 12.4 | – |
| (Profit)/loss on sale of tangible fixed assets | (0.5) | 0.1 |
| Pension scheme contributions paid | (15.3) | (6.7) |
| Net pension credit for the year | (0.2) | (6.0) |
| Share of results from joint ventures | 0.2 | (0.4) |
| Share-based payment (credit)/charges | (0.5) | 2.3 |
| Operating cash flows before movements in working capital | 77.9 | 118.2 |
| Movements in working capital: | ||
| Inventories | (18.3) | (21.5) |
| Receivables | 12.2 | (36.8) |
| Payables | (26.1) | 52.0 |
| Provisions | 11.8 | 1.1 |
| Cash generated from operations | 57.5 | 113.0 |
At the balance sheet date, the Group had outstanding commitments for future minimum lease payments under non-cancellable operating leases over certain of its office properties, which fall due as follows:
| 2012 £m |
2011 £m |
|
|---|---|---|
| Within one year | 2.8 | 4.5 |
| In the second to fifth years inclusive | 9.1 | 10.4 |
| Over five years | 7.5 | 10.1 |
The Group leases a number of premises. These are subject to review dates ranging from 2012 to 2023.
The Group makes share-based payments to senior executives under three schemes. These are the Performance Share Plan; Deferred Annual Share Bonus Scheme; and the Executive Share Option Scheme. The total credit in the year relating to the three schemes was £0.5 million (2011: charge £2.3 million).
The Group operates a share option scheme for senior executives. Options are exercisable at a price equal to the average quoted market price of the Company's shares on the dealing day before the option is granted. Options are forfeited if the employee leaves the Group for any reason outside of the scheme rules. Options under the scheme are exercisable in a period beginning no earlier than three years from the date of grant and are subject to performance conditions.
Equity settled share-based payments are measured at fair value at the date of grant. The fair value determined at the date of grant is expensed on a straight-line basis over the vesting period, based on the Group's estimate of shares that will eventually vest.
Fair value is measured by use of a Black-Scholes model according to the relevant measures of performance. The model includes adjustments, based on management's best estimate, for the effects of exercise restrictions, behavioural considerations and expected dividend payments. The option life is derived by the models based on these assumptions and other assumptions identified below. The total expense included within operating profit in respect of the share option scheme was nil (2011: nil).
No options have been granted during the current or previous year under the Executive Share Option Scheme.
The movement in total outstanding options in respect of the Executive Share Option Scheme is provided below:
| Number of share options |
Weighted average exercise price £ |
|
|---|---|---|
| Outstanding at 1 June 2010 Exercised |
2,604,470 (868,756) |
1.4 1.4 |
| Outstanding at 31 May 2011 Exercisable at 31 May 2011 |
1,735,714 1,735,714 |
1.4 1.4 |
| Lapsed Exercised |
(26,837) (234,091) |
1.1 1.3 |
| Outstanding at 31 May 2012 Exercisable at 31 May 2012 |
1,474,786 1,474,786 |
1.5 1.5 |
| Price/share £ |
Weighted average exercise price £ |
|
| Range of prices: 31 May 2012 31 May 2011 |
0.7–1.7 0.7–1.7 |
1.5 1.4 |
| Number of share options |
Weighted average contract term (years) |
|
| Weighted average contractual remaining life: 31 May 2012 31 May 2011 |
1,474,786 1,735,714 |
4.0 5.0 |
There were no options outstanding at 31 May 2012 or 31 May 2011 that are outside of the scope of IFRS 2 'Share-based payments'.
The Group operates a Performance Share Plan (PSP) for main Board Executive Directors and certain key senior executives. The extent to which such rights vest will depend upon the Group's performance over the three year period following the award date. The Group's performance is measured by reference to the growth of adjusted earnings per share over the retail price index over a single three year period. The fair value of the award is taken as the share price at the date of grant.
On 21 July 2011, the Group made 1,038,070 awards under the PSP scheme (2011: 973,908). The number of shares exercised in the year was 1,399,482 at a market value of £4,719,665 based on the market price at the date of exercise. In addition the number of lapsed share options totalled 56,572. The number of awards outstanding but not yet exercisable is 3,029,109 at 31 May 2012 (2011: 3,447,093). The total credit included in operating profit in relation to these awards was £0.5 million (2011: expense £2.3 million). The credit relates to the movement in the cumulative charge for the awards in issue based on expected vesting.
| £m | |
|---|---|
| 2% of share capital of PZ Cussons Nigeria Plc | 8.6 |
| Acquisition of Fudge hair-care brand and related inventory | 26.3 |
| 34.9 |
Throughout the year to 31 May 2012, the Group has acquired additional share capital of its existing subsidiary PZ Cussons Nigeria Plc, increasing the Group's stake from 66.8% to 68.8%. The consideration for these additional shares was £8.6 million, resulting in the acquisition of a non-controlling interest of £3.1 million and an amount debited to the consolidated statement of changes in equity of £5.5 million.
The Fudge brand, intellectual property, inventory and certain other business assets were acquired from Sabre Corporation (Aus) Pty Ltd and Sabre Europe (UK) Ltd in an asset deal which completed on 24 January 2012. No legal entities were acquired. The consideration paid at completion was £26.0 million and was settled in cash. A further £0.3 million was paid after completion. No further consideration is due and there are no clauses for contingent consideration at a future date. Fudge brand sales have contributed revenue of £5.0 million and operating profit of £1.0 million to the Group's result in the four months since acquisition. Details of the acquisition are as follows:
| £m | |
|---|---|
| Total purchase consideration | 26.3 |
The provisional assets and liabilities recognised as a result of the acquisition are as follows:
| fair value £m |
|---|
| 24.6 |
| 2.1 |
| (0.4) |
| 26.3 |
| – |
| 26.3 |
Acquisition related costs of £1.1 million are included in the income statement and are treated as exceptional.
No fair value adjustments have been made in the current year in relation to the prior year acquisition of St Tropez Holdings Ltd. The fair values of assets and liabilities acquired, which were disclosed as provisional in the prior year financial statements, are now final.
Provisional
The following related party transactions were entered into by subsidiary companies during the year under the terms of a joint venture agreement with Glanbia Plc:
At 31 May 2012 the outstanding long-term loan balance receivable from Milk Ventures (UK) Ltd was £23.7 million (2011: £23.7 million). The Group received interest from Milk Ventures (UK) Ltd of £0.1 million (2011: £0.1 million).
The Group sourced and then sold fixed assets, power and raw materials to Nutricima Ltd to the value of £41.2 million (2011: £52.1 million). In addition the Group received distribution fee income of £5.0 million (2011: £4.3 million) from Nutricima Ltd. At 31 May 2012 the amount outstanding from Nutricima Ltd was £4.4 million (2011: £7.7 million). The amount outstanding from the Group at 31 May 2012 was nil (2011: £1.1 million).
During the year the Group advanced a short-term deposit to Nutricima Ltd. This is repayable on demand and interest is charged at market rates. As at 31 May 2012 the outstanding balance was £6.7 million (2011: £10.3 million).
All trading balances will be settled in cash.
There were no provisions for doubtful related party receivables at 31 May 2012 (2011: nil) and no charges to the income statement in respect of doubtful related party receivables (2011: nil).
The following related party transactions were entered into by subsidiary companies during the year under the terms of a joint venture agreement with Singapore based Wilmar International Ltd:
At 31 May 2012 the outstanding long-term loan balance receivable from PZ Wilmar Ltd was £18.0 million (2011: £1.2 million).
The Group sourced and then sold certain raw materials to PZ Wilmar Ltd to the value of £0.4 million (2011: £2.6 million ). At 31 May 2012 the amount outstanding from PZ Wilmar Ltd was £0.5 million (2011: £0.1 million). The amount outstanding from the Group at 31 May 2012 was £3.3 million (2011: nil).
All trading balances will be settled in cash.
There were no provisions for doubtful related party receivables at 31 May 2012 (2011: nil) and no charges to the income statement in respect of doubtful related party receivables (2011: nil).
Details of the Company's principal subsidiaries at 31 May 2012 are as follows:
| Company | Operation | Incorporated in: |
Parent Company's interest |
Proportion of voting interest |
|---|---|---|---|---|
| PZ Cussons Australia Pty Ltd | Manufacturing | Australia | †100% | †100% |
| PZ Cussons Middle East and South Asia FZE | Distribution | Dubai | †100% | †100% |
| Seven Scent Ltd | Manufacturing | England | †100% | †100% |
| PZ Cussons (Holdings) Ltd | Holding Company | England | *100% | *100% |
| PZ Cussons (International) Ltd | Provision of services to Group companies | England | *100% | *100% |
| PZ Cussons (UK) Ltd | Manufacturing | England | †100% | †100% |
| PZ Cussons Ghana Ltd | Manufacturing | Ghana | †90% | †90% |
| Minerva SA | Manufacturing | Greece | *100% | *100% |
| PT PZ Cussons Indonesia | Manufacturing | Indonesia | †100% | †100% |
| PZ Cussons East Africa Ltd | Manufacturing | Kenya | †100% | †100% |
| HPZ Ltd¹ | Manufacturing | Nigeria | †52% | †52% |
| PZ Cussons Nigeria Plc | Manufacturing | Nigeria | †69% | †69% |
| Harefield Industrial Nigeria Ltd | Distribution | Nigeria | †100% | †100% |
| PZ Power Company Ltd | Power generation | Nigeria | †69% | †69% |
| PZ Tower Ltd | Manufacturing | Nigeria | †69% | †69% |
| PZ Cussons Polska SA | Manufacturing | Poland | †99% | †99% |
| PZ Cussons (Thailand) Ltd | Manufacturing | Thailand | †100% | †100% |
During the year PZ Cussons Beauty LLP was formed of which PZ Cussons (Holdings) Ltd has a 100% interest as the Corporate member. PZ Cussons Beauty LLP brings together the Charles Worthington, Sanctuary and St Tropez businesses and as such its principal operations are the marketing and distribution of beauty products. PZ Cussons Beauty LLP has a 100% interest in St Tropez Inc., a US beauty product distribution company.
| Operation | Incorporated in: |
Parent Company's interest |
|---|---|---|
| Holding Company | England | †50% |
| Manufacturing | Nigeria | †50% |
| Manufacturing | Nigeria | †51% |
| Manufacturing | Nigeria | †49% |
| Norpalm Ghana Ltd | Manufacturing | Ghana | †31% |
|---|---|---|---|
| Other investments | Operation | in: | interest |
| Incorporated | Company's | ||
| Parent |
¹ HPZ Ltd is 74.99% owned by PZ Cussons Nigeria Plc and is therefore consolidated.
* Shares held by the Parent Company.
† Shares held by a subsidiary.
| Year to 31 May | 2012 £m |
2011 £m |
2010 £m |
2009 £m |
2008 £m |
|---|---|---|---|---|---|
| Operating profit before exceptional items Net finance (expense)/income |
93.4 (1.1) |
108.1 0.8 |
101.4 0.4 |
90.6 (1.8) |
76.4 0.1 |
| Profit before taxation and exceptional items Exceptional items |
92.3 (43.8) |
108.9 (0.8) |
101.8 – |
88.8 (4.4) |
76.5 – |
| Profit before taxation Taxation |
48.5 (10.5) |
108.1 (28.2) |
101.8 (29.1) |
84.4 (24.0) |
76.5 (21.2) |
| Profit for the year | 38.0 | 79.9 | 72.7 | 60.4 | 55.3 |
| Attributable to: Equity holders of the parent Non-controlling interests |
34.4 3.6 |
70.4 9.5 |
63.7 9.0 |
49.6 10.8 |
47.0 8.3 |
| Net assets attributable to equity owners of the Company | 458.3 | 474.0 | 454.8 | 389.9 | 348.7 |
| Nets (debt)/funds | (17.9) | 51.8 | 86.5 | 23.2 | (32.0) |
| Per Ordinary Share: Basic earnings Adjusted basic earnings Dividend (interim and final declared post year-end) Times cover – after exceptional items Times cover – before exceptional items Net assets |
8.03p 14.74p 6.717p 1.2 2.2 106.90p |
16.48p 16.20p 6.61p 2.5 2.5 110.56p |
14.89p 14.89p 5.90p 2.5 2.5 106.08p |
11.64p 12.39p 5.27p 2.2 2.4 90.94p |
11.04p 10.78p 4.70p 2.3 2.3 81.33p |
We have audited the Parent Company financial statements of PZ Cussons Plc for the year ended 31 May 2012 which comprise the Company Balance Sheet and the related notes. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
As explained more fully in the Statement of Directors' responsibilities set out on page 49, the Directors are responsible for the preparation of the Parent Company financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express an opinion on the Parent Company financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's Ethical Standards for Auditors.
This report, including the opinions, has been prepared for and only for the Company's members as a body in accordance with Chapter 3 of Part 16 of the Companies Act 2006 and for no other purpose. We do not, in giving these opinions, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.
An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or error. This includes an assessment of: whether the accounting policies are appropriate to the Parent Company's circumstances and have been consistently applied and adequately disclosed; the reasonableness of significant accounting estimates made by the Directors; and the overall presentation of the financial statements. In addition, we read all the financial and non-financial information in the Annual Report and Accounts to identify material inconsistencies with the audited financial statements. If we become aware of any apparent material misstatements or inconsistencies we consider the implications for our report.
In our opinion the Parent Company financial statements:
In our opinion:
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
We have reported separately on the Group financial statements of PZ Cussons Plc for the year ended 31 May 2012.
for and on behalf of PricewaterhouseCoopers LLP Chartered Accountants and Statutory Auditors Manchester 24 July 2012
| Notes | 2012 £m |
2011 £m |
|
|---|---|---|---|
| Fixed assets | |||
| Investments: | |||
| Subsidiary companies | 4 | 123.4 | 123.4 |
| 123.4 | 123.4 | ||
| Current assets | |||
| Debtors falling due within one year | 5 | 131.2 | 106.2 |
| Investments | 6 | 0.3 | 0.3 |
| 131.5 | 106.5 | ||
| Creditors – amounts falling due within one year | 7 | (218.8) | (178.7) |
| Net current liabilities | (87.3) | (72.2) | |
| Total assets less current liabilities | 36.1 | 51.2 | |
| Creditors – amounts falling due after one year | 7 | (6.2) | (21.2) |
| Net assets | 29.9 | 30.0 | |
| Capital and reserves | |||
| Equity ordinary share capital | 8 | 4.3 | 4.3 |
| Capital redemption reserve | 9 | 0.7 | 0.7 |
| Profit and loss account | 9 | 24.9 | 25.0 |
| Total shareholders' funds | 29.9 | 30.0 |
Approved by the Board of Directors and signed on its behalf by:
24 July 2012
R Harvey G A Kanellis
PZ Cussons PLC Registered number 19457
The principal accounting policies applied under UK GAAP are detailed below. They have all been applied consistently throughout the year and the preceding year.
The accounts have been prepared in accordance with the Companies Act 2006 and United Kingdom Generally Accepted Accounting Practice (UK GAAP), under the historical cost convention. As permitted by section 408 of the Companies Act 2006, an entity profit and loss account is not included as part of the published consolidated financial statements of PZ Cussons Plc. The profit for the financial year dealt with in the accounts of the Parent Company is £31.7 million (2011: £21.6 million).
No cash flow statement has been included as the cash flows of the Company are included in the consolidated financial statements of PZ Cussons Plc which are publicly available. The consolidated financial statements of PZ Cussons Plc have been prepared in accordance with International Financial Reporting Standards.
Amounts paid to the Company's auditors in respect of the statutory audit were £6,000 (2011: £6,000).
Assets and liabilities are translated at exchange rates prevailing at the date of the Company balance sheet. Exchange gains or losses are recognised in the profit and loss account.
Current tax including UK corporation tax is provided at amounts expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred taxation is provided in full on timing differences that result in an obligation at the balance sheet date to pay more tax, or a right to pay less tax, at a future date, at rates expected to apply when they crystallise based on current tax rates and law. Timing differences arise from the inclusion of items of income and expenditure in taxation computations in periods different from those in which they are included in financial statements. Deferred tax is not provided on timing differences arising from the revaluation of fixed assets where there is no binding contract to dispose of these assets, nor on unremitted earnings where there is no binding commitment to remit these earnings. Deferred tax assets are recognised to the extent that it is regarded as more likely than not that they will be recovered. Deferred tax assets and liabilities are not discounted.
Borrowing costs are not capitalised; they are recognised in profit or loss in the period in which they are incurred.
Financial assets and financial liabilities are recognised on the Company's balance sheet when the Company becomes a party to the contractual provisions of the instrument.
Interest-bearing bank loans and overdrafts are recorded at the proceeds received, net of direct issue costs. Finance charges, including premiums payable on settlement or redemption and direct issue costs, are accounted for on an accruals basis through the profit and loss account using the effective interest method and are added to the carrying amount of the instrument to the extent they are not settled in the period in which they arise. The Company has not entered into any transactions involving derivative instruments.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Investments (other than interests in joint ventures) are recognised and derecognised on a trade date when a purchase or sale of an investment is under a contract whose terms require delivery of the investment within the timeframe established by the market concerned, and are initially measured at cost, including transaction costs.
Transactions of the Company-sponsored ESOT are treated as being those of the Company and are therefore reflected in the Company's financial statements. In particular, the trust's purchases and sales of shares in the Company are debited and credited directly to equity.
Dividend distribution to the Company's shareholders is recognised as a liability in the Company's financial statements in the period in which the dividends are approved by the Company's shareholders. In respect of interim dividends these are recognised once paid.
continued
Investments in subsidiaries are held at cost, less any provision for impairment. Where equity settled share-based payments are granted to the employees of subsidiary companies, the fair value of the award is treated as a capital contribution by the Company and the investment in subsidiaries are adjusted to reflect this capital contribution.
None of the above accounting policies are considered to be critical to the financial statements of the Company. There are no significant areas of estimation uncertainty.
The Company has not adopted any new United Kingdom Financial Reporting Standards in the year and there are none in issue but not yet effective that are expected to have an impact on the Company.
| 2012 £m |
2011 £m |
|
|---|---|---|
| Aggregate amount of Directors' emoluments | 2.8 | 4.3 |
| Emoluments of the highest paid Director | 0.6 | 0.7 |
For the year ended 31 May 2012 the highest paid Director received Company pension contributions of £95,000 (2011: £90,000).
| 2012 £m |
2011 £m |
|
|---|---|---|
| Amounts recognised as distributions to Ordinary Shareholders in the year comprise: | ||
| Final dividend for the year ended 31 May 2011 of 4.487p (2010: 3.970p) per Ordinary Share | 19.2 | 17.0 |
| Interim dividend for the year ended 31 May 2012 of 2.23p (2011: 2.123p) per Ordinary Share | 9.6 | 9.0 |
| 28.8 | 26.0 | |
| Proposed final dividend for the year ended 31 May 2012 of 4.487p (2011: 4.487p) per Ordinary Share | 19.2 | 19.2 |
The proposed final dividends for the years ended 31 May 2011 and 31 May 2012 were subject to approval by shareholders at the Annual General Meeting and hence have not been included as liabilities in the financial statements at 31 May 2011 and 31 May 2012 respectively.
At 31 May 2012, the Employee Share Option Trust held 334,856 Ordinary Shares (2011: 1,334,578 Ordinary Shares). The trust waived any entitlement to the dividends on these shares.
| Shares £m |
Loans £m |
Total £m |
|
|---|---|---|---|
| Cost at 1 June 2011 and 31 May 2012 | 125.0 | 3.0 | 128.0 |
| Provisions at 1 June 2011 and 31 May 2012 | (4.6) | – | (4.6) |
| Net book value at 31 May 2012 | 120.4 | 3.0 | 123.4 |
| Net book value at 1 June 2011 | 120.4 | 3.0 | 123.4 |
Details of the Company's direct subsidiaries at 31 May 2012 are as follows:
| Subsidiary companies | Operation | Incorporated in: |
Parent Company's interest |
Proportion of voting interest |
|---|---|---|---|---|
| Charles Worthington Hair & Beauty Ltd | Holding Company | England | 100% | 100% |
| PZ Cussons (Holdings) Ltd | Holding Company | England | 100% | 100% |
| PZ Cussons (International) Ltd | Provision of services to Group companies | England | 100% | 100% |
| Minerva SA | Manufacturing | Greece | 100% | 100% |
| 2012 £m |
2011 £m |
|
|---|---|---|
| Amounts owed by Group companies | 130.7 | 104.2 |
| United Kingdom corporation taxation recoverable | – | 1.4 |
| Overseas taxation recoverable | – | 0.1 |
| Deferred taxation | 0.5 | 0.5 |
| 131.2 | 106.2 |
£19.7 million (2011: £34.7 million) of amounts owed by Group companies are interest bearing and are based on market rates of interest. £111.0 million (2011: £69.5 million) of amounts owed by Group companies are non-interest bearing. All of the balances are unsecured, have no fixed date of repayment and are repayable on demand.
| 2012 £m |
2011 £m |
|
|---|---|---|
| Unlisted | 0.3 | 0.3 |
| 7. Creditors | ||
| 2012 £m |
2011 £m |
|
| Due within one year | ||
| Bank loan | 89.4 | 62.0 |
| Amounts owed to Group companies | 123.7 | 111.9 |
| United Kingdom corporation taxation payable | 5.6 | 4.5 |
| Overseas corporation taxation payable | – | 0.1 |
| Accruals and deferred income | 0.1 | 0.2 |
| 218.8 | 178.7 | |
| 2012 | 2011 | |
| £m | £m | |
| Due after one year | ||
| Bank loan | – | 15.0 |
| Amounts owed to Group companies | 6.2 | 6.2 |
| 6.2 | 21.2 |
Amounts owed to Group companies are unsecured, non-interest bearing, have no fixed date of repayment and are repayable on demand.
At 31 May 2012, the Company had undrawn overdraft facilities of £10.0 million (2011: £30.0 million) available to it and committed facilities of £45.0 million (2011: £61.0 million).
The Company is exposed to financial risks arising from changes in interest rates. Other financial risks are not considered significant.
Financial instruments utilised by the Company during the years ended 31 May 2012 and 31 May 2011, together with information regarding the methods and assumptions used to calculate fair values, can be summarised as follows:
In accordance with FRS 25 'Financial instruments: recognition and measurement', unlisted investments are held in the Company's balance sheet at cost because their fair value cannot be measured reliably due to the lack of quoted market prices.
Financial instruments included within current assets and liabilities (excluding cash and borrowings) are generally short-term in nature and accordingly their fair values approximate to their book values.
The carrying values of cash and short-term borrowings and current asset investments approximate to their fair values because of the short-term maturity of these instruments.
The financial instruments held by the Company do not, either individually or as a class, create a potentially significant exposure to market, credit, liquidity or cash flow interest rate risk.
continued
| 2012 | 2011 | ||||||
|---|---|---|---|---|---|---|---|
| Number 000 |
Amount £m |
Number 000 |
Amount £m |
||||
| Authorised: | |||||||
| Ordinary Shares: | |||||||
| Ordinary Shares of 1p each | 570,000 | 5.7 | 570,000 | 5.7 | |||
| Total authorised share capital | 570,000 | 5.7 | 570,000 | 5.7 | |||
| Allotted, called up and fully paid: | |||||||
| Ordinary Shares: | |||||||
| Ordinary Shares of 1p each | 428,725 | 4.3 | 428,725 | 4.3 | |||
| Total called up share capital | 428,725 | 4.3 | 428,725 | 4.3 |
| At 31 May 2012 | 4.3 | 0.7 | 24.9 | 29.9 |
|---|---|---|---|---|
| Dividends paid | – | – | (28.8) | (28.8) |
| Share-based payments | – | – | (0.2) | (0.2) |
| Acquisition of shares for ESOT | – | – | (2.8) | (2.8) |
| Profit for the financial year | – | – | 31.7 | 31.7 |
| At 1 June 2011 | 4.3 | 0.7 | 25.0 | 30.0 |
| £m | £m | £m | £m | |
| Called up share capital |
redemption reserve |
Profit and loss account |
Total | |
| Capital |
Included within retained earnings is the Employee Share Option Trust (ESOT).
The ESOT purchases shares to fund the Deferred Annual Share Bonus Scheme, the Executive Share Option Scheme and the Performance Share Plan, details of which are provided in the Report on Directors' Remuneration. At 31 May 2012, the trust held 334,856 (2011: 1,334,578) Ordinary Shares with a book value of £1.2 million (2011: £3.9 million). The market value of these shares as at 31 May 2012 was £1.1 million (2011: £4.9 million). During the year the ESOT purchased 854,383 shares of the Company at a cost of £2.8 million (2011: 780,650 at a cost of £2.3 million). The trust has waived any entitlement to dividends in respect of all the shares it holds.
The Company makes share-based payments to senior executives under a Performance Share Plan and until 31 May 2010 a Deferred Annual Share Bonus Scheme. The total credit in the year relating to the two schemes was £0.3 million (2011: £1.3 million charge).
The Company operates a Performance Share Plan (PSP) for main Board Executive Directors (excluding the Chairman) and certain key senior executives. The extent to which such rights vest will depend upon the Company's performance over the three year period following the award date. The Company's performance is measured by reference to the growth of adjusted earnings per share over a single three year period. The fair value of the award is taken as the share price at the date of grant.
On 21 July 2011, the Group made 1,038,070 awards under the PSP scheme (2011: 973,908). The number of shares exercised in the year was 1,399,482 at a market value of £4,719,665 based on the market price at the date of exercise. In addition the number of lapsed share options totalled 56,572. The number of awards outstanding but not yet exercisable is 3,029,109 at 31 May 2012 (2011: 3,447,093). The total credit included in operating profit in relation to these awards was £0.3 million (2011: expense £1.3 million). The credit relates to the movement in the cumulative charge for the awards in issue based on expected vesting.
The Company is a guarantor to a borrowing facility relating to loans provided to certain Group UK entities. The amount borrowed under this agreement at 31 May 2012 was £82.0 million (2011: £40.0 million).
In addition the Company is party to cross guarantee arrangements relating to an overdraft facility for certain Group companies' accounts at Barclays Bank Plc. The maximum exposure at 31 May 2012 was £10.0 million (2011: £10.0 million).
PZ Cussons aims to maintain a safe workplace at all locations in which it operates. We continue to ensure that our business activities are undertaken in a responsible manner and in accordance with the relevant statutory legislation and that employees at all levels participate in the development, promotion and maintenance of a safe and healthy working environment for employees, visitors and the public. The Company employs health and safety specialists and, where appropriate, provides on-site medical facilities for employees.
The Company continues to monitor and increase standards of health and safety at work through risk assessment, safety audits, formal incident investigation and training. Our investment in plant and equipment enables us to modernise designs and operate safer and more efficient processes.
As an international group, and particularly bearing in mind our operations in developing countries, we focus resource on the employment and development of local staff with the intention of assisting both our operations in those countries and the local community. Employees are involved at all levels of decision-making throughout the Group with effective communication via regular consultation groups and briefings. Training is vital to ensuring continuous improvements in performance and over the past year employees of all grades have received training through a wide range of courses.
The employment policies of the Group embody the principles of equal opportunity, training and development and rewards appropriate to local markets which are tailored to meet the needs of its businesses and the areas in which they operate. This includes procedures to support the Group's policy that disabled persons shall be considered for appropriate employment and subsequent training and career development. The Company continues to share valuable experience and best practice within the Group through employee secondment.
We support a range of charitable causes, both in the UK and overseas, mainly through a UK based shareholding trust and additional contributions are made through staff time and gifts in kind. PZ Cussons continues to provide assistance and donations to significant global fund-raising initiatives and recognises its responsibility to the communities in which it operates. We are committed to establishing and maintaining strong relationships with community groups, particularly in developing markets.
PricewaterhouseCoopers LLP has signified its willingness to continue in office and a resolution for its appointment will be proposed at the forthcoming Annual General Meeting.
For the purposes of section 234 of the Companies Act 2006, the report of the Directors of PZ Cussons Plc for the year ended 31 May 2012 comprises this page and the information contained in the Report of the Directors on pages 34 to 36.
Manchester Business Park 3500 Aviator Way Manchester M22 5TG
Company registered number 19457
Computershare Investor Services Plc PO Box 82 The Pavilions Bridgwater Road Bristol BS99 7NH
S P Plant
PZ Cussons Plc
Manchester Business Park 3500 Aviator Way Manchester M22 5TG 0161 435 1000
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.